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GENERAL INTRODUCTION 
 
In the recent decades, our world has been facing a series of communicable diseases 
threats such as avian influenza, SARS, MERS-CoV, Ebola, Zika… Beside of the that, the 
re-emergence of other communicable diseases still remains major burden for human. Hand, 
foot and mouth disease (HFMD) is the ones that reported for long time ago. This disease is 
an acute febrile illness in children with a papulovesicular skin rash at the palms or soles of 
the feet, or both. Presentation can be with or without inclusion of mouth ulcers. HFMD can 
result in severe complications such as encephalitis, aseptic meningitis, pulmonary edema, 
myocarditis, and death (1). HFMD is caused by types of Enterovirus A species which 
includes some Coxsackievirus A (CV-A) and Enterovirus A71 (EV-A71) (2), (3). The 
transmission can be faecal-oral and respiratory secretions route by direct person-to-person 
contact, droplets or fomites. Recent, the widespread community outbreaks of HFMD have 
occurred mostly in Asia Pacific region with notable amount of cases and deaths. The 
disease still has neither no specific treatment or vaccines so far. 
 
It was thought that the disease attacks mostly in the poor hygiene areas because of 
transmission mode. However, HFMD has been hitting both developing and developed 
countries since reported. In 1969, in California, USA, EV-A71 strain firstly was isolated 
from a 9 months aged child with encephalitis diagnostic (1). There are then small and large 
outbreaks of HFMD have been reported throughout the world (2). In the early 1970s, 
several countries in different continent including Sweden, Australia, USA and Japan had 
reported small HFMD outbreaks with some tens of cases and almost of them are children 
whose clinical aspects are mostly typical of HFMD, sometimes aseptic meningitis (3), (4), 
(5), (6). After that, HFMD was only reported in Europe in late half of the 1970s with two 
large outbreaks in Bulgaria (year 1975, 451 cases and 44 deaths), Hungary (year 1978, 
1550 cases and 47 deaths) and a small number of cases in France in 1979 (7), (8), (9). The 
1980s there are also some small outbreaks in Hong Kong, Australia, USA (10), (11), (12) 
and no reported cases from other countries 
 
In the late 1990s, many country members of Asia Pacific region have experienced 
large HFMD outbreaks. It began in 1997 with two large widespread community outbreaks 
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in Sarawak, Malaysia and Taiwan, with 2628 and 129,106 cases reported, respectively 
(13), (14). Following that, a series of small and large outbreaks happen throughout the 
region in which Japan, Australia, China, Malaysia, Singapore, Taiwan (China), Korea, 
Mongolia, Vietnam, Brunei has been the hotpots of epidemic with cycle of every 2–3 years 
period (15), (16), (17). So far, the latest large outbreak in the region was in one province 
named Anhui of China in 2008 with around 490,000 cases and 126 deaths in children were 
reported, the case-fatality rate is around 0.03% but in certain local outbreaks, such as in 
Fuyang City of Anhui Province, this rate can reach up to 0.3% (18), (19). During those 
outbreaks, almost of the cases are under 5 years old children and although clinical 
manifestations were mostly typical of HFMD, a cluster of deaths among young children 
was identified. Moreover, cases involving the central nervous system complication and/ or 
pulmonary oedema have also been observed for the first time (20), (21). There were 
several small outbreaks or sporadic HFMD cases outside the Asia-Paciﬁc region.  
  
Vietnam is located in South Eastern Asia and shares the border with China, Laos, 
and Cambodia. The climate is tropical in south; monsoonal in north with 4 seasons are 
spring, summer, autumn and winter. Although EV-A71 was isolated for the first time in 
Vietnam in 2003, the first outbreak of HFMD was not reported in the southern provinces 
until 2005. The 2005 outbreak was associated with EV-A71 C1, C4 and C5 subgenogroups 
and CV-A16 (22), (23). For the southern part of the country, in the periods of 2007 - 2009, 
the numbers of reported cases and deaths were 5,719 and 23; 10,958 and 25, and 10,632 
and 23, respectively. In contrast, there were a few sporadic HFMD cases in the northern. In 
2005 - 2007 periods, seven cases were identified. In 2008, 88 cases were reported from 
13/28 provinces. No severe or fatal cases were reported. Since 2011, Vietnam have 
experienced continuously large outbreaks of HFMD and the disease became a notifiable 
one in the national communicable disease surveillance system. According to data of Viet 
Nam Ministry of Health (MoH) from 2011 to 2015, number of reported cases and deaths 
were 113,121 and 170 (2011), 157,391 and 45 (2012), 78,818 and 23 (2013), 77,296 and 9 
(2014), 56,329 and 5 (2015), respectively which have been reported from across all 63/63 
provinces. HFMD outbreaks have continuously occurred nationwide. Responding to 
HFMD outbreaks, MoH issued two specific guidelines applied nationwide. The first one 
published on the February 24, 2012 concerned surveillance, prevention and control of 
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HFMD. The second guideline was issued on March 30, 2012 were about diagnosis and 
treatment. 
 
Indeed, in Viet Nam, HFMD is now important public health concern. Recent 
studies mainly observe for basic epidemiology and etiology characteristics (23), (24), (22), 
(25). Besides, the relationship between etiological agents and clinical epidemiological 
behavior, temporal and spatial analysis, pathogenicity-related mutations of virus, modeling 
approach for prediction,  evaluation of countermeasures has not been reported. In order to 
more comprehensive understanding which contribute to prevention and control of HFMD 
in Vietnam, This work analyzed all HFMD cases reported in Hai Phong city by both the 
community and hospitals in 2011 and 2012. Since it was the very first outbreak to occur in 
Hai Phong city, it was a good model for investigating the dynamic of the disease without 
interference and potential remains from previous outbreaks or patient immunological 
adaptation and it provide findings related to influence of HFMD guidelines during the 
outbreak period too. This work is also an integrative analysis including spatial analysis and 
social evolution as well as genetic evolution to describe the dynamic of HFMD in a well 
delimited area. We will also analyze the VP1 gene of strains isolated throughout Northern 
Vietnam during the 2011-2012 outbreak and develop the modeling the dynamic of a 
multiphase disease. This part of the study is coordinated with Montpellier University 2, 
Montpellier, France. 
 
The specific objective of the research aims: 
 
1.! To describe the epidemiological and etiological characteristics during 2011-2012 
outbreak in Hai Phong City, Vietnam.  
2.! To monitor influence of HFMD new guidelines on patients care during 2011-2012 
outbreak in Hai Phong City, Vietnam. 
3.! To spatial analyze the HFMD dynamic during 2011-2012 outbreak in Hai Phong City, 
Vietnam 
4.! To analyze pathogenicity-related mutations in the VP1 sequence of EV-A71 strains 
isolated throughout Northern Vietnam during the 2011-2012 outbreak. 
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5.! To better understand the monitor HFMD throughout modeling the HFMD dynamic 
during 2011-2012 outbreak in Hai Phong City, Vietnam. 
The outline will be displayed in form of chapters with results presented as a form of 
in press, submitted or in preparation articles. The articles included in this thesis are listed 
below: 
 
FIRST PART  
Nghia Ngu Duy, Tran Nhu Duong, Christian Devaux, Roger Frutos. Emergence of 
EV-A71 infection in Asia Pacific region. Asia Pacific Jounal of Tropical Medicine 
 
SECOND PART  
 
CHAPTER 1 
Nghia Ngu Duy, Le Thi Thanh Huong, Patrice Ravel, Le Thi Song Huong, Ankit 
Dwivedi, October Michael Sessions, Yan’An Hou, Robert Chua, Guilhem Kister, 
Aneta Afelt, Laurent Gavotte, Catherine Moulia, Christian Devaux, Duane J Gubler, 
Vu Dinh Thiem, Nguyen Thi Hien Thanh, Tran Nhu Duong, Nguyen Tran Hien, 
Emmanuel Cornillot, Roger Frutos. Monitoring influence of Hand, Foot and Mouth 
Disease new guidelines on patients care during 2011-2012 outbreak in Hai Phong 
City, Vietnam. Asian Pacific Journal of Public Health. 
 
CHAPTER 2 
Nghia Ngu Duy, Le Thi Thanh Huong, Patrice Ravel, Le Thi Song Huong, Ankit 
Dwivedi, October Michael Sessions, Yan’An Hou, Robert Chua, Guilhem Kister, 
Aneta Afelt, Catherine Moulia, Duane J Gubler, Vu Dinh Thiem, Nguyen Thi Hien 
Thanh, Christian Devaux, Tran Nhu Duong, Nguyen Tran Hien, Emmanuel 
Cornillot, Laurent Gavotte, Roger Frutos*.!Valine/isoleucine variants drive selective 
pressure in the VP1 sequence of EV-A71 enteroviruses. BMC Infectious Diseases  
 
CHAPTER 3 
Patrice Ravel, Nghia Ngu Duy, Aneta Afelt, Guilhem Kister, Le Thi Thanh Huong, 
Le Thi Song Huong, Ankit Dwivedi, October Michael Sessions, Yan’An Hou, Robert 
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Chua, Catherine Moulia, Duane J Gubler, Vu Dinh Thiem, Nguyen Thi Hien Thanh, 
Christian Devaux, Tran Nhu Duong, Nguyen Tran Hien, Laurent Gavotte, Emmanuel 
Cornillot, Roger Frutos.!Modelling the dynamic of a multiphase disease: the example 
of HFMD. In preparation. 
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TÓM TẮT 
Những thập kỷ gần đây, thế giới đang đối mặt với hàng loạt các bệnh truyền nhiễm 
mới nổi như cúm gia cầm, dịch SARS, MERS-CoV, Ebola, Zika…Bên cạnh đó, sự tái nổi 
trội của các bệnh truyền nhiễm khác cũng là gánh nặng bệnh tật rất lớn cho con người. 
Bệnh Tay chân miệng (TCM) là một trong số đó, TCM là bệnh sốt cấp tính, thường xảy ra 
ở trẻ em với biểu hiện chủ yếu là các ban dạng phỏng nước, thường xuất hiện ở gan bàn 
chân, bàn tay, mông, đầu gối và niêm mạc miệng. Bệnh đa số ở thể nhẹ, có thể tự khỏi 
trong vòng 1 tuần. Tuy nhiên có một số trường hợp có biến chứng thần kinh có thể dẫn tới 
tử vong. Căn nguyên gây bệnh là vi rút đường ruột, trong đó quan trọng nhất là EV-A71 và 
CA-16. Bệnh lây qua đường tiêu hoá, tiếp xúc với bề mặt bị ô nhiễm. Hiện nay chưa có 
vắc xin và thuốc điều trị đặc hiệu. 
Bệnh TCM do EV-A71 lần đầu tiên ghi nhận tại California, Mỹ. Sau đó bệnh lưu 
hành và gây các vụ dịch nhỏ tại châu Mỹ, Châu Âu, Úc… Đến cuối những năm 1990s, 
TCM bùng phát và gây dịch lớn tại các quốc gia thuộc khu vực Châu á Thái bình dương, 
biến chứng thần kinh viêm thân não lần đầu tiên được ghi nhận. Tại Việt Nam, mặc dù EV-
A71 được ghi nhận từ 2003, nhưng từ năm 2011, hàng năm, bệnh TCM gây dịch trên phạm 
vi cả nước với số mắc và tử vong cao. Thực vậy, TCM hiện nay là mối quan tâm về y tế 
công cộng. Một số nghiên cứu gần đây mới chỉ tập trung vào các đặc điểm dịch tễ, căn 
nguyên cơ bản nhất. Bên cạnh đó các mối liên hệ giữa tác nhân gây bệnh và đặc điểm dịch 
tễ học lâm sàng; các phân tích về phân bố bệnh theo không gian, thời gian; các biến đổi 
của vi rút liên quan đến độc lực; mô hình hoá sự biến động của bệnh dịch; đánh giá các 
biện pháp can thiệp kiểm soát bệnh dịch… vẫn chưa được nghiên cứu đầy đủ. Để cung cấp 
các kiến thức, thông tin toàn diện hơn về bệnh TCM góp phần phòng chống bệnh dịch này 
hiệu quả hơn, Nghiên cứa này phân tích toàn bộ các ca bệnh TCM được báo cáo trong vụ 
dịch đầu tiên tại Hải Phòng năm 2011-2012 tại cả cộng đồng và bệnh viện. Vụ dịch lớn đầu 
tiên này là một thực địa rất tốt cho điều tra , nghiên cứu bệnh dịch này. Nghiên cứu này tập 
trung phân tích các đặc điểm dịch tễ học, tác nhân gây bệnh, tác động của những hướng 
dân kiểm soát bệnh dich, biến động bệnh theo không gia, thời gian; phân tích các bieens 
đổi về di truyền liên quan đến độc lực; mô hình sự biến động bệnh dịch… 
Một số khuyến cáo đối với lĩnh vực giám sát: Sự đa dạng về I/V variants là cách tốt 
để giám sát và xác định sự lưu hành của các chủng EV-A71; Chẩn đoán EV-A71 với bộ 
mồi MAS nên đuọc thực hiện một cách hệ thống từ sản phẩm của mồi SO. Cần chú ý tới 
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nhũng mẫu âm tính khi thực hiện giám sát do có thể mồi phát hiện không phù hợp. Bộ mồi 
AN89 nên được thiết kế lại để phát hiện EVs tốt hơn. Đối với kiểm soát bệnh: Tiếp tục áp 
dụng các hướng dẫn giám sát và kiểm soát của Bộ Y tế. Các biện pháp can thiệp nên tập 
trung vào nhóm nguy cơ cao (trẻ < 5 tuổi) và gia đình, người chăm sóc trẻ ở cả khu vực đô 
thị và nông thôn. Giai đoạn ưu tiên can thiệp là tháng 3 – 5 và tháng 9-10 hàng năm. Quan 
tâm đặc biệt đến trẻ dưới 1 tuổi do có nguy cơ diễn biến nặng. Mô hình biến động nên 
được áp dụng để quản lsy tốt các đợt dịch trong tương lai. Đối với nghiên cứu: Phân tích 
toàn bộ gen của tác nhân gây bệnh để thấy rõ hơn mối liên hệ giữa các biến đổi di truyền 
và độc lực, nghiên cứu nguyên nhân bùng phát dịch nên tập trung them vào các yếu tố khác 
ngoài tác nhân gây bệnh. Sau cùng, nghiên cứu này đã đóng góp những kết quả cần thiết và 
quan trọng giúp phần phát triển các công cụ giám sát và kiểm soát bệnh TCM tốt hơn. 
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PART I. LITERATURE REVIEW 
 
 
1. Picornaviridae 
 
1.1. Classification 
 Picornaviruses are viruses which belonging to the family Picornaviridae. The name 
is derived from pico, meaning small, and RNA, referring to the ribonucleic acid genome, so 
"picornavirus" means small RNA virus (26). According to International committee on 
Taxonomy of Viruses (27), Picornaviruses are separated into 12 genera which consisting of 
Enterovirus, Cardiovirus, Aphthovirus, Hepatovirus, Parechovirus, Erbovirus, Kobuvirus, 
Teschovirus, Sapelovirus, Senecavirus, Tremovirus, Avihepatovirus. There are many 
important pathogens of humans in the family Picornaviridae (28), (Figure 1). 
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Figure 1: Phylogenetic tree based on the deduced amino-acid sequence of the 
structural P1 region of representatives of the different genera within Picornaviridae. 
Within the genera, types infecting humans among other species are shown in bold, 
(28). 
For the disease manifestation, Picornaviruses can cause diseases in both human and 
animal. They are grouped by genus based on their pathogenic properties and/or route of 
infection. For example, the enterovirus genus includes poliovirus and coxsackieviruses 
based upon the natural oral route of entry into the host and replication in gut tissue (29), 
(Table 1). 
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Genus Virus 
Principal Species 
Affected 
Disease 
Aphthovirus 
Foot-and-mouth disease 
viruses 
Equine rhinitis A virus 
Bovine rhinitis B virus 
Cattle, sheep, 
swine, ruminant 
species 
Horses, camelids 
Cattle 
Foot-and-mouth 
disease 
Systemic infection 
Mild respiratory 
Cardiovirus 
Encephalomyocarditis 
virus 
Theiler’s mouse 
encephalomyelitis virus 
Rodents, swine, 
elephants, primates, 
mammals in contact 
with rodents 
Mice 
Encephalomyelitis 
and myocarditis in 
swine and elephants; 
rarely in other species 
Murine poliomyelitis 
Enterovirus 
Human enteroviruses 
A, B, C, and D 
Human rhinoviruses A, 
B, and C 
Bovine enteroviruses 
Simian enteroviruses 
Porcine enterovirus B 
Humans 
 
Humans 
 
Cattle 
Primates 
Swine 
Aseptic meningitis, 
poliomyelitis, 
myocarditis 
Respiratory disease 
Vesicular disease 
Mild enteric and 
respiratory disease 
Usually asymptomatic 
Erbovirus Equine rhinitis B virus Horses Mild rhinitis 
Kobuvirus Bovine kobuvirus Cattle Possible enteritis 
Teschovirus 
Porcine teschovirus 1 
Porcine teschoviruses 
 
Swine 
Encephalomyelitis 
mild diarrhea, 
pericarditis 
Tremovirus 
 
Avian ncephalomyelitis 
virus 
Chickens Encephalomyelitis 
Avihepatovirus Duck hepatitis A virus Ducks Hepatitis 
Table 1: Importance of Piconaviruses of Humans and Animals (29) 
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However, Base upon serology aspect (neutralized antibody against to capsid 
antigens), the Picornaviruses are further subclassified on the basis of serotype. This can 
range from a single serotype in the case of hepatitis A virus (HAV), or, in the case of 
rhinovirus, to about 100 identified serotypes (26) (Table 2). 
Genus Species Serotypes 
Enterovirus 
Bovine enterovirus 2 types: bovine enterovirus 1-2 
Human enterovirus A 
21 types including some coxsackie A 
viruses and enteroviruses 
Human enterovirus B 
59 types: enteroviruses, coxsackie B, 
echoviruses, swine vesicular disease 
virus 
Human enterovirus C 
19 types including poliovirus 1-3, 
some coxsackie A viruses, 
enteroviruses 
Human enterovirus D 3 types: EV-68, EV-70, EV-94 
Porcine enterovirus B 2 types: porcine enterovirus 9-10 
Simian enterovirus A 1 type: simian enterovirus A1 
Human rhinovirus A 75 types 
Human rhinovirus B 25 types 
Human rhinovirus C 7+ types 
Cardiovirus 
Encephalomyocarditis virus 1 type: encephalomyocarditis virus.  
Theilovirus 
12 types: Theiler's murine 
encephalomyelitis virus, Vilyuisk 
human encephalomyelitis virus, Thera 
virus, Saffold virus 1-9 
Aphthovirus 
Foot-and-mouth disease 
virus 
7 types: O, A, C, Southern African 
Territories 1 - 3 and Asia 1 
Equine rhinitis A virus 1 type: equine rhinitis A virus 
Bovine rhinitis B virus 1 type: bovine rhinitis B virus 
Hepatovirus Hepatitis A virus 1 type: Hepatitis A virus 
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Parechovirus 
Human parechovirus 14 types: Human parechovirus 1-14 
Ljungan virus 4 types: Ljungan virus 1-4 
Erbovirus Equine rhinitis B virus 3 types: equine rhinitis B virus 1-3 
Kobuvirus 
Aichi virus 1 type: Aichi virus 
Bovine kobuvirus 1 type: bovine kobuvirus 
Teschovirus Porcine teschovirus 11 serotypes: porcine teschovirus   
Sapelovirus 
Porcine sapelovirus 1 type: porcine sapelovirus  
Simian sapelovirus 3 types: simian sapleovirus 1-3 
Avian sapelovirus 1 type: avian sapelovirus  
Senecavirus Seneca Valley virus 1 type: Seneca Valley virus  
Tremovirus 
Avian encephalomyelitis 
virus 
1 type: avian encephalomyelitis virus  
Avihepatovirus Duck hepatitis A virus 3 types: duck hepatitis A virus 1-3 
Table 2: Picornaviruses: Genera, Species and Serotypes 
 
1.2. Virion 
Picornaviruses have a simple structure with a small single-stranded RNA inside. 
The RNA is covered by a capsid, which is spherical shape with diameter of about 25–30 
nm (30), (Figure 2). 
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Figure 2: The picornavirus virion.VPg: virus protein, genome linked. Electron 
micrograph courtesy of J. Esposito (US-CDC) and Professor Frederick A. Murphy 
(University of Texas Medical Branch) (30). 
 
1.3 Capsid 
According to (30), There are 4 capsid proteins named VP1-VP4 which numbered 
from the largest to smallest one. 60 copies each of these four proteins create the virus 
capsid with icosahedral symmetry. Each of the proteins VP1–3 contains an eight-stranded 
β-barrel like many virus capsid proteins. For human rhinovirus 14, the N termini of VP1–3 
and all 60 VP4 molecules are completely internal while all the rest parts of VP1–3 are at 
the surface of the virion. Moreover, in many picornaviruses, there is an approximately 2 
nm deep groove as canyon around each of the 12 vertices of the icosahedron (Figure 3). 
The canyons which contain the virus attachment sites are lined by the C termini of VP1 
and VP3 molecules. Evolution of picornaviruses has generated a lot of variability in the 
capsid proteins, some of which is reﬂected in the existence of distinct serotypes such as 
poliovirus with 3 serotyps or rhinovirus with more than 100 serotypes.  
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Figure 3: The capsid of human rhinovirus 14. The canyons are visible in the 
reconstructed image, courtesy of J.Y. Sgro, University of Wisconsin – Madison (30). 
1.4. Genome structure and features 
All picornaviruses have a similar genomic organization that is conserved in some 
but varies in other regions (31) (32). According to (26), picornaviruses have a quite short 
genome which containing a single molecule of positive-sense RNA within the capsid. The 
length of the RNA genome ranges from 6500 to 9500 nucleotides for whole. The genome 
consists of one single open reading frame (ORF) preceded by a long 5’-UTR and followed 
by a much smaller 3’UTR and a genetically encoded poly-(A) tail (Figure 4).  
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Figure 4: Organization of a typical picornavirus RNA genome. (26) 
The 5’ end of the viral genome is covalently linked to the viral polypeptide VPg 
(virus protein, genome linked). The ORF which is divided into three consecutive regions, 
P1, P2 and P3 which translated into a single large polyprotein with approximately 2200 
amino acid residues size. It is subsequently cleaved by viral protease(s) into mature 
proteins and their intermediates. For details, the P1 region encodes for the structural 
(capsid-forming) proteins 1A–1C which also known as VP4, VP2, VP3, and VP1, 
respectively. VP4 may not be formed in every picornavirus. The P2 and P3 region encodes 
for the nonstructural replication proteins 2A–2C and 3A–3D, respectively, as well as 
cleavage intermediates. In some picornaviruses, two or three unrelated 2A proteins may be 
formed while in others, two or three paralogous copies of 3B (also known as VPg) are 
(predicted to be) produced. The L region encodes for a leader protein in viruses of ﬁve 
genera. The L and 2A proteins may not be homologous, thus performing lineage-speciﬁc 
functions in different picornaviruses (33), (28), (27), (Figure 5), (Table 3). 
 16 
 
 
Figure 5:  Genome structure and gene organization of members of the family 
Picornaviridae. Each of the 12 genera is represented, as are species where there is a 
significant difference within a genus (27). 
 
 
Genomic 
region 
Protein 
designation 
Genus Protein function 
L Leader 
Aphthovirus, 
Erbovirus 
Papain-like cysteine protease implicated in 
virus–host interaction 
L Leader Cardiovirus 
Involved in internal ribosome entry 
site-mediated translation of viral RNA 
L Leader Kobuvirus 
No protease activity; involved in both viral 
RNA replication and encapsidation 
P1 
VP2, VP3, 
VP1, VP4
All majority 
Major capsid proteins 
Small capsid protein implicated in virion 
uncoating that is present in viruses of most 
genera 
P2 2A Enterovirus 
Chymotrypsin-like cysteine protease 
releasing capsid precursor from the 
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nascent polypeptide; implicated in the 
control of RNA synthesis 
2A 
Cardiovirus 
Aphthovirus 
Parechovirus 
Senecavirus 
Erbovirus 
Teschovirus 
Small protein whose synthesis is 
accompanied by termination and 
reinitiation of translation to separate 2A 
and 2B proteins 
2A Hepatovirus Structural protein 
2A 
 
Parechovirus 
Tremovirus 
Putative acyltransferase implicated in 
virus–host interaction 
2B All 
Membrane–anchoring protein for the virus 
replication complex 
2C All 
Multifunctional protein with ATPase and 
predicted helicase activity implicated in 
capsid assembly, virion uncoating, and 
RNA synthesis 
P3 
3A 
Enterovirus and 
likely all 
Membrane–anchoring protein for the virus 
replication complex; inhibits ER to Golgi 
membrane and secretory trafﬁc 
3B, VPg All  
Protein primer for the initiation of 
RNA-synthesis 
3C All 
Chymotrypsin-like cysteine protease 
mediating most cleavages in polyprotein 
3D All RNA-dependent RNA polymerase 
3CD Enterovirus 
Responsible for processing capsid P1 
precursor and regulation of RNA synthesis 
through binding to two RNA cis signals 
Table 3: Major demonstrated and predicted functions of picornavirus proteins (28). 
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1.5. Replication 
 
Attachment 
The cell receptors for many picornaviruses have been characterized as the 
glycoprotein which is glycoprotein CD155 for poliovirus (30). It is the molecules with 
three immunoglobulin-like domains; the virus attachment site is located in the outermost 
domain. CD155 is found only in humans and some primate species. There are the major 
changes to capsid structure when virion binds to receptors which are the N termini of VP1 
move to the exterior capsid surface and VP4 move out from virus capsid (Figure 7). 
 
Entry 
There are two modes of genome entry into the host cell have been proposed for 
picornaviruses. The first one is directly transfer of the RNA from the virion into the 
cytoplasm at the plasma membrane, leaving the capsid at the cell surface and the other is 
endocytosis. The VPg is removed from the 5’end by a cell enzyme as the virus genome is 
free in the cytoplasm (Figure 7). 
 
Translation and post-translational modiﬁcations 
The 40S ribosomal subunit binds internally at the IRES of the RNA. After a single 
polyprotein is created it is ﬁrstly cut to yield P1, P2 and P3. P1 becomes myristylated at the 
N terminus before being cleaved to VP0, VP3 and VP1, the proteins that will form 
procapsids; VP0 will later be cleaved to produce VP2 and VP4. Other cleavage products 
include 3B (VPg), 2C (an ATPase) and 3D (the RNA polymerase) (Figure 6). 
 
Transcription/genome replication 
RNA synthesis occurs in replication complexes are associated with membranous 
vesicles that created in the cytoplasm of infected cells and also contain cell proteins, as 
well as virus proteins and RNA. Multiple copies of (−) RNA are transcribed from infecting 
(+) RNA and then used as templates for (+) RNA synthesis. The small VPg is primer for 
both strands synthesis. Many RNA in the replication complexes play a role as replicative 
intermediates (RIs). Indeed, some RIs consist of a (+) RNA associated with growing (−) 
RNAs, while other RIs consist of a (−) RNA associated with growing (+) RNAs. Also 
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associated with RIs are copies of the RNA polymerase. The poly (A) sequence at the 3’end 
of the plus strand is transcribed and synthesized from a poly (U) sequence at the 5’end of 
the minus strand (Figure 7).  
 
 
Figure 6: Poliovirus translation and post-translational modiﬁcations (30). 
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Assembly and exit
A procapsid is created by 12 pentamer which assembled from 5 copies each of 
VP0, VP3 and VP1. Each procapsid acquires a copy of the virus genome, with VPg still 
attached at the 5’end. Then the 60 copies of VP0 are cut into VP4 and VP2. The virions are 
released as cell lysis (Figure 7). 
 
 
Figure 7: The picornavirus replication cycle. Note that translation gets under way 
before transcription, and that transcription and genome replication involve a single 
process (synthesis of (+) RNA). myr: myristyl group. RI: replicative intermediate (30). 
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2. Enterovirus 
 
2.1. Classification 
According to International Committee on Taxonomy of Viruses (27), enteroviruses 
are classified into 10 species and based on their sequence homologies, each species 
contains numerous viruses that are pathogenic to humans and animals (Table 4).  
 
Species Subspecies 
Bovine enterovirus 
Bovine enterovirus 1   
Bovine enterovirus 2  
Human enterovirus A 
 
Coxsackievirus A2 [Fleetwood]  
Other types: CV-A3 to A8, CV-A10, CV-A12, CV-A14, 
CV-A16, EV-A71, EV-A76, EV-A89 to EV-A92, 
EV-A114, SV19, SV43, SV46, baboon enterovirus A13 
Human enterovirus B 
 
Coxsackievirus B1  
Other types: CV-B2 to CV-B6, CV-A9, EV-B1, EV-B2 to 
7, EV-B9, EV-B11 to 21, EV-B24 to 27, EV-B29 to 33, 
EV-B69, EV-B73 to EV-B74, EV-B75, EV-B77 to EV-B88, 
EV-B93, EV-B97 to 101, EV-B106 to 107, EV-B110, SA5 
Human enterovirus C 
 
Poliovirus 1 
Other types: PV-2, PV-3, CV-A1, CV-A11, CV-A13, 
CV-A17, CV-A19, CV-A20, CV-A21, CV-A22, CV-A24, 
EV-C95, EV-C96, EV-C99, EV-C102, EV-C104, EV-C105, 
EV-C109, EV-C113, EV-C116 
Human enterovirus D 
Enterovirus D68 
Other types: EV-D70, EV-D94, EV-D111 
Porcine enterovirus B 
Porcine enterovirus 9 
Porcine enterovirus 10 
Simian enterovirus A 
Simian enterovirus A1 
Other types: SV28, SA4 
Human rhinovirus A Human rhinovirus A1 
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 Other types: HRV-A2, HRV-A7, HRV-A8 to HRV-A13, 
HRV-A15, HRV-A16, HRV-A18 to HRV-A25, HRV-A28 
to HRV-A34, HRV-A36, HRV-A38 to HRV-A41, 
HRV-A43 to HRV-A47, HRV-A49 to HRV-A51, 
HRV-A53 to HRV-A68, HRV-A71, HRV-A73 to 
HRV-A78, HRV-A80 to HRV-A82, HRV-A85, HRV-A88 
to HRV-A90, HRV-A94 to HRV-A96, HRV-A98, 
HRV-A100 to HRV-A103 
Human rhinovirus B 
 
Human rhinovirus B3 [FEB]  
Other types: HRV-B4 to HRV-B6, HRV-B14, HRV-B17, 
HRV-B26, HRV-B27, HRV-B35, HRV-B37, HRV-B42, 
HRV-B48, HRV-B52, HRV-B69, HRV-B70, HRV-B72, 
HRV-B79, HRV-B83, HRV-B84, HRV-B86, HRV-B91 to 
HRV-B93, HRV-B97, HRV-B99 
Human rhinovirus C 
Human rhinovirus C1 [NAT001]  
Other types: HRV-C2 to HRV-C49 
 
Table 4: Enterovirus genus and species, abbreviated as follows: bovine enterovirus (BEV); 
coxsackievirus (CV); echovirus (E); enterovirus (EV); human rhinovirus (HRV); 
poliovirus (PV); porcine enterovirus (PEV); simian agent (SA); simian virus (SV); simian 
enterovirus (SEV) (27). 
 
2.2. Human Enteroviruses cause Hand, Foot and Mouth Disease 
 
Origin, gene groups, evolution, and geographical distribution of EV-A71 
Human enteroviruses have been classiﬁed into four species, HEV-A, HEV-B, 
HEV-C, and HEV-D. HFMD is caused by types of Enterovirus A species which includes 
some Coxsackievirus A (CV-A) and Enterovirus A71 (EV-A71) (34). The EV-A71 viruses 
are genetically related to CV-A; indeed, it has been suggested that these viruses may have 
diverged as recently as the 1920s. EV-A71 isolates are classified on the basis of VP1 gene 
into six independent genogroups: A, B, C, D, E and F. The EV-A71 B and C genogroups 
are each further subdivided into subgenogroups, B0 to B5 and C1 to C5 (Bessaud et al., 
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2014). CV-As are subdivided into serotypes CV-A2-8, CV-A10, CV-A12, CV-A14, CV-
A16. Both EV-A71 and CV-A infection has been associated with severe HFMD in young 
children, sometimes resulting in death. But EV-A71 strain frequently causes severe HFMD 
as neurological forms and death in large epidemics while mild disease with other serotypes 
(35), (36), (37). 
 
There is only one member in Group A, the prototype BrCr strain of EV-A71, which 
was ﬁrst isolated in California, USA, in 1969. So far, the secondly isolates were reported in 
a HFMD epidemic among children in Anhui province of central China (38). Surveillance 
for HFMD by the Chinese Center for Disease Control and Prevention which do not seem to 
indicate any group A viruses (19). 
 
Group B viruses were firstly separated into B1 and B2 subgenogroups with 12% 
divergence at the nucleotide level. These subgenogroups were the predominant circulating 
strains in the 1970s and 1980s. In details, B1 was circulating in USA, Europe, Japan and 
Australia in 1970s and B2 mainly were isolated in USA in the 1980s. After that 
subgenogroup B3 was emerged from 1997 in Sarawak, Malaysia in several large outbreaks 
of Asia Pacific region. These viruses were also found in Singapore (39), (40), (41). 
Subgenogroup B4 were circulating and associated with the large outbreaks through Asia 
Pacific region in the 1990s but were also sampled by 2000. In 2003, subgenogroup B5 
replaced subgenogroup B4 in Sarawak, Malaysia and circulate as the important viruses in 
Japan, Malaysia, Singapore and Taiwan (42), (43), (44), (15), (45), (Figure 6). 
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Figure 8: Genogroupe B of Enterovirus 71(EV-A71) 
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Group C viruses were initially separated into the C1 and C2 subgroups. 
Subgenogroup C1 viruses were first reported in USA and Australia in the 1970s, 1980s. 
From its initial detection, up to now these viruses have been identified continuously in 
many countries throughout Europe, Asia Pacific region. But they have not caused any large 
epidemics since the major community outbreak in Sydney in 1986 (46), (44). 
Subgenogroups C2, C4, and C5 is the novel subgenogroups which divers from genogroup 
C in the Asia Paciﬁc region in the late 1990s.  They cause fatal HFMD cases in Taiwan 
(14), China (47), and Vietnam (22), respectively. Subgenogroup C3 was isolated in Japan 
in 1994, and in Korea in 2000 (40), (48), (49). According to (45), subgenogroups C1, C2, 
and C4 globally distribute in many parts of the world while the C3 and C5 lineages are 
restricted to Korea and Vietnam, respectively (Figure 7). 
 
 
Figure 9: Genogroupe C of Enterovirus 71(EV-A71).
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Recombination and reservoir of EV-A71 
The recombination of EV-A71 has been observed most frequently in the 5’UTR 
and 3’UTR regions. This rarely happens in the structural protein gene region (50), (51), 
(52). So far, the effect of EV71 recombination on the virulence or transmissibility is 
unknown. But some studies observe the replacement of the 3’ half of the genome of a non-
recombinant EV-A71 field isolate with a EV-B species virus which improves growth in 
cell culture compared with a non-recombinant strain (53). Reservoir of EV-A71 is human 
and replication happens both in the intestinal tract and upper respiratory tract. The virion 
typically shed from 2 to 4 weeks and especially up to 12 weeks after infection. The 
transmission mode is through direct person-to-person contact, droplets or fomites by 
faecal-oral and respiratory secretions (54).  
 
3. Pathogenesis 
 
3.1. Virus entry and spread 
The main transmission mode of HFMD is via the faces-oral route. It can also get 
infection through contact with virus contaminated surfaces, secretions, fluid or fomites. 
The virus can spread by respiratory droplets as well (55). According to (56), the 
enteroviruses initially replicate in the lymphoid tissues of the oropharyngeal cavity 
(tonsils) and small bowel resulting a mild viraemia. Most infections are asymptomatic at 
this time. The viruses follow bloodstream to other organs as the reticuloendothelial system 
(liver, spleen, bone marrow, and lymph nodes), heart, lung, pancreas, skin, mucous 
membranes, and center nervous system (CNS) at the onset time of disease with given 
clinical symptom. For virus shedding, it is up to 2 weeks from throat or 11 weeks from 
intestine after an acute EV71 infection (57). 
 
3.2. Pathological findings 
Clinical manifestations for HFMD widely vary from asymptomatic, mild to 
neurologic cases. But CNS infection is the features most frequently seen of EV-A71 
infection (58). 
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For uncomplicated HFMD, regarding (59), the experiment on a mouse model 
shows the virus infect to skin which suggest the same results with human skin or oral 
mucosa lesions. But the information for skin or oral mucosa biopsies is still lacking.  
 
For neurologic case, there is no inflammatory in cerebella cortex, basal ganglia, 
thalamus, peripheral nerve or autonomic ganglia. In contrast, the grey matter of the spinal 
cord and the whole medulla oblongata is affected predominantly and the hypothalamus, 
subthalamic, dentate nuclei as well. The motor cortex is also influenced but lesser. 
However, virus, viral antigen or RNA in the brainstem has not been seen or very rare for 
some cases in neuronal processes and phagocytic cells (20), (60). 
 
For severe pulmonary oedema and cadiac dysfunction, It is supposed that explosive 
pulmonary oedema especially associated with neurogenic mechanisms secondary to 
brainstem inﬂammation, cardiac dysfunction, increased vascular permeability, and 
cytokine storm but its exact mechanism is still unclear and the pathogenesis is not 
completely understood (2), (Figure 8). In-vivo models, including those in mice and non-
human primates, have replicated some of the features of severe EV-A71 disease, such as 
neuroinvasion with inﬂammatory changes, but none has yet been able to reproduce the 
severe systemic features, such as pulmonary oedema (59), (61), (62). 
 
3.3. Virus virulence and host factors 
So far, there is still not clear evidence from genetic analysis on virus-virulence 
factor. But data from some HFMD outbreaks show that the difference of genogroup may 
contribute to virulence aspect.  Subgenogroup C2 from the epidemic in Taiwan (1998) was 
almost  exclusively isolated from children with severe neurological disease. In contrast, 
subgroup B3 from the epidemic in Sarawak, Malysia (1997) was isolated mainly from 
children with mild HFMD (41), (44). As well, to date, still lack of information about 
infective virus doses related to the illness severity. It should be investigated further. In 
EV71 infection with explosive pulmonary oedema, there is a storm of cytokines and 
chemokines in cerebrospinal fluid and serum such as interleukin IL-6, IL-1beta, IL-10, IL-
8, interferon induced protein (IP-10) and monokine induced by interferon gamma (MIG) 
(63), (64), (65). In contrast, number of T lymphocytes and NK cells reduce (66). 
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According to (67), HLA-A33, which is a common phenotype in Asian populations 
but is rare in white populations, was most significantly associated with EV-A71 infection 
and HLA-A2 was significantly related to cardiopulmonary failure. Receptors on the host 
target cell were identified as scavenger receptor B2 (68), and P-selectin glycoprotein 
ligand-1 (69), which expressed or limited to leukocytes, respectively.  
!
Figure 10: The postulated pathogenesis of enterovirus-71-associated acute pulmonary 
oedema (2). EV71=enterovirus 71. CNS=central nervous system. SVR=systemic 
vascular resistance. SBP=systemic blood pressure. HR=heart rate. LV=left ventricular. 
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Age and gender may play a role on susceptibility as a higher incidence of disease 
has been reported in male children. The relative immaturity of the innate and adaptive 
immune system in children aged between one and five years could contribute as well (70), 
(71), (25). 
 
3.4. Protective immunity  
According to (72), the cellular and humoral immune responses are both essential 
for decreasing the viral load and mortality in mice.  In details, by mouse model, the disease 
severity, mortality, and tissue viral loads of mice lack of B, CD4 T, or CD8 T cells were 
signiﬁcantly higher than those of wild-type mice after infection. Further, use a virus-
speciﬁc antibody as therapy before or after infection signiﬁcantly reduced the disease 
severity, mortality, and tissue viral loads of mice deﬁcient in B cells. On the other hand, 
cellular immunity in human plays an  important role of prevention of serious complications 
from HEV-71 infection (73), (74). Beside that there are some evidences of the protective 
immunity against infection by neutralizing antibodies from the humoral response (75), 
(76), (77). In humans, presence of maternal anti-EV-A71 antibodies has also been 
demonstrated in neonates, the prevalence and titer of which correlate with those levels in 
the mothers (78), (25). In mice, transplancental transfer of antibodies following maternal 
immunization against EV-A71 protects against lethal infection of newborn mice (79). 
Thus, it appears that the seroprevalence of neutralizing antibodies in women of 
childbearing age is important in protecting infants aged less than 6 months. 
 
4. Diagnosis  
 
4.1. Case definition and classification 
For outbreaks, there are several kinds of clinical manifestation. It could be HFMD 
or Herpangina (HA) which usually is self-limiting and benign illness. But there is also a 
small number of cases can develop to neurological and systemic complication that may 
lead to death (Figure 9). According to (80), Case definition and classification is defined as 
below.  
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HFMD is a brief febrile illness in children with skin rash which typically is 
papulovesicular at the palms or soles of the feet, or both. This can be with or without 
mouth ulcers. Normally in younger children and infants the rash may be maculopapular 
without vesicles, and may also involve the buttocks, knees or elbows. HA is also fever and 
typically with multiple, painful mouth ulcers at mainly the posterior oral cavity (the 
anterior pharyngeal folds, uvula, tonsils and soft palate). In some cases, the mouth ulcers 
also affect other parts of the mouth such as the buccal mucosa and tongue. 
 
For neurological and systemic complication, the enteroviruses, in general, can 
cause central nervous system complications as aseptic meningitis, acute ﬂaccid paralysis, 
encephalitis. In particular, brainstem encephalitis is typically by EV-A71 infection and is 
frequently together with severe cardiorespiratory symptoms that have been attributed to 
neurogenic pulmonary oedema (21), (2). This typically clinical syndrome starts normally 
after 3–5 days of fever by a sudden deterioration as shock and pulmonary oedema or 
haemorrhages resulting from an acute and rapidly progressing cardiorespiratory failure. 
Finally, the children will die before reaching hospital or in the first day of admission, 
despite intensive care support (13), (20). 
 
Fatal case firstly undergoes a short period of febrile illness with subtle neurological 
signs. Then dramatically suffer an acute refractory myocardial dysfunction and fulminant 
pulmonary oedema within hours of developing tachycardia, poor peripheral perfusion and 
tachypnea (80). 
 
 
Disease Proposed Case Definition 
HFMD 
Febrile illness with papulovesicular rash on palms and soles, with 
or without mounth vesicles/ulcers. Rash may be maculopapular 
without vesicular lesion, and may also involve the buttocks, knees 
or elbows, particularly in younger children and infants.  
Herpangina Febrile illness with multiple oral ulcers on the posterior parts of the 
oral cavity. 
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Aseptic meningitis 
Febrile illness with headache, vomiting and meningism associated 
with presence of more than 5 – 10 white cells per cubic millimeter 
in cerebrospinal (CSF) fluid, and negative results on CSF bacterial 
culture.  
Brainstem  
Encephalitis 
Myoclonus, ataxia, nystagmus, oculomotor palsies, and bulbar 
palsy in various combinations, with or without MRI. In resource-
limited settings, the diagnosis of brainstem encephalitis can be 
made in children with frequent myoclonic jerks and CSF 
pleocytosis. 
Encephalitis Impaired consciousness, including lethargy, drowsiness or coma, 
or seizures or myoclonus. 
Encephalomyelitis 
Acute onset of hyporeflexic flaccid muscle weakness with 
myoclonus, ataxia, nystagmus, oculomotor palsies and bulbar 
palsy in various combinations. 
Acute flaccid 
paralysis 
Acute onset of flaccid muscle weakness and lack of reflexes. 
ANS 
dysregulation 
Presence of cold sweating, mottled skin, tachycardia, tachypnea, 
and hypertension. 
Pulmonary 
oedema/ 
haemorrhage 
Respiratory distress with tachycardia, tachypnea, rales, and pink 
frothy secretion that develops  after ANS dysregulation, together 
with a chest radiograph that shows bilateral pulmonary infiltrates 
without cardiomegaly. 
Cardiorespiratory  
failure 
Cardiorespiratory failure is defined by the presence of tachycardia, 
respiratory distress, pulmonary oedema, poor peripheral perfusion 
requiring inotropes, pulmonary congestion on chest radiography 
and reduced cardiac contractility on echocardiography. 
Table 5: Proposed clinical case definitions for HFMD/HA and associated complications 
(80). 
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4.2. Laboratory diagnosis 
 
Clinical samples  
Throat swab, vesicle swab and stool, all can be used for virus detection. However, 
in the rate of detection point, throat and vesicle swab are considered to be the most useful 
specimens for both inpatients and outpatients. Especially, vesicle isolates always represent 
current systemic infection. It can also detect the virus from cerebrospinal fluid of central 
nervous system complication-patient, but the detection rate is very low (less than 5%). 
Serum sample from the patient is used in serological test as well (80) (81). The detection of 
the virus from the throat swabs was more frequent than from stool specimens; the time to 
positivity by viral culture was also shorter (82). In practice, it should be taken both kinds of 
sample as throat and vesicle swab or throat swab and stool in order to increase the 
possibility of virus detection. 
 
Virus isolation  
As usual for enterovirus isolation, some specimen pre-treatment such as complete 
mixing, filtration, chloroform treatment which needs to be implemented before inoculation. 
Two cell lines have been widely used for EV-A71 and CV-A16 virus detection are RD 
cells and Vero cells because of their relatively high sensitivity and the apparent cytopathic 
effect. For more, there are also some cell lines which are MRC-5, HEL, HeLa, L20B can 
be used as well (83). In addition, mouse cell lines are considered to give functional cellular 
receptors for enterovirus 71 which can be used for the selective isolation of EV-A71 or 
CV-A16 from clinical specimens (68), (69). Virus isolation and identification using 
suckling mice are still useful for some EV-A isolates, particularly for clinical samples from 
herpangina cases, but requires equipment, human resources and time (84).  
 
Identification of virus isolates 
Neutralization test recently gives confidence for virus identification. From virus  
isolation in cultured cells, conventional neutralization test which use a qualified type 
specific anti serum to identified the serotype of EV-A71 and CV-A16 virus, but these 
antisera are still not commercially available and it normally wait for a week to get the test 
result (80). 
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Reverse transcription - polymerase chain reaction (RT-PCR) and sequencing 
always has advantage of universal detection and  amplification of gene targets, with any 
serotypes and genotypes, even though it is newly emerged variants or new serotypes of 
enteroviruses (85), (86), (39). With virus  isolation from cultured cells, various gene targets 
which are 5’untranslated region, VP1 and VP4/VP2 genes have been widely used for 
molecular identification through by RT-PCR amplification of viral RNA and sequencing of 
the DNA amplicons (80). Indirect immunofluorescence assay (IFA) tests can provide 
quick, technically simple and reliable EV-A7 identification. It uses anti-EV-A71 
monoclonal antibodies that are commercially available (80). 
 
Rapid diagnosis directly from clinical samples  
Nested RT-PCR: According to (87), use consensus-degenerate hybrid 
oligonucleotide primer (CODEHOP) on the VP1 region has enabled partial VP1 
sequencing with a high sensitivity and broader specificity for all known enterovirus 
serotypes. Indeed, these viruses will be identified by VP1 sequences derived from the 
CODEHOP PCR products directly from clinical samples. It makes the advantage of 
quicker identification than virus culture. EV-A71-specific primers can be revised based on 
the sequences of newly emerging EV-A71 genogroups and variants for ensuring reliability 
of the test (88), (89). Multiplex RT-PCR methods are already developed for combined EV-
A71and CV-A16 identification (90) and for the specific detection of EV-A71and CV-A16 
(91). 
 
Real-time PCR can reduce the risk of cross-contamination when compared with 
conventional RT-PCR, particularly nested PCR systems. The reliability of recently EV-
A71-specific real-time RT-PCR systems needs to be addressed by using different 
genogroups of EV-A71, CV-A16, EV-A strains, and clinical samples. In general, EV-A71-
specific primers can be revised based on the sequences of newly emerging EV-A71 
genogroups and variants for ensuring reliability of the test (80). 
 
Molecular epidemiological analysis (genotyping) of EV-A71 strains 
Determination of geographic and evolutional origin of a virus is normally today by 
genotyping technique (the molecular characterization genomes). For EV-A71 trains, based 
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upon a capsid VP1 sequence database, it can develop a quick way to tracking the regional 
transmission and current prevalence of EV-A71strains by comparing the extent of genetic 
changes that are observed between strains. For detailed molecular epidemiological analysis 
of EV-A71 strains, the entire VP1 sequence should be determined and analyzed, beside 
partial VP1 sequencing would be enough to genotype each EV71isolate (80). 
 
Serological analysis 
Testing for neutralizing antibodies against enteroviruses is not recommended for 
routine use in the diagnosis of enterovirus infections because of interpretation of serum 
antibody titers is sometimes difficult. In contrast, this test is useful for evaluating of 
immunity levels for EV-A71 infection within communities (54), also for monitoring the 
cross-reactivity of serum among different genogroups of EV71 (92) Serum samples from 
inpatients could be useful for the rapid immunoglobulin M (IgM) detection of EV71 (93), 
but the specificity and sensitivity of serological tests for EV-A71 infection remains 
difficulties in evaluation. 
 
5. Epidemiology of Hand, Foot and Mouth Disease 
 
5.1. History and epidemiological features of HFMD 
In 1969, in California, USA, EV-A71 strain firstly was isolated from a 9 months 
aged child with encephalitis diagnostic (1). There are then small and large outbreaks of 
HFMD have been reported throughout the world (2), (Figure 10).  
 
In the early 1970s, several countries in different continent including Sweden, 
Australia, USA and Japan had reported small HFMD outbreaks with some tens of cases 
and almost of them are children whose clinical aspects are mostly typical of HFMD, 
sometimes aseptic meningitis (3), (4), (5), (6). After that, HFMD was only reported in 
Europe in late half of the 1970s with two large outbreaks in Bulgaria (year 1975, 451 cases 
and 44 deaths), Hungary (year 1978, 1550 cases and 47 deaths) and a small number of 
cases in France in 1979 (7), (8), (9). 
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The 1980s there are also some small outbreaks in Hong Kong, Australia, USA (10), 
(11), (12) and no reported cases from other countries. 
 
In the late 1990s, many country members of the Asia Pacific region have 
experienced large HFMD outbreaks. It began in 1997 with two large widespread 
community outbreaks in Sarawak, Malaysia and Taiwan, with 2628 and 129,106 cases 
reported, respectively (13), (14). Following that, a series of small and large outbreaks 
happen throughout the region in which Japan, Australia, China, Malaysia, Singapore, 
Taiwan (China), Korea, Mongolia, Vietnam, Brunei has been the hotpots of epidemic with 
cycle of every 2–3 years period (15), (16), (17). So far, the latest large outbreak in the 
region was in one province named Anhui of China in 2008 with around 490,000 cases and 
126 deaths in children were reported, the case-fatality rate is around 0.03% but in certain 
local outbreaks, such as in Fuyang City of Anhui Province, this rate can reach up to 0.3% 
(18), (19). The explosive emergence of the disease in the region may be related to the 
association between HLA-A33 (which is higher prevalence in Asian populations than 
white population) and susceptibility to HEV-71 infection (67). During those outbreaks, 
almost of the cases are under 5 years old children and although clinical manifestations 
were mostly typical of HFMD, a cluster of deaths among young children was identified. 
Moreover, cases involving the central nervous system complication and/ or pulmonary 
oedema have also been observed for the first time (20), (21). The major pathogens of 
Hand, Foot and Mouth Disease (HFMD) are the EV-A in which some main serotypes are 
coxsackievirus A6, coxsackievirus A10, particularly coxsackievirus A16 (CV-A16) and 
enterovirus 71 (EV-A71). In the Asia Pacific region, EV-A71 strain frequently causes 
severe HFMD as neurological forms and death in large epidemics while mild disease with 
other serotypes (81), (36). Moreover, some EV71 subgenotypes can co-circulate in the 
same epidemic, as well as other non-EV-A71enteroviruses, such as Coxsackievirus-A. 
There are evidences show that the co-infection is possible in HFMD and it is not a primary 
cause leading to severe form (94), (21), (Table 10). Recurrent epidemics could be due to 
both of the accumulation of susceptible individuals in the community and introduction of 
new genotypes or strains in the Asia Paciﬁc region (42). For instances, the outbreaks in 
Taiwan in 1998 and 2000 are caused by C2 and B4 strains, respectively (95), and by 
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sentinel surveillance in Sarawak, Malaysia, the emergence of a new subgenotype C1 is the 
cause of 2003 epidemic (15). 
 
There were several small outbreaks or sporadic HFMD cases outside the Asia-
Paciﬁc region. In The Netherlands, there are only 58 cases of EV-A71 infection requiring 
hospitalization were reported in 2007 during 21 year period of very low endemicity by 
surveillance (96). In the United Kingdom, there were also only 32 patients, 01 death in 
2003 with EV-A71 infection accompanied by neurological complications and/or cutaneous 
manifestations during that  1998 to 2006 period (97). 20 children with EV-A71 were 
admitted to a tertiary hospital in Canada in 1998, but no symptoms were severe and all 
improved rapidly (98). Similarly, in 2003 and 2005 in Denver, CO, USA, 16 children aged 
4 weeks to 9 years get EV-A71 infection; one child died (99). A longitudinal study from 
Norway (2001- 2003), indicated asymptomatic circulation of EV71. Prevalence of EV-A71 
in stool samples showed that EV-A71was circulating widely. But no clinical cases during 
this same period (100). In Nairobi, Kenya, two small institutional outbreaks of EV-A71 
infection were reported in an HIV orphanage in 1999 and 2000 (101).  
  
 
Figure 10: History of Hand, Foot and Mouth Disease (1969 – 2011) 
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Year Location Genotype of EV-A71 and other co-circulating 
viruses 
1997 Peninsular and Sarawak, 
Malaysia 
EV-A71 (B3, B4, C1, C2); CV-A (16, 2, 4, 6, 9); 
CV-B5; EV (1,4,5,7) 
1998 Taiwan EV-A71 (C2); CV-A16; CV-B (1, 2, 3, 5); EV(6, 
7, 11, 22, 27). 
1999 Australia EV-A71 (C2). 
2000 Australia  EV-A71 (B4). 
2000 Singapore EV-A71 (B4); CV-A(16, 3, 4, 5, 6, 10, 23); HEV-
18. 
2000 Taiwan EV-A71 (B4), CV(A16, A9, A24); CV-B (1, 3, 4); 
EV (4, 9). 
2001 Taiwan EV-A71 (B4); CV-A(16, 6, 9, 24); CV-B(4, 5); 
EV (4, 6). 
2000 Sarawak, Malaysia EV-A71 (B4); CV-A16. 
2000 Peninsular 
Malaysia 
EV-A71 (C1, B4) 
2003 Sarawak, Malaysia EV-A71 (B4, B5, C1); CV-A16. 
2005 Peninsular, Malaysia EV-A71 (B5, C1) 
2006 Singapore EV-A71 (B5); CV-A16 
2008, 
2009 
China EV-A71 (C4) 
Table 6: Recent outbreaks of HFMD due to in the Asia Paciﬁc region (102). 
 
5.2. Sources, Transmission and Susceptibility of HFMD  
 
Sources and transmission modes 
Human beings now are the only known natural hosts of EV-A71. This pathogen can 
replicates in both the intestinal tract and the upper respiratory tract. It is typically shed for 
from 2 to 12 weeks and two weeks post-infection, respectively (57). So disease 
transmission can be faecal-oral and respiratory secretions route by direct person-to-person 
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contact, droplets or fomites. Indeed, there are evidences of intra-familial transmission of 
EV-A71 which can be up to 84% among family member contact in Taiwan and attendance 
at childcare settings was signiﬁcant risk factors associated with EV-A71 infection (103), 
(70). For more factors related personal hygiene which associated to getting disease also 
suggested that the faeco-oral route is probably important (104). It thought that in 
developing countries, hygiene maybe an important role for disease transmission by the 
faeco-oral route. In contrast for developed countries with much better sanitation, 
respiratory transmission may become more signiﬁcant. Further, faeco-oral transmission 
may contribute more to an endemic disease in the community and the respiratory tract may 
contribute more to the epidemic spread of the viruses during outbreak situations.  
 
Susceptibility  
Almost of HFMD cases occur in preschool-aged children, especially less than 3 
years old group, boys more than girls (105). A seroepidemiology study in Singapore shows 
that EV71 infection outside preschool years is rare. This finding is supported by the 
following observations: 1) the small proportion of children <2 years old who were 
seropositive; 2) the proportion of seropositive children reached a steady state after 5 years 
of age; and 3) The geometric mean titer of anti-HEV71 antibody declined with age (106). 
In addition, seroprevalance study among children in South Vietnam in 2007 shows the 
EV71 neutralizing antibody seroconversion rate was 5.6% in the first year and 14% in the 
second year of life. In children 5–15 yrs of age, seroprevalence of EV71 neutralizing 
antibodies was 84% and in cord blood it was 55% (25). Studies in Taiwan showed that the 
age-speciﬁc seroprevalence are correlated with the incidence of severe disease and 
mortality rates (70). 
  
5.3. HFMD in Vietnam  
Vietnam is located in South Eastern Asia and shares the border with South China 
Sea, China, Laos, and Cambodia. The climate is tropical in south; monsoonal in north with 
4 seasons are spring, summer, autumn and winter. Although EV-A71 was isolated for the 
first time in Vietnam in 2003, the first outbreak of HFMD was not reported until 2005. The 
2005 outbreak in the southern was associated with EV-A71 C1, C4 and C5 subgenogroups 
and CV-A16 (22), (23). For the southern part of the country, in the periods of 2007 - 2009, 
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the numbers of reported cases and deaths were 5,719 and 23; 10,958 and 25, and 10,632 
and 23, respectively. In contrast, there were a few sporadic HFMD cases in the northern. In 
2005 - 2007 periods, seven cases were identified. In 2008, 88 cases were reported from 
13/28 provinces. No severe or fatal cases were reported.  
 
Since 2011, Vietnam have experienced continuosly large outbreaks of HFMD and 
the disease became a notifiable one in the national communicable disease surveillance 
system. According to data of Viet Nam Ministry of Health (MoH) from 2011 to 2015, 
number of reported cases and deaths were 113,121 and 170 (2011), 157,391 and 45 (2012), 
78,818 and 23 (2013), 77,296 and 9 (2014), 56,329 and 5 (2015), respectively which have 
been reported from across all 63/63 provinces. HFMD outbreaks have continuously 
occurred nationwide. Responding to HFMD outbreaks, MoH issued two specific guidelines 
applied for whole country. The first one published on the February 24, 2012 concerned 
surveillance, prevention and control of HFMD. The second guideline was issued on March 
30, 2012 were about diagnosis and treatment. 
 
This study (22), shows information as most of the cases (96.2%) were less than five 
years of age. 173 specimens (42.1%) were identified as EV-A71, and 214 (52.1%) as CV-
A16. Of those patients with EV-A71 infections, 51(29.3%) were complicated by acute 
neurological disease and three (1.7%) were fatal. EV-A71 was isolated throughout the year 
but peak of occurrence is from October to November. Phylogenetic analysis of 23 EV-A71 
isolates showed that during the ﬁrst half of 2005, viruses belonging to 3 subgenogroups, 
C1, C4, and a previously undescribed subgenogroup, C5, cocirculated in southern 
Vietnam. In the second half of the year, viruses belonging to subgenogroup C5 
predominated during a period of higher EV-A71 activity. Another study (25), pointed out 
seroprevalance study among children the EV-A71 neutralizing antibody seroconversion 
rate was 5.6% in the first year and 14% in the second year of life. In children 5–15 yrs of 
age, seroprevalence of EV-A71 neutralizing antibodies was 84% and in cord blood it was 
55%. The first peak of the disease seemed to be in April and September for the second one 
(Figure 11). During those outbreaks, almost of the cases are under 5 years old children, 
severe cases and deaths was identified that involving the central nervous system 
complication and/ or pulmonary oedema and most of them are under 3 years old (24). 
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Gender of the HFMD cases seem trend to boys than girls. The etiology are both CV and 
EV-A71. Moreover, some EV-A71 subgenotypes can co-circulate in the same epidemic, as 
well as other non-EV-A71 enteroviruses, such as Coxsackievirus-A. 39.7% positive with 
EV-A71. EV-A71 infection is primary cause of the death by HFMD (76%). 
 
 
Figure 11: Monthly distribution of HFMD in Vietnam, 2011-2015  
 
6. Prevention and control measures of HFMD 
 
6.1. Options for prevention and control 
So far, the public health approaches are only measures for disease prevention and 
control with the aim is to interrupt the chain of virus transmission. In addition, by the 
heightened surveillance activities, the outbreaks will be detected early and especially early 
recognition and intervention of severe cases are very important to minimize the impact of 
the disease. There are many measures can be implemented to effectively reduce 
transmission but the key is a combination of interventions. The main measures (80), 
currently being taken to manage HFMD outbreaks include: 
1.! Establishing and strengthening surveillance; 
2.! Conducting information and education campaigns on good hygiene and basic 
sanitation; 
3.! Providing assistance to kindergartens, day-care facilities and schools during outbreaks 
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4.! Strengthening infection-control measures in both health care facilities and the 
community; 
5.! Improving clinical case-management services, particularly for severe manifestations 
requiring intensive medical care; 
6.! Exchanging information and disseminating best practices related to the preparedness, 
response and management of HFMD, particularly during outbreaks;  
7.! Providing an administrative framework to national agencies/bodies to implement 
prevention and control options, including the: 
-! Delegation of powers to act to key ministries, including through supportive 
legislation; 
-! Development of mechanisms to establish and support interagency/intersectoral 
collaboration; and  
-! Strengthening of coordinated risk communication. 
8.! Monitoring and evaluation. 
At the individual level, the risk of infection can be lowered by following good hygiene 
practices which include: 
1.! Washing hands frequently and correctly and especially after changing diapers and 
after using the toilet;  
2.! Cleaning dirty surfaces and soiled items, including toys, first with soap and water and 
then disinfecting them by cleansing with a solution of chlorine bleach (made by 
adding 1 tablespoon of bleach to 4 cups of water); and  
3.! Avoiding close contact (kissing, hugging, sharing eating utensils or cups, etc.) with 
persons with HFMD. 
 
6.2. Vaccines 
 
For communicable disease, especially without antiviral therapies, vaccine is always 
powerful in term of prevention and disease control. To date, No available vaccines against 
EV71 exist but there are several ones are currently under development in the preclinical 
stage. In which, there still have been some limitations need to improve before application. 
Moreover, the cost and availability of the vaccine plays very important role in term of the 
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vaccine widely dissemination in poor Asian countries. It needs to be concerned as the 
cheap, easily produced, and readily available vaccine. 
 
Inactivated virus vaccine 
There are several evidences of the inactivated virus vaccine for the effective control 
of EV71 (75), (107). In which formalin-inactivated and heat inactivated virus vaccine was 
used to immunize adult mice. As the result neonatal mice were protected from EV-A71 
deathly infection and also for suckling mice it can prolong the survival. In the past, an EV-
A71 strain named YN3-4a was developed in laboratory which shows the advantage on 
rapid growth rate in Vero cells with a larger plaque size and a lower lethal dose 50 in 
newborn mice. It also induced to produce mouse antiserum that can neutralize a wide range 
of EV-A71 strains circulating around the word (108). This strain has potential for 
development as an inactivated vaccine strain. 
 
Attenuated strain vaccine 
The EV71 (S1-3’) strain with mutations in the 5’UTR, 3D polymerase and 3’UTR 
5’non-translated same as the attenuation determinants of poliovirus have been developed 
as candidate strain for attenuated vaccine (109), (110), has attenuated neurovirulence and 
limited spread features. In experiment on cynomolgus monkeys with EV-A71 (S1-3’), after 
lethal challenge with the prototype virulent strain EV-A71 (BrCr-TR), these monkeys 
survived without severe symptoms and their sera can neutralized against many different 
genotypes of EV-A71 (111). But it still causes mild neurological symptoms when 
inoculated via the intravenous route and the genetic stability need to concern of the 
attenuated strain before application. 
 
Subunit vaccine (recombinant vaccine) 
For enteroviruses, the VP1, VP2, and VP3 capsid protein are responsible for the 
antigenic diversity, especially in the VP1 there is cluster of neutralization epitopes which 
become potentially the focused area of antiviral subunit vaccine (112). Indeed, 2001, an 
experiment have showed that the VP1 protein with a complete adjuvant is able to induce a 
neutralizing antibody response, enhance T helper cell proliferation, and induce high levels 
of interleukin (IL)-10 and interferon (IFN)-g in mice. These findings provide the 
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possibility of developing subunit vaccines against EV71 with direct evidence that the VP1 
protein contains neutralizing epitopes independent of other viral capsid proteins (107). 
 
DNA vaccine 
There are two experiments (107), (113), of development an EV-A71 DNA vaccine 
in mice. The results showed that the neutralization of the sera of mice immunized with the 
VP1 DNA vaccine was much lower when compare to effects of EV-A71-infected human 
serum and the anti-VP1 IgG level declined after boosting immunization. Indeed, strategies 
to increase the immune stimulation ability of DNA vaccines need to be concerned because 
the DNA vaccine contains fewer antigenic epitopes and it induces a weaker immune 
stimulation than the whole virus particles. 
 
Virus-like particle (VLP) vaccine 
According to (114), the VLP immunization of mother mice conferred protection to 
neonatal mice against the lethal viral challenge inducing both Th1 and Th2 immune 
responses. Their VPLs is assembled from VP1, VP3, and VP0 capsid protein through the 
CD3 protein by using a recombinant baculovirus expression system. They also found that 
the denatured VLPs elicited signiﬁcantly lower levels of neutralizing antibodies and 
conferred lower protection level against virus challenge when compared to the intact VLPs 
(115). These findings provide evidence for preserving the conformation-dependent 
epitopes in preventing EV-A71 infection. 
 
Moreover, by optimizing the process parameters, the resultant VLPs not only 
resembled the VLPs produced from Bac-P1-3CD infection in density, size and shape, but 
also induced potent antibody responses in mouse models. The antibodies neutralized EV-
A71 strains of homologous and heterologous genogroups, implicating the potential of the 
VLPs to confer cross-protection for the prevention of future epidemics. Summary, Bac-P1-
C3CD and the bioprocess render mass production more economical obviate the need for 
cell lyses and hold promise for future industrial vaccine production (116). 
 
The results of this work are summarized in the article entitled “Emergence of EV-
A71 infection in the Asia Pacific region”. This article submitted to “Asian Pacific Journal 
of Tropical Medicine” is presented thereafter. 
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Abstract 
 EV-A71 was first isolated in 1969 in California, USA. Since the late 1990s, many 
country members of the Asia Pacific region have experienced large widespread HFMD 
outbreaks including Malaysia, Taiwan, Japan, Korea, Singapore, China, Thailand, Vietnam 
or Cambodia, with hundred thousand HFMD cases and deaths. For the first time, brainstem 
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encephalitis was observed. EV-A71 strain frequently causes severe HFMD as neurological 
forms and death in large epidemics while mild symptoms are usually associated with other 
serotypes. Moreover, the co-circulation of different serotypes and alternation between EV-
A71 and Coxsackievirus (CV-A) has been commonly observed during HFMD epidemics. 
HFMD epidemics could be due to both the accumulation of susceptible individuals in the 
community and introduction of new genotypes or strains in the Asia Paciﬁc region. HFMD 
due to EV-A71 has become a major public health concern in the Asia Pacific region, which 
has been a hotspot for outbreaks with a 2–3 year period and show two picks around April 
and October. No available vaccines against EV-A71 exist but there are several currently 
under development. Public health approaches are therefore the best measures for disease 
prevention and control with the aim to interrupt the chain of virus transmission.  
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1.! Introduction 
Enterovirus A71 (EV-A71) belong to Enterovirus genus in the family Picornaviridae. 
It is first reported in 1969 in California, USA. Since, EV71has emerged and caused hand, 
foot and mouth disease outbreaks worldwide especially across Asia Pacific region. In 
which, the EV-A71 was frequently linked to severe neurological complication leading to 
death in large outbreaks while mild forms were usually associated other serotypes. EV-
A71 is classified into three independent genogroups: A, B, and C. The EV-A71 B and C 
genogroups are each further subdivided into five genotypes, B1 to B5 and C1 to C5 [1]. 
Recently decades the disease mostly has been reported in the Asia Pacific region with 
unclear explanation for the reason. In this Review we discuss epidemiology, etiology, 
genetics, evolution and pathogenicity and prospects for control. 
 
2.! Epidemiology 
EV-A71 strain of enterovirus was first isolated in 1969 in California, USA, from a 9-
month child diagnosed with encephalitis [2]. Since then many HFMD outbreaks of 
differing magnitude have been reported throughout the world [3], (Figure 1). 
In the early 1970s, several countries in different continent including Sweden, 
Australia, USA and Japan had reported small HFMD outbreaks with some tens of cases for 
most of which clinical aspects typical to HFMD and sometimes aseptic meningitis [4], [5], 
[6], [7]. HFMD was then reported in Europe in Bulgaria in 1975 (451 cases and 44 deaths), 
in 1978 (1550 cases and 47 deaths) and in France in 1979 [8], [9], [10]. In the 1980s small 
outbreaks were reported in Hong Kong, Australia and USA [11], [12], [13]. Since the late 
1990s, many countries in the Asia-Pacific region experienced large HFMD outbreaks. In 
1997 two large widespread community outbreaks occurred in Sarawak, Malaysia and in 
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Taiwan, with 2628 and 129,106 cases reported, respectively [14], [15]. Following these 
two initial episodes, a series of small and large HFMD outbreaks happen throughout the 
region with Japan, Australia, China, Malaysia, Singapore, Taiwan, Korea, Mongolia, 
Vietnam, Brunei as epidemic hotspots with cycles of 2–3 years period [16], [17], [18]. The 
most recent large outbreak in the Asia-Pacific region occurred in the province of Anhui in 
China in 2008 with around 490,000 cases and 126 deaths. The case-fatality rate was around 
0.03% but in certain local outbreaks, such as in the city of Fuyang, this rate was up to 0.3% 
[19], [20]. 
 
3.! Etiology 
The explosive emergence of the disease in the region might have been related to the 
association between HLA-A33 (which display a higher prevalence in Asian populations 
than white populations) and susceptibility to Enterovirus A71 infection [21]. During those 
outbreaks, almost all cases were children under 5 and although clinical manifestations were 
mostly typical of HFMD, a cluster of deaths among young children was identified. 
Moreover, cases involving central nervous system complications and/ or pulmonary 
oedema have also been observed for the first time [22], [23]. The causative agents of 
HFMD are Enterovirus A which include Coxsackievirus A (CV-A) and Enterovirus A71 
(EV-A71). In the Asia-Pacific region, the EV-A71 serotype was frequently linked to severe 
neurological forms leading to death in large epidemics while mild symptoms were usually 
associated with the other serotype [24][25]. The co-circulation of different serotypes and 
alternation between EV-A71 and CV-A were commonly observed during HFMD 
epidemics [26], [27], [28], [19]. However, this co-infection was not a primary cause of 
severe forms [29], [23], (Table 1). Epidemics could be due to both the accumulation of 
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susceptible individuals in the community and introduction of new genotypes or strains into 
the Asia-Paciﬁc region [30]. For instances, the outbreaks in Taiwan in 1998 and 2000 were 
caused by EV-A71 C2 and B4 strains, respectively [31]. Sentinel surveillance in Sarawak, 
Malaysia, demonstrated that the emergence of the novel subgenotype C1 of EV-A71 was 
the cause of the 2003 outbreak [16]. 
Outside the Asia-Pacific region, several EV-A71 small outbreaks or sporadic HFMD 
cases were reported. In The Netherlands, only 58 cases of EV-A71 infection requiring 
hospitalization were reported, in 2007, over a 21-year period of very low endemicity [32]. 
In UK, only 32 EV-A71 patients, including 1 death in 2003, displaying neurological 
complications and/or cutaneous manifestations were reported during the 1998 to 2006 
period [33]. 20 children infected with EV-A71 but with no severe symptoms were admitted 
to a tertiary hospital in Canada in 1998 and all improved rapidly [34]. Similarly, in 2003 
and 2005 in Denver, CO, USA, a total of 16 children from 1 month to 9 years old were 
infected resulting in one death [35]. A longitudinal study conducted in Norway from 2001 
to 2003, indicated a wide asymptomatic circulation of EV-A7 but with no clinical cases 
during this same period [36]. In Nairobi, Kenya, two small institutional outbreaks of EV-
A71 infection were reported in an HIV orphanage in 1999 and 2000.[37]. 
 
4.! Transmission 
Human beings are currently the only known natural hosts of EV-A71. This virus can 
replicate in both the intestinal tract and the upper respiratory tract. It is typically shed for 
from 2 to 12 weeks and two weeks post-infection, respectively. [38]. EV-A71 can therefore 
be transmitted through faecal-oral and respiratory secretions route by direct person-to-
person contact, droplets or fomites. Indeed, there is evidence of intra-familial transmission 
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of EV-A71 which can be up to 84% among family members while attendance at childcare 
settings was another signiﬁcant risk factor associated with HEV-71 infection [39], [40]. 
The faeco-oral route was however considered the most important one [41] in particular in 
developing countries where hygiene-related factors may play a more important role in the 
transmission. In contrast, in developed countries with higher sanitation, respiratory 
transmission may become more signiﬁcant. Faeco-oral transmission may contribute more 
to an endemic disease in the community while the respiratory route may contribute more to 
the epidemic spread of viruses during outbreak situations. Almost of HFMD cases occur in 
preschool-aged children, especially below 3 years old with boys being more infected than 
girls [42]. A seroepidemiology study conducted in Singapore showed that EV-A71 
infection outside preschool years was rare. The proportion of seropositive children below 2 
was very small and reached a steady state after 5 while the geometric mean titer of anti-
HEV-A71 antibody declined with age [43]. In addition, seroprevalance studies among 
children in southern Vietnam in 2007 demonstrated that the EV-A71 neutralizing antibody 
seroconversion rate was 5.6% in the first year and 14% in the second year of life [44]. In 
children of 5 to 15 years old, seroprevalence of EV-A71 neutralizing antibodies was 84% 
while it was 55% in cord blood [44]. Age-speciﬁc seroprevalence was also correlated with 
the incidence of severe forms and mortality rates [40]. 
Most outbreaks showed two picks of occurrence around April and October with a 
sharp decrease of the total number of cases during dry periods in January and July. These 
fluctuations were observed in Taiwan [45], China [46], [47], Singapore [48] and Malaysia 
[23]. The reasons for this cyclic variation is still unclear but a study conducted in 
Singapore [49] showed that the risk of HFMD incidence significantly increased with short 
term variability of weekly temperature difference (above 7°C), maximum temperature 
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(above 32°C), and moderate weekly cumulative rainfall (below 75 mm) at time lag of 1 to 
2 weeks. Higher air temperature and humidity as well as lower rainfall and duration of 
daylight increased incidence of HFDM [50] [51]. Epidemiological surveillance and 
prevention efforts should thus be focused at the end of the dry period to anticipate large 
outbreaks. 
Several kinds of clinical manifestation have been described which correspond to Hand, 
foot and mouth disease (HFMD) or Herpangina (HA), a usually self-limiting and benign 
illness. However, in a small number of cases, neurological and systemic complication 
could develop and lead to death. HFMD is a brief febrile illness in children with skin rash 
which typically is papulovesicular at the palms or soles of the feet, or both. These 
symptoms can be accompanied or not mouth ulcers. Usually, in younger children and 
infants the rash is maculopapular without vesicles, and may also involve the buttocks, 
knees or elbows. HA is also characterized by fever and typically with multiple, painful 
mouth ulcers mainly at the posterior oral cavity (anterior pharyngeal folds, uvula, tonsils 
and soft palate). In some cases, the mouth ulcers also affect other parts of the mouth such 
as the buccal mucosa and tongue. Neurological and systemic complications usually 
correspond to aseptic meningitis, acute ﬂaccid paralysis and encephalitis. In fatal cases, 
there is first a short period of febrile illness with subtle neurological signs followed then by 
an acute refractory myocardial dysfunction, fulminant pulmonary oedema  ithin hours of 
developing tachycardia, poor peripheral perfusion and tachypnea [52].  Brainstem 
encephalitis was also observed as a typical sign EV-A71 infection and was frequently 
associated with severe cardiorespiratory symptoms attributed to neurogenic pulmonary 
oedema [22], [23], [23], [3]. This specific clinical syndrome begins usually 3–5 days after 
onset and and is accompanied by a sudden deterioration such as shock and pulmonary 
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oedema or haemorrhages resulting from an acute and rapidly progressing cardiorespiratory 
failure. Finally, children die before reaching hospital or in the first day of admission, 
despite intensive care support [14], [22]. Clinical manifestations of HFMD vary widely 
from asymptomatic, mild to neurologic cases. But central neurological system infection is 
the feature most frequently seen in EV-A71 infection [53]. Uncomplicated HFMD, is 
suspected, as shown on a mouse model, to infect skin or oral mucosa [54]. However, 
information on human skin or oral mucosa biopsies is still lacking. 
Neurologic cases are not associated with inflammatory in cerebella cortex, basal 
ganglia, thalamus, peripheral nerve or autonomic ganglia. In contrast, the grey matter of 
the spinal cord and the whole medulla oblongata are predominantly affected along with the 
hypothalamus, subthalamic and dentate nuclei. The motor cortex is also affected but to a 
lower extend. However, virus, viral antigen or RNA have not been seen in the brainstem 
except in some very rare cases in neuronal processes and phagocytic cells [22], [55]. It is 
supposed that explosive pulmonary oedema is associated with neurogenic mechanisms 
secondary to brainstem inﬂammation, cardiac dysfunction, increased vascular 
permeability, and cytokine storm but the exact mechanism is still unclear and the 
pathogenesis is not completely understood [3]. In-vivo models, including mice and non-
human primates, have replicated some of the features of severe EV-A71 disease, such as 
neuroinvasion with inﬂammatory changes, but none has yet been able to reproduce the 
severe systemic features, such as pulmonary oedema [54], [56], [57]. 
 
5.! Etiology 
Human enteroviruses have been classiﬁed into four species, HEV-A, HEV-B, HEV-C, 
and HEV-D. HFMD is caused by several genotypes of Enterovirus A species which 
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include some Coxsackievirus A (CV-A) and Enterovirus A71 (EV-A71) [48]. EV-A71 
viruses are genetically related to CV-A; indeed, it has been suggested that these viruses 
may have diverged as recently as the 1940s [1]. EV-A71 isolates are classified on the basis 
of the VP1 gene sequence into six independent genogroups: A, B, C, D, E and F. The EV-
A71 B and C genogroups are each further subdivided into subgenogroups, B0 to B5 and 
C1 to C5 [58]. CV-As are subdivided into serotypes CV-A2-8, CV-A10, CV-A12, CV-
A14, CV-A16. Both EV-A71 and CV-A infections have been associated with severe 
HFMD in young children, sometimes resulting in death while other genotypes are usually 
associated with milder forms of the disease [59], [25], [47], [24].  
Group A comprises only one member, the prototype BrCr strain of EV-A71, which was 
ﬁrst isolated in California, USA, in 1969. BrCr secondly isolates were reported in a HFMD 
epidemic among children in Anhui province of central China [60]. Surveillance for HFMD 
by the Chinese Center for Disease Control and Prevention did not indicate the presence of 
group A viruses in China [20]. 
Group B viruses were first separated into B1 and B2 subgenogroups with 12% 
divergence at the nucleotide level. These subgenogroups were the predominant circulating 
strains in the 1970s and 1980s. In details, B1 was circulating in USA, Europe, Japan and 
Australia in 1970s and B2 viruses were mainly isolated in USA in the 1980s. The 
subgenogroup B3 emerged in 1997 in Sarawak, Malaysia in relation with several large 
outbreaks in the Asia-Pacific region. This subgenogroup was also found in Singapore [1], 
[61], [62]. Subgenogroup B4 was circulating and associated with the large outbreaks 
through the Asia-Pacific region in the 1990s but was also sampled in 2000. In 2003, 
subgenogroup B5 replaced subgenogroup B4 in Sarawak, Malaysia and became the most 
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important group circulating in Japan, Malaysia, Singapore and Taiwan [30], [63], [64], 
[16], [65], (Figure 2). 
Group C viruses were initially separated into the C1 and C2 subgroups. 
Subgenogroup C1 viruses were first reported in USA and Australia in the 1970s, 1980s. 
Since the initial detection of the group, these viruses have been continuously isolated in 
many countries throughout Europe and the Asia-Pacific region. However, they have not 
caused any large epidemics since the major community outbreak in Sydney in 1986 [66], 
[64]. Subgenogroups C2, C4, and C5 emerged within genogroup C in the Asia-Paciﬁc 
region in the late 1990s. They caused fatal HFMD cases in Taiwan [15], China [67], and 
Vietnam [26]. Subgenogroup C3 was isolated in Japan in 1994, and in Korea in 2000 [61], 
[68], [69]. According to [65], subgenogroups C1, C2, and C4 are present worldwide while 
the C3 and C5 lineages are restricted to Korea and Vietnam, respectively, (Figure 3). 
 
6.! Genetics, Evolution and Pathogenicity 
Recombination of EV-A71 has been observed most frequently in the 5’UTR and 
3’UTR regions. This rarely happens in the structural protein gene region [70], [71], [72]. 
So far, the effect of EV-A71 recombination on the virulence or transmissibility is 
unknown. But some studies observe the replacement of the 3’ half of the genome of a non-
recombinant EV-A71 field isolate with a HEV-B species virus which improves growth in 
cell culture compared with a non-recombinant strain [73]. The reservoir of EV-A71 is 
human and replication happens both in the intestinal tract and upper respiratory tract. The 
virion typically shed from 2 to 4 weeks and especially up to 12 weeks after infection. The 
transmission mode is through direct person-to-person contact, droplets or fomites by 
faecal-oral and respiratory secretions [74]. 
 54 
 
 
Although there is still no clear genetic evidence of virus-virulence factor, data from 
HFMD outbreaks suggest that the difference of genogroup may contribute to virulence 
aspect. Subgenogroup C2 from the epidemic in Taiwan (1998) was almost exclusively 
isolated from children with the severe neurological form. In contrast, subgroup B3 viruses 
from the 1997 outbreak in Sarawak, Malaysia, were isolated mainly from children with 
mild HFMD [62], [64]. As per today, there is still a lack of information about the relation 
between viral load and illness severity. In the case of EV-A71, infection with explosive 
pulmonary oedema, there is a storm of cytokines and chemokines in cerebrospinal fluid 
and serum such as interleukin (IL)-6, IL-1beta, IL-10,  IL-8, interferon induced 
protein (IP-10) and monokine induced by interferon gamma (MIG) [75], [76], [77]. In 
contrast, the number of T lymphocytes and NK cells is lower [78]. HLA-A33, which is a 
common phenotype in Asian populations, but rare in white populations, was most 
significantly associated with enterovirus 71 infection and HLA-A2 was significantly 
related to cardiopulmonary failure [21], Receptors on the host target cell were identified as 
the scavenger receptor B2 [79], and the P-selectin glycoprotein ligand-1 [80], which are 
associated with leukocytes. 
 
7.! Prevention and control measures of HFM 
Current public health approaches are only measures for disease prevention and control 
with the aim OF interrupting the chain of virus transmission. In addition, by the heightened 
surveillance activities, the outbreaks will be detected early and especially early recognition 
and intervention of severe cases are very important to minimize the impact of the disease. 
There are many measures can be implemented to effectively reduce transmission but the 
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key is a combination of interventions. The main measures [52], currently being taken to 
manage HFMD outbreaks include: Establishing and strengthening surveillance; 
Conducting information and education campaigns on good hygiene and basic sanitation; 
Providing assistance to kindergartens, day-care facilities and schools during outbreaks; 
Strengthening infection-control measures in both health care facilities and the community; 
Improving clinical case-management services, particularly for severe manifestations 
requiring intensive medical care; Exchanging information and disseminating best practices 
related to the preparedness, response and management of HFMD, particularly during 
outbreaks; Providing an administrative framework to national agencies/bodies to 
implement prevention and control options; Monitoring and evaluation. 
At the individual level, the risk of infection can be lowered by following good hygiene 
practices which include: Washing hands frequently and correctly and especially after 
changing diapers and after using the toilet; Cleaning dirty surfaces and soiled items, 
including toys, first with soap and water and then disinfecting them by cleansing with a 
solution of chlorine bleach (made by adding 1 tablespoon of bleach to 4 cups of water); 
and Avoiding close contact (kissing, hugging, sharing eating utensils or cups, etc.) with 
persons with HFMD. 
 
8.! Vaccines  
For communicable disease, especially without antiviral therapies, vaccine is always 
powerful in term of prevention and disease control. To date, no vaccine against EV-A71 
exists but there are several ones are currently under development in the preclinical stage. In 
which, there still have been some limitations need to improve before application. 
Moreover, the cost and availability of the vaccine plays very important role in term of the 
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vaccine widely dissemination in poor Asian countries. It needs to be concerned as the 
cheap, easily produced, and readily available vaccine. 
8.1!Inactivated virus vaccine 
 There are several evidences of the inactivated virus vaccine for the effective control 
of EV-A71 [81], [82]. In which formalin-inactivated and heat inactivated virus vaccine was 
used to immunize adult mice. As the result neonatal mice were protected from EV-A71 
deathly infection and also for suckling mice it can prolong the survival. In the past, an EV-
A71 strain named YN3-4a was developed in laboratory which shows the advantage on 
rapid growth rate in Vero cells with a larger plaque size and a lower lethal dose 50 in 
newborn mice. It also induced to produce mouse antiserum that can neutralize a wide range 
of EV-A71 strains circulating around the word [83]. This strain has potential for 
development as an inactivated vaccine strain.  
8.2!Attenuated vaccine 
The EV-A71 (S1-3’) strain with mutations in the 5’UTR, 3D polymerase (3Dpol) and 
3’UTR 5’non-translated same as the attenuation determinants of poliovirus have been 
developed as a candidate strain for an attenuated vaccine [84], [85]. It has attenuated 
neurovirulence and limited spread features. In experiment on Cynomolgus monkeys with 
EV-A71 (S1-3’), after lethal challenge with the prototype virulent strain EV-A71 (BrCr-
TR), these monkeys survived without severe symptoms and their sera could neutralize 
many different genotypes of EV-A71 [86]. But it still causes mild neurological symptoms 
when inoculated via the intravenous route and the genetic stability need to concern of the 
attenuated strain before application. 
8.3. Subunit vaccine (recombinant vaccine) 
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Enteroviruses VP1, VP2, and VP3 capsid proteins are responsible for the antigenic 
diversity, especially in the VP1 there is cluster of neutralization epitopes which become 
potentially the focused area of antiviral subunit vaccine [87]. Indeed, 2001, an experiment 
have showed that the VP1 protein with a complete adjuvant is able to induce a neutralizing 
antibody response, enhance T helper cell proliferation, and induce high levels of 
interleukin (IL)-10 and interferon (IFN)-g in mice. These findings provide the possibility 
of developing subunit vaccines against EV-A71 with direct evidence that the VP1 protein 
contains neutralizing epitopes independent of other viral capsid proteins [82]. 
8.4. DNA vaccine 
Two experiments [82, 88] of development an EV-A71 DNA vaccine in mice were 
conducted. Results showed that the neutralization of the sera of mice immunized with the 
VP1 DNA vaccine was much lower when compare to effects of EV-A71-infected human 
serum and the anti-VP1 IgG level declined after boosting immunization. Indeed, strategies 
to increase the immune stimulation ability of DNA vaccines need to be concerned because 
the DNA vaccine contains fewer antigenic epitopes and it induces a weaker immune 
stimulation than the whole virus particles. 
8.5. Virus-like particle (VLP) vaccine 
According to [89], the VLP immunization of mother mice conferred protection to 
neonatal mice against the lethal viral challenge inducing both Th1 and Th2 immune 
responses. Their VPLs is assembled from VP1, VP3, and VP0 capsid protein through the 
CD3 protein by using a recombinant baculovirus expression system. They also found that 
the denatured VLPs elicited signiﬁcantly lower levels of neutralizing antibodies and 
conferred lower protection level against virus challenge when compared to the intact VLPs 
[90]. These findings provide evidence for preserving the conformation-dependent epitopes 
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in preventing EV-A71 infection. Moreover, by optimizing the process parameters, the 
resultant VLPs not only resembled the VLPs produced from Bac-P1-3CD infection in 
density, size and shape, but also induced potent antibody responses in mouse models. The 
antibodies neutralized EV-A71 strains of homologous and heterologous genogroups, 
implicating the potential of the VLPs to confer cross-protection for the prevention of future 
epidemics. Summary, Bac-P1-C3CD and the bioprocess render mass production more 
economical obviate the need for cell lyses and hold promise for future industrial vaccine 
production [91]. 
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1.! Figures and table legends 
Figure 1: History of Hand, Foot and Mouth Disease (1969 – 2011) 
Figure 2: Genogroup B of Enterovirus 71(EV-A71) 
Table 1: Recent outbreaks of HFMD due to in the Asia Paciﬁc region [92] 
 
 
Figure 1: History of Hand, Foot and Mouth Disease (1969 – 2011) 
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Figure 2: Genogroupe B of Enterovirus 71(EV-A71) 
 
 
Figure 3: Genogroupe C of Enterovirus 71(EV-A71) 
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Table 1. Recent outbreaks of HFMD due to in the Asia Paciﬁc region 
Year Location Genotype of EV-A71 and other co-circulating viruses 
1997 Peninsular and  
Sarawak, Malaysia 
EV-A71 (B3, B4, C1, C2); CV-A (16, 2, 4, 6, 9); CV-B5; 
EV (1,4,5,7) 
1998 Taiwan EV-A71 (C2); CV-A16; CV-B (1, 2, 3, 5); EV (6, 7, 11, 
22, 27). 
1999 Australia EV-A71 (C2). 
2000 Australia  EV-A71 (B4). 
2000 Singapore EV-A71 (B4); CV-A (16, 3, 4, 5, 6, 10, 23); HEV-18. 
2000 Taiwan EV-A71 (B4), CV (A16, A9, A24); CV-B (1, 3, 4); EV 
(4, 9). 
2001 Taiwan EV-A71 (B4); CV-A (16, 6, 9, 24); CV-B(4, 5); EV (4, 6). 
2000 Sarawak, Malaysia EV-A71 (B4); CV-A16. 
2000 Peninsular 
Malaysia 
EV-A71 (C1, B4) 
2003 Sarawak, Malaysia EV-A71 (B4, B5, C1); CV-A16. 
2005 Peninsular, Malaysia EV-A71 (B5, C1) 
2006 Singapore EV-A71 (B5); CV-A16 
2008, 
2009 
China EV-A71 (C4) 
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CHAPTER 1. EPIDEMIOLOGY AND ETIOLOGY OF HAND, FOOT 
AND MOUTH DISEASE, VIETNAM 
 
 
1.1. Context of study 
 
Hai Phong, the biggets seaport city of the Northern, Viet Nam. It is a large urban 
city with a population estimated at 2 million, encompassing an area of 1,507.57 km² for the 
seven urban and six countryside districts and one large island.  
Figure 12: Location of Hai Phong city, Vietnam. 
 
Hai Phong is also a major economic center. Industry is a key sector including food 
processing, light industries and heavy industries. Despite its status as a city, around one 
third of Hai Phong's area are used for agriculture. Hai Phong is also a regional junction 
with international airport, hydro transportation with major seaport and large river system, 
many national highways and railway as well. The city features a humid subtropical 
climate, with hot, humid summers and warm, dry winters. 
 
Before 2011, there were no reported HFMD cases in Hai Phong city.  The first 
large outbreak in Hai Phong city started in 2011 and was followed until the end of year 
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2012. The first reported case was a 6 years old girl admitted in an urban district hospital in 
week 16th (17, Apr 2011). Later weeks (weeks 17 - 38), HFMD occurred sporadically in 
almost all part of the city with low incidence (8 cases per week in average). The number of 
HFMD cases increased suddenly in middle of September (week 39th), 2011. The incidence 
peaked at 472 cases per week on early December 2011. The second period of activity of 
the virus is between February and May 2012. A third peak of illness appears in early 
October 2012. Then it decreased to 18 cases per week by last week of December 2012. The 
disease has been occurring continuously until now but with lower burden. So far there is 
no studies published on the epidemiology of HFMD in Northern Vietnam, just are only 
few for the southern part of the country. All based on hospital based data with limited 
number of HFMD cases. These studies mainly observe for basic epidemiology and 
etiology characteristics. Besides, the relationship between etiological agents and clinical 
epidemiological behavior, temporal and spatial analysis, evaluation of countermeasures has 
not been reported. In order to more comprehensive understanding which contribute to 
prevention and control of HFMD in Vietnam, In this work we analyzed all HFMD cases 
reported in Hai Phong city by the community and hospitals in 2011 and 2012. Since it was 
the very first outbreak to occur in Hai Phong city, it was a good model for investigating the 
dynamic of the disease without interference and potential remains from previous outbreaks 
or patient immunological adaptation and provide findings related to influence of HFMD 
guidelines during the outbreak period. This work is also an integrative analysis including 
spatial analysis and social evolution as well as genetic evolution to describe the dynamic of 
HFMD in a well delimited area.!
 
1.2. Objective 
To describe the epidemiological and etiological characteristics during 2011-2012 
outbreak in Hai Phong City, Vietnam. To monitor influence of HFMD new guidelines on 
patients care during 2011-2012 outbreak in Hai Phong City, Vietnam. To spatial analyse the 
HFMD dynamic during 2011-2012 outbreak in Hai Phong City, Vietnam. 
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1.3. Discussion and conclusions 
This study analyzed all HFMD cases reported in Hai Phong city by the community 
and hospitals in 2011 and 2012. The 2011-2012 HFMD epidemic was the largest to have 
ever occurred in Vietnam and the first recorded in the northern part of the country while 
Hai Phong city experienced the highest HFMD incidence in North Vietnam. However, no 
fatal cases were reported in Hai Phong unlike what was observed in South Vietnam (9). 
Age-specific incidence was the highest in the 1-2 year age group. This would be in 
agreement with both the persistence of maternally-derived neutralizing antibodies for up to 
6 months and the kinetics of seroprevalence of EV-A71 virus neutralizing antibodies which 
increases with age (15,16). However, this was the very first recorded outbreak of HFMD in 
northern Vietnam questioning thus the existence of maternally-derived neutralizing 
antibodies or pre-existing immunity. Children under 3 represented 85.85% of cases. They 
are in Vietnam traditionally cared for at home by family members. The high HFMD 
incidence in this population may thus have resulted from contact with adults and older 
children acting as asymptomatic carriers of the virus (17,18). 
 
The first guideline released related to surveillance, prevention and control and gave 
clear HFMD case definition, reporting procedure and strategy for collecting clinical 
samples. The first effect of the guideline release was a significant increase of the severity 
score. The number of moderate and severe cases admitted to Hai Phong pediatric hospital 
increased significantly after guidelines publication while the proportion of the mild cases 
decreased sharply. Another positive effect was the reduced delay between onset and 
admission after guidelines publication. It decreased during the second period and remained 
very homogeneous. The most important feature of the second guideline was the 
decentralization and transfer of responsibility to health care facilities. A more 
homogeneous spatial distribution of patients visiting pediatric hospitals was visible. Mild 
cases were treated at the commune level whereas districts were in charge of mild and 
moderate cases. At the province level, all cases were addressed. All patients recorded as 
severe went to province hospitals during period 2 while local health facilities hosted 
patients unable to go to main hospitals. Patients who remained at home only displayed 
mild symptoms. This positive effect of guidelines is also of an increased awareness and 
precautious approach from parents and physicians leading to patients being majoritarily 
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declared with severe symptoms in order to ensure a better treatment and surveillance. This 
could explained why a higher disease severity scores was observed in CV-A-infected 
patients (wave 3) than in EV-A71 cases (p< 0.01). Awareness led to the modification of 
guidelines but changes occurred only after publication, suggesting that the legal framework 
created by the guidelines is needed for implementation eventhough awareness is present. 
Public and professional awareness are not sufficient for implementing changes. 
Furthermore, emergence of CV-A (wave 3) during the second period did not lead to 
variation in severity and time to admission. Conversely, the publication of guidelines 
during phase 2 led to different patient patterns although the virus was the same. Evolution 
of clinical patterns should not be considered only in the light of the evolution or 
replacement of pathogens or host-pathogen interactions but also according to the evolution 
of behavior and social perception. 
 
During the Hai Phong outbreak, circulation of both EV-A71 and CV-A was 
recorded, a feature already reported (8,19,20,21,22). EV-A71 virus is considered to be the 
most frequent cause of severe HFMD disease (10,23,24) although CV-A have been shown 
to cause severe infections with meningitis (25). An uncharacterized virus might also have 
circulated during wave 1 and mostly wave 2. The high number of EV non-positive PCR 
reactions on clinically positive samples suggests that the set of primers used for enterovirus 
detection might not have been discriminative enough. The ratio of non-positive tests was 
similar to those previously reported (26,27,28,29). EV-A71 detection with MAS primers 
should thus be systematically performed on SO primers products and SO222 primer should 
be redesigned to match with the 5’ part of the AN88 primer used for EVs detection. More 
attention should be therefore paid to the PCR negative patients. 
 
Nguyen et al. (9) have shown the presence of HFMD in provinces west of Hai 
Phong after the outbreak started in South Vietnam, making the northwestern side of Hai 
Phong is the most likely route of entry. Despite, the main economical role of Hai Phong no 
early cases occurred along or at the end of the main highway linking Hai Phong to the rest 
of the country, indicating that major industrial and export commercial movements are not 
linked to the dynamic of the disease. Instead the disease seems to have expanded following 
the eastbound river system to reach densely populated settlements from where it 
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secondarily expanded through local roads. Disease expansion might thus have followed 
secondary local commercial routes. This commercial route allows time for the disease to be 
transmitted and involves a lot of favorable human to human contacts. The presence of early 
cases in the island and in isolated coastal localities in the southern part of the city also 
illustrates the role of sea transportation and role of the local trade and occupational 
activities in the spread of the disease. The southern part may have been affected later due 
to fragmentation of the territory and isolation of the communes by the complex river 
system. The early occurrence of the disease in northwestern communes not connected to 
the main local road might be related to a specific occupational activities. Considering the 
average age of the patients, around 2, the source of contamination must be sought for 
within asymptomatic adults being contaminated during their occupational activities and in 
local and regional movements. 
 
The results of this work are summarized in the article entitled “Monitoring 
influence of Hand, Foot and Mouth Disease new guidelines on patients care during 2011-
2012 outbreak in Hai Phong City, Vietnam”. This article in Press in “Asian Pacific Journal 
of Public Health” is presented thereafter. 
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Abstract 
 
In 2011-2012, Northern Vietnam suffered its first large scale hand foot and mouth disease 
(HFMD) epidemic. Two sets of official guidelines were issued during the outbreak to 
handle the HFMD crisis. The city of Hai Phong was therefore used as a model to analyze 
the impact of the guidelines release. 9621 HFMD cases were reported in Hai Phong city 
from April 2011 to December 2012. Three distinct waves of HFMD occurred. Enterovirus 
A71, Coxackievirus A16 and an unknown virus were associated to the epidemics. The 
incidence of the disease was the highest in the 0.5-3 year age group. Two periods, before 
and after guidelines realease, could be distinguished which were characterized by different 
patient patterns time to admission and severity changed notably. Guidelines publication 
improved the system. The main routes of infection were rivers and local secondary roads 
most likely through local trade and occupational movements of people. 
 
Running title: Monitoring impact of HFMD guidelines in Hai Phong 
Key words: HFMD, Enterovirus, EV-A71, CV-A16, Hai Phong, Vietnam 
 
 80 
 
Introduction 
 
Hand, foot and mouth disease (HFMD) is an acute febrile illness in children with a 
papulovesicular skin rash at the palms or soles of the feet, or both. Presentation can be with 
or without inclusion of mouth ulcers. HFMD can result in severe complications such as 
encephalitis, aseptic meningitis, pulmonary edema, myocarditis, and death (1). HFMD is 
caused by types of Enterovirus A species which includes some Coxsackievirus A (CV-A) 
and Enterovirus A71 (EV-A71) (2,3). The EV-A71 viruses are genetically related to CV-
A, and have diverged as recently as the 1920s (4). Both EV-A71 and CV-A infections have 
been associated with severe HFMD in young children, sometimes resulting in death 
(1,5,6,7). 
Although EV-A71 was isolated for the first time in Vietnam in 2003, the first 
outbreak of HFMD was reported in the South in 2005 (8). The 2011 HFMD epidemics 
which caused fatal cases in South Vietnam (9) was the first one to occur in the North. 
 
Materials and methods. 
 
Epidemiological information and specimen collection. All HFMD cases in Hai Phong 
city were reported to the National Institute of Hygiene and Epidemiology (NIHE) through 
the national communicable disease surveillance system since 2011. HFMD patients that 
were present to health centers or hospitals were diagnosed and classified in 4 severity 
levels. The evaluation of the disease was performed according to the guidelines 
specifically published by the Vietnamese Ministry of Health (Supplementary table 1) 
which are based on but slightly differ from WHO (1) and Taiwanese guidelines (10). 
 
PCR amplification and nucleotide sequencing. Molecular analyses were done on 257 
throat swabs collected at the main pediatric hospital in Hai Phong city from HFMD-
diagnosed patients from 14 out of the 15 districts. From February 2012 through August 
2012, following authority requirements, samples were collected only on patients presenting 
severe symptoms (severity level 2b up). Enterovirus-positive and EV-A71-positive 
samples were identified according to Nix et al (11) using SO, AN and MAS primers (12).  
Samples collected in November 2011, December 2011, March 2012 and from September 
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2012 to December 2012 were subjected to Sanger sequencing and analyzed with the 
Enterovirus Genotyping Tool (http://www.rivm.nl/mpf/enterovirus/typingtool). 
 
Statistical analysis and hierarchical classification. Population size was estimated using 
2009 census data for comparative analysis (13). Hierarchical classification was used to 
cluster the clinical data set from 8585 cases (children older than 5 were excluded). 
Incomplete data (less than 5%) were excluded. Each patient was described by four 
parameters: age, severity, time between onset of the disease and admission to hospital, and 
date of onset. Patients were clustered according to the first three parameters (clinical 
parameters) using an un-weighted average Euclidean distance. The three clinical 
parameters used for clustering analysis were combined into a scoring formula to generate a 
parameter called Global score. Scores from 1 to 4 were set for each value. The age of 
patients (S1) was scored according to the following rule: age ∈ [0,2]=> S1 = 4, age ∈ [2,3] 
=> S1 = 3, age ∈ [3,4]=> S1 = 2 and age ∈ [4,5] => S1 = 1. The severity score (S2) was 
kept as established by physicians. The score of the delay of onset to admission (S3) was 
based on the time lapse between onset of disease and admission of 1 day or less, 2 days, 3 
days or 4 days or more. The values for S3 were 2, 4, 3 and 1, respectively. The sum S of all 
scores was S=S1+S2+S3. All patients displaying the same values for the first three 
parameters were grouped together into a ‘type case’ category. A histogram of occurrence 
over time was computed for all individuals in each type case using the fourth parameter 
(date of onset). A Mann-Whitney U test was applied to each cluster and for all clinical 
parameters. Correlations between the distribution of the total number of patients obtained 
by hierarchical classification and date of occurrence were assessed by a chi-square test. 
Clusters of median time were tested with a non-parametric Mann-Whitney U test. Type I 
error was set at 5% for all statistical tests. Hierarchical classification was conducted using 
MATLAB v5.07. Statistical tests on clinical data were performed using Stata 9.0 for 
Windows. Mean comparison was implemented by a Student’s T-test. A Chi-square test 
was used for proportion comparison of Hai Phong city population and a one-way ANOVA 
test was used for the variance analysis. 
 
Bias and Ethics. Training session HFMD cases definition and reporting were organized 
for the staff of the routine surveillance system to enhance quality and consistency of case 
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report. This work was conducted following the requirements of the Vietnamese Ministry of 
Health and under the Law of Communicable Diseases Prevention and Control passed in 
2007. 
 
Spatial and landscape analysis. GoogleEarth Pro satellite images were downloaded from 
January 14 to January 20, 2015 (initial satellite data from May 2014). LandSat 
CNS/Astrum images were used as source data for roads and main river networks. 
Multispectral images with a 30-meter resolution were obtained from GlobeLand30 
operated by the National Geomatics Center of China (14). Initial data were produced in 
2010 with an update in 2014. Spatial analyses were conducted with Quantum GIS, version 
2.6.1. Brighton. All spatial data are in the WGS 84 coordinate system. Six classes of land 
cover out of ten possible were found in Hai Phong city: cultivated land, forest, grassland, 
wetland, water bodies and artificial aera (settlement area). Figures were done with 
CorelDRAW Graphics Suite X5. The period of occurrence of the index case is shown as a 
cartogram. 
 
Results 
 
Monitoring of the HFMD burden during the 2011-2012 epidemic. The large HFMD 
epidemic of 2011-2012 was the first such outbreak to occur in northern Vietnam (65,039 
cases). However, the number of cases was higher in the Southern part where epidemic 
HFMD has been observed since 2005 (157,975 cases). Hai Phong was the hardest hit 
among the 28 northern Vietnam provinces during the 2011-2012 HFMD epidemic with an 
average prevalence of 524/100,000 persons. A total of 9621 cases were collected during 
this period from health centers and the main pediatric hospital of Hai Phong city. The city 
of Hai Phong is composed of 7 urban districts, 6 countryside districts and 1 large island. 
HFMD cases were reported throughout the entirety of the city (Supplementary Table 2) 
and the epidemic was slightly delayed in 2011 when compared to the rest of northern 
Vietnam (Figures 1a and 1b). The HFMD epidemic could be subdivided into three separate 
waves of infection: the first one stretching from August 2011 to January 2012 (Wave 1), 
the second from February 2012 to July 2012 (Wave 2) and the third one from August 2012 
to January 2013 (Wave 3). Before the first wave started HFMD occurred sporadically in all 
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parts of the city with low incidence (8 cases per week on average). The number of cases 
increased suddenly in mid-September, 2011. The outbreak peaked at 472 cases per week 
on early December 2011 followed by two smaller peaks in April and October of 2012 
(Figure 1b). Two periods, corresponding to different epidemiological patterns, could be 
distinguished: from August 2011 to March 2102 and from March 2012 to January 2013. 
The limit between the two periods is marked by the publication of two specific guidelines 
by the Ministry of Health (MoH). The first one published on the February 24, 2012 
concerned surveillance, prevention and control of HFMD. The second guideline was issued 
on March 30, 2012 were about diagnosis and treatment. The evaluation process of the 
disease burden was therefore changed during wave 2. Moderate forms (severity level 2a) 
were reported for the majority of cases (5262 cases, 54.92%), but 218 patients were 
encountering severe symptoms (2.28%). Among this group, only 9 patients had severity 
score of 3 and no case with the highest level of 4 (Supplementary Table 2). Gender was not 
associated with severity. Moderate forms of HFMD were particularly pronounced in 
children below 2 years old (p< 0.01, Supplementary Table 4). The level of moderate cases 
was significantly lower during wave 1 (p< 0.01, Supplementary Table 5 and 6). The level 
of moderate cases was significantly higher during the second period. Conversely, the level 
of mild cases decreased notably to significantly lower after the first period of the epidemic 
(Figure 1b), (p< 0.01, Supplementary Table 7). The age of patients ranged from 24 days to 
15 years (median at 2 years, IQR of 2 years, Supplementary Table 2). Out of 9142 cases, 
8857 (96.9%) were under the age of 5 with the age-specific incidence highest in the 1-2 
year age group (3067 cases, 33.6%) and remained very low for older children. The lowest 
incidence was observed in infants <5 months (1.88%) and children above 10 years old 
(0.4%). Boys had a significantly higher prevalence rate (59.74%). Wave 1 was associated 
to an increase of the number of children between 2 and 5. Variations in patient age after 
guideline release were noticeable (Figure 1c). The proportion of cases below 2 was 
significantly higher to the end of second period (p<0.01, Supplementary Table 7) and 
during wave 3 (p<0.01, Supplementary Table 3). The time after onset to admission was the 
third epidemiological parameter followed in the present study. It varied greatly over the 
first period (Figure 1d, Supplementary Table 6). The curves for time to admission after 
onset to admission corresponding to 1-day and 2-days crossed in March 2012 (Figure 1d) 
concomitantly with those representing mild and moderate level of severity (Figure 1b). 
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INSERT FIGURE 1
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Evolution of HFMD admission at Hai Phong city pediatric hospital. The proportion of 
the moderate and severe cases admitted at the pediatric hospital increased significantly 
during the second period (Supplementary Table 8). Concomitantly, the number of HFMD 
admissions increased in district hospitals. The number of outpatients (treatment at home) 
also increased notably with mild level of severity during the second period. The ratio 
between young (below 2) and old patients admitted at the pediatric hospital was reversed 
after March 2012, but not in district hospitals and local health stations (Supplementary Table 
9). The share of patients between the pediatric hospital and the local health facilities clearly 
improved during the second period (Supplementary Table 10a). The number of patient 
admited at the pediatric hospital coming from non-urban districts compared to urban ones 
remained the same over the two periods. This ratio was similar for the total number of cases 
(Supplementary Table 10b), but the number of non-urban district patients with severe 
symptoms admitted at the pediatric hospital increased (Supplementary Table 10c). 
 
Variation in disease assessment. Severity score, age of patient and time from onset to 
admission were combined together in a single analysis to evaluate the effect of guidelines 
recommendations on surveillance and diagnosis. Ten groups (clusters) of patients (clusters) 
were identified through hierarchical classification (Supplementary Figure 1) and each 
cluster was associated to specific presentations according to average values of quantitative 
parameters (Supplementary Table 11). New guidelines publication modified drastically the 
distribution of patients among the different clusters. The diversity of presentations in 
patients decreased sharply after March 2012. From 60% to 100% of patients were declared 
during the first period of the study in 8 clusters. A large majority of patients associated 
with extreme presentations (old patients, high severity or long time from onset to 
admission from clusters 5 to 9) were diagnosed before guidelines release. Patients with low 
severity and long onset to admission delay (cluster 6) were no longer seen after guideline 
publications whereas clusters 4 and 10 emerged as the two main ones after guidelines 
release. These two groups differed on delay and severity. Cluster 4, the largest, 
corresponded to young children (1.3 y in average) with moderate symptoms admitted in 
average two days after onset. A similar group of patient was also present before guidelines 
publications (cluster 2). Children from cluster 10 were presented after only one day but 
with a severity from moderate to severe. Patients from clusters 3 and 10 were mostly from 
non urban areas.  
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Both EV-A71 and CV-A were present during the epidemic. Molecular diagnostic 
confirmation was conducted by PCR on 257 samples from cases clinically identified as 
HFMD. Nearly 71% were positive for Human Enterovirus (182/257). Of the 182 positives, 
101 (55%) were EV-A71 and 81 (45%) corresponded to other enteroviruses (EVs) (Figure 
2a). The identified EV-A71 isolates belonged to subgenogroup C4 present on northern and 
central city and C5 present also in northern, central and southern city (Figure 2b). 75 
patients diagnosed as HFMD during waves 1 and 2 (Figure 2a) were not positive for 
enterovirus. EV-A71 coincided with wave 1 and wave 2 (Figure 2a). Wave 3 was 
associated with the co-circulation of CV-A6 and CV-A16 (Figure 2b). The rate of EV 
negative samples started to increase in December, 2011 to reach a maximum in March, 
2012 and was very low during wave 3.  
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Spread of the disease in Hai Phong city. With one exception (commune 214), no early 
case was found along the main motorway (Supplementary Figure 2a). Early cases appeared 
in the northern and urban zone of the city (Supplementary Figure 3) and expanded to the 
west and to the south (Figure. 3). Each waves displayed a different main site of emergence 
(Figure 3, Supplementary Table 12). Wave 1 started in the city center whereas waves 2 and 
3 emerged at the periphery. The order of occurrence defined five groups of districts 
(Supplementary Figure 3): Hai Phong city center (Group 1), New urban areas in the 
southern part of the City and a western rural district (Group 2), peripheric districts and Do 
Son (Group 3), two rural districts not connected to the main road netwok (Group 4) and 
Cat Hai islands (Group 5). The diffusion of the disease to the south followed the axis 
supported by two main roads allowing to cross rivers and canals. No direct transmission of 
the disease was observed between the city center and these new urban areas during wave 2 
and 3. Patterns of transmission among groups were similar for the three waves. Re-
emergence of the disease during wave 2 and 3 shows similarity despite the presence of 
different etiological agent. 
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Discussion 
 
The first HFMD outbreak in North Vietnam. The 2011-2012 HFMD epidemic was the 
largest to have ever occurred in Vietnam and the first recorded in the northern part of the 
country while Hai Phong city experienced the highest HFMD incidence in North Vietnam. 
However, no fatal cases were reported in Hai Phong unlike what was observed in South 
Vietnam (9). The age of the patient was the single most important variable. Age-specific 
incidence was the highest in the 1-2 year age group. This would be in agreement with both 
the persistence of maternally-derived neutralizing antibodies for up to 6 months and the 
kinetics of seroprevalence of EV-A71 virus neutralizing antibodies which increases with 
age (15,16). However, this was the very first recorded outbreak of HFMD in northern 
Vietnam questioning thus the existence of maternally-derived neutralizing antibodies or 
pre-existing immunity. Children under 3 represented 85.85% of cases. They are in Vietnam 
traditionally cared for at home by family members. The high HFMD incidence in this 
population may thus have resulted from contact with adults and older children acting as 
asymptomatic carriers of the virus (17,18).  
 
Guidelines positively influence disease management. The first guideline released related 
to surveillance, prevention and control and gave clear HFMD case definition, reporting 
procedure and strategy for collecting clinical samples. The first effect of the guideline 
release was a signifcant increase of the severity score. Indeed, 73.41% of patients were 
scored 2a after guidelines publication but only 25.59% before. The number of moderate 
and severe cases admitted to Hai Phong pediatric hospital increased significantly after 
guidelines publication while the proportion of the mild cases decreased sharply. Another 
positive effect was the reduced delay between onset and admission after guidelines 
publication. It decreased during the second period and remained very homogeneous. The 
presence of 9 out of 10 clusters in the first half of the outbreak supports this conclusion. 
The most important feature of the second guideline was the decentralization and transfer of 
responsibility to health care facilities. A more homogeneous spatial distribution of patients 
visiting pediatric hospitals was visible. Mild cases were treated at the commune level 
whereas districts were in charge of mild and moderate cases. At the province level, all 
cases were addressed. All patients recorded as severe went to province hospitals during 
period 2 while local health facilities hosted patients unable to go to main hospitals. Patients 
who remained at home only displayed mild symptoms.  
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Awareness and legal framework. This positive effect of guidelines is not only the 
consequence of the publication of guidelines but also of an increased awareness and 
precautious approach from parents and physicians leading to patients being majoritarily 
declared with severe symptoms in order to ensure a better treatment and surveillance. This 
could explained why a higher disease severity scores was observed in CV-A-infected 
patients (wave 3) than in EV-A71 cases (p< 0.01). Awareness led to the modification of 
guidelines but changes occurred only after publication, suggesting that the legal framework 
created by the guidelines is needed for implementation eventhough awareness is present. 
Public and professional awareness are not sufficient for implementing changes. 
Furthermore, emergence of CV-A (wave 3) during the second period did not lead to 
variation in severity and time to admission. Conversely, the publication of guidelines 
during phase 2 led to different patient patterns although the virus was the same. Evolution 
of clinical patterns should not be considered only in the light of the evolution or 
replacement of pathogens or host-pathogen interactions but also according to the evolution 
of behavior and social perception. 
 
Shift of etiology. Improvement of molecular diagnostic was not considered by the new 
guidelines and they therefore had no impact on the detection of etiological agents in 
patients. During the Hai Phong outbreak, circulation of both EV-A71 and CV-A was 
recorded, a feature already reported (8,19,20,21,22). EV-A71 virus is considered to be the 
most frequent cause of severe HFMD disease (10,23,24) although CV-A have been shown 
to cause severe infections with meningitis (25). An uncharacterized virus might also have 
circulated during wave 1 and mostly wave 2. The high number of EV non-positive PCR 
reactions on clinically positive samples suggests that the set of primers used for enterovirus 
detection might not have been discriminative enough. The ratio of non-positive tests was 
similar to those previously reported (26,27,28,29). EV-A71 detection with MAS primers 
should thus be systematically performed on SO primers products and SO222 primer should 
be redesigned to match with the 5’ part of the AN88 primer used for EVs detection. More 
attention should be therefore paid to the PCR negative patients. 
 
Spatio-temporal dynamic and disease control. Nguyen et al. (9) have shown the 
presence of HFMD in provinces west of Hai Phong after the outbreak started in South 
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Vietnam, making the northwestern side of Hai Phong is the most likely route of entry. 
Despite, the main economical role of Hai Phong no early cases occurred along or at the end 
of the main highway linking Hai Phong to the rest of the country, indicating that major 
industrial and export commercial movements are not linked to the dynamic of the disease. 
Instead the disease seems to have expanded following the eastbound river system to reach 
densely populated settlements from where it secondarily expanded through local roads. 
Disease expansion might thus have followed secondary local commercial routes. This 
commercial route allows time for the disease to be transmitted and involves a lot of 
favorable human to human contacts. The presence of early cases in the island and in 
isolated coastal localities in the southern part of the city also illustrates the role of sea 
transportation and role of the local trade and occupational activities in the spread of the 
disease. The southern part may have been affected later due to fragmentation of the 
territory and isolation of the communes by the complex river system. The early occurrence 
of the disease in northwestern communes not connected to the main local road might be 
related to a specific occupational activities. Considering the average age of the patients, 
around 2, the source of contamination must be sought for within asymptomatic adults 
being contaminated during their occupational activities and in local and regional 
movements. 
 
Supplementary Figure 1 
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Supplementary Figure 2 
 
 
 
Supplementary Figure 3 
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Supplementary Table 2. Characteristics of reported HFMD cases in Hai Phong city, 
2011-2012 
 
Characteristics HFMD cases in Hai Phong city during Children(< 14 years 
old) in Hai Phong 
city (%) 
p value 
2011 (n=3029) 
n (%) 
2012 (n=6592) 
n (%) 
Total (n=9621) 
n (%) 
  
Gender      
    girls 1,162(38.36) 2,711(41.13) 3,873(40.26) 186.445 (47)  
    boys 1,867(61.64) 3,881(58.87) 5,748(59.74) 206.291 (53) p< 0.01 
Age (year)      
    median (IQR) 2 (2) 2 (2) 2 (2) NA  
< 0.5 71(2,41) 101(1.63) 172 (1.88) NA  
    0.5 - 1 726 (24.60) 2109 (34.08) 2835 (31.02) NA  
    1-2 970 (32.87) 2097 (33.88) 3067 (33.56) NA  
    2-3 629 (21.31) 1143 (18.47) 1772 (19.39) NA  
    3-4 283 (9.59) 407 (6.58) 690 (7.55) NA  
    4-5 139 (4.71) 180 (2.91) 319 (3.49) NA  
    5-10 119 (4.03) 129 (2.08) 248 (2.71) NA  
>10 14 (0.47) 23 (0.37) 37 (0.40) NA NA 
Severity*      
   mild 2109 (69.63) 1993 (30.41) 4102 (42.81) NA  
   moderate 849 (28.03) 4413 (67.34) 5262 (54.92)   
   severe 71 (2.34) 147 (2.24) 218 (2.28) NA NA 
   fatal 0 0 0   
Living area      
   not urban 1474 (48.66) 4080 (61.89) 5554 (57.73) 177.518 (0.55)  
   urban 1555 (51.33) 2512 (38.11) 4067 (42.27) 215.219 (0.45) p<0.01 
Pathogen      
   Non EV-A71 13 (20) 68 (58.12) 81(44.51) NA  
   EV-A71 52 (80) 49 (41.88) 101 (55.49) NA p<0.01 
p value (Chi-square test); NA: not available 
*Mild cases correspond to uncomplicated disease (severity level =1). 
*Moderate cases correspond to uncomplicated disease (severity level =2a). 
*Severe cases correspond to more complicated forms of the disease (severity level = 2b,3 or 4). 
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Supplementary Table 3: Age of HFMD patients by epidemic waves in Hai Phong City 
(2011-2012) 
 
Age groups of HFMD cases Wave 1 
 
Wave 2  
 
Wave 3  
 
p value 
under 2 years 1150  
(34.57) 
907  
(25.41) 
1191  
(59.11) 
p< 0.01 
2 years & more 2177  
(65.43) 
2663  
(74.59) 
824  
(40.89) 
Total 3327 (100%) 3570 (100%) 2015 (100%)  
p value (Chi-square test) 
 
Supplementary Table 4: Gender, age, living area, pathogen, delay of admission of 
HFMD reported cases by severity in Hai Phong city, 2011 - 2012.  
 
Characteristics Mild cases Moderate cases Severe cases p value 
Gender 
female 1680 (40.96)b 2094 (39.79) 86 (39.45) 
p = 0.50 
male 2422 (59.04) 3168 (60.21) 132 (60.55) 
Age 
>= 2 years 2838 (69.19) 3023 (57.45) 142 (65.14) 
p < 0.01* 
< 2 years 1264 (30.81) 2239 (42.55) 76 (34.86) 
Living area 
not urban 2431 (59.26) 2976 (56.56) 125 (57.34) 
p < 0.05* 
urban 1671 (40.74) 2286 (43.44) 93 (42.66) 
Pathogen 
Non EV-A71 54 (78.26) 15 (19.23) 12 (34.29) 
p < 0.01* 
EV-A71 15 (21.74) 63 (80.77) 23 (65.71) 
Delay of 
admission 
> 1 day 2451 (59.75) 4551 (86.49) 193 (88.53) 
p < 0.01* 
= < 1 day 1651  (40.25) 711 (13.51) 25 (11.47) 
p value (Chi-square test) 
 
Mild cases correspond to uncomplicated disease (severity level =1). 
Moderate cases correspond to uncomplicated disease (severity level =2a). 
Severe cases correspond to more complicated forms of the disease (severity level = 2b,3,4). 
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Supplementary Table 5. Age groups and severity of reported HFMD cases by 
epidemic outcomes in Hai Phong city between 2011 and 2012 
Severity 
Wave 1  Wave 2  Wave 3  
Age of HFMD patient Age of HFMD patient Age of HFMD patient 
under  
2 years 
2 years 
& 
more 
p value 
under  
2 years 
2 years 
& more 
p 
value 
under  
2 years 
2 years 
& 
more 
p 
value 
Mild 
727 
(63.33) 
1492 
(68.76) 
P < 
0.05 
203              
(22.43) 
1027 
(38.98) 
p< 
0.01 
190 
(15.95) 
174 
(21.12) 
p< 
0.01 
Moderate 
387 
(33.71) 
636 
(29.31) 
683 
(75.47) 
1528 
(57.99) 
981 
(82.37) 
635 
(77.06) 
Severe 
34 
(2.96) 
42 
(1.94) 
19  
(2.1) 
80 
(3.04) 
20           
(1.68) 
15 
(1.82) 
Total 
1148 
(100%) 
2170 
(100%)   
905 
(100%) 
2635 
(100%)   
1191 
(100%) 
824 
(100%)   
p value (Chi-square test) 
 
Mild cases correspond to uncomplicated disease (severity level =1). 
Moderate cases correspond to uncomplicated disease (severity level =2a). 
Severe cases correspond to more complicated forms of the disease (severity level = 2b,3,4). 
 
p < 0.05, indicating that the severity distribution differs significantly between both age 
groups.
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Supplementary Table 6. Gender, Severity, Living area and Delay of admission of reported HFMD cases by epidemic waves in Hai Phong city (2011-2012) 
Epidemic 
waves 
Gender Severity  Living area  Delay of admission 
Male female Test* mild moderate 
sever
e 
Test§ urban rural Test* 
mea
n 
SD test# 
All period 
5748 
(59.74) 
3874 
(40.26) 
p< 
0.01 
3813 
(42.97) 
4850 
(54.66) 
210 
(2.37) NA 
4067 
(42.27) 
5554 
(57.73) 
p< 
0.01 2.08 
1.0
6 NA 
Wave 1 
 
2023 
(60.81) 
1304 
(39.19) 
p< 
0.01 
2219 
(66.88) 
1023 
(30.83) 
76 
(2.29) 
p< 
0.01 
1628 
(48.93) 
1699 
(51.07) 
p< 
0.01 2.47 
1.3
7 p< 
0.01 Wave 2 
 
2063 
(57.79) 
1507 
(42.21) 
p< 
0.01 
1230 
(34.75) 
2211 
(62.46) 
99 
(2.8) 
1286 
(36.02) 
2284 
(63.98) 
p< 
0.01 1.85 
0.7
9 
Wave 3 
 
1227 
(60.89) 788 (39.11) 
p< 
0.01 364 (18.06) 1616 (80.2) 
35 
(1.74) 838 (41.59) 
1177 
(58.41) 
p< 
0.01 1.87 
0.7
3  
*: Chi2 one sample, proportion comparison with whole population (male rate = 0.53 and urban rate = 0.45) 
§: Chi2 test for proportion comparison of multi groups 
#: one-way ANOVA test for mean comparison of multi groups 
 
Mild cases correspond to uncomplicated disease (severity level =1). 
Moderate cases correspond to uncomplicated disease (severity level =2a). 
Severe cases correspond to more complicated forms of the disease (severity level = 2b,3,4). 
p < 0.001, indicating that the severity distribution differs significantly between the three waves 
 
 98 
 
Supplementary Table 7. Age groups, severity, delay duration and living area of reported HFMD cases by epidemic period in Hai Phong city 
between 2011 and 2012 
 
 
Epidemic 
periods 
Age groups Severity 
 
Delay duration 
 
 
Living area 
under  
2 years 
2 years 
& more 
p 
value 
mild moderate severe p value 
1 day  
& less 
2 days 3 days 
4 days  
& more 
p 
value 
Not 
urban 
urban 
p 
value 
1st period 
1337 
(39.30) 
2850 
(55.93) 
P < 
0.01 
2817              
(80.28) 
1271 
(25.59) 
88 
(44.44) 
p< 
0.01 
1265 
(63.44) 
1118 
(27.14) 
1036 
(66.71) 
768 
(92.42) 
p< 
0.01 
2168 
(45.91) 
2019 
(53.47) 
p< 
0.01  
2nd period  
 
2065 
(60.70) 
2246 
(47.07) 
692 
(19.72) 
3509 
(73.41) 
110 
(55.56) 
729 
(36.56) 
3002 
(72.86) 
517 
(33.29) 
63 
(7.85) 
2554 
(54.09) 
1757 
(46.53) 
Total 
3402 
(100%) 
5096 
(100%) 
  
3509 
(100%) 
4780 
(100%) 
198 
(100%) 
  
1994  
(100%) 
 
4120  
(100%) 
 
1553  
(100%) 
831 
(100%) 
  
4722 
(100%) 
3776 
(100%) 
 
p value (Chi-square test) 
 
Mild cases correspond to uncomplicated disease (severity level =1). 
Moderate cases correspond to uncomplicated disease (severity level =2a). 
Severe cases correspond to more complicated forms of the disease (severity level > 2b,3,4). 
1st period: first half of the epidemic (Apr 2011 – 24th Feb 2012). 
2nd period: second half of the epidemic (30th Mar 2012 – 31th Dec 2012). 
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Supplementary Table 8. Severity of reported HFMD cases at place of admission by epidemic periods in Hai Phong city between 2011 and 2012 
 
 
Epidemic 
periods 
Commune health station District hospital Hai Phong Pediatric hospital At home (outpatient) 
mild moderate severe sum mild moderate severe sum mild moderate severe sum mild moderate severe sum 
1st period 
4  
(67) 
- 
2 
(34) 
6  
(100) 
508             
(93) 
34  
(6.5) 
3 
(0.5) 
545 
(100) 
1742 
(62) 
1012 
(36) 
59  
(2) 
2813 
(100) 
6 
(60) 
4 
(40) 
- 
10 
(100) 
 
2nd period  
 
21 
(95) 
- 
1 
(5) 
22 
(100) 
429 
(28) 
1086  
(71.8) 
3 
(0.2) 
1518 
(100) 
93 
(3.5) 
2418 
(93) 
93  
(3.5) 
2604 
(100) 
147 
(100) 
0 
(0) 
- 
147 
(100) 
  p value: not apply  p value < 0.01  p value < 0.01   p value: not apply  
p value (Chi-square test) for proportion comparison between mild group vs (moderate + severe) group 
Mild cases correspond to uncomplicated disease (severity level =1). 
Moderate cases correspond to uncomplicated disease (severity level =2a). 
Severe cases correspond to more complicated forms of the disease (severity level > 2b,3,4). 
1st period: first half of the epidemic (Apr 2011 – 24th Feb 2012). 
2nd period: second half of the epidemic (30th Mar 2012 – 31th Dec 2012). 
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Supplementary Table 9. Age groups of reported HFMD cases at place of admission in Hai Phong city in 2 periods of the epidemic 
 
 
Age 
group 
1
st
 Period of epidemic 2
nd
 Period of epidemic 
Commune  
health station &  
At home 
District 
hospital 
Hai Phong  
Pediatric hospital 
Sum p value 
Commune  
health station &  
At home 
District 
hospital 
Hai 
Phong  
Pediatric 
hospital 
Sum p value 
under  
2 years 
 
5 
(0.5) 
 
 
168 
(16.5) 
 
822               
(83) 
995  
(100) 
p = 0.261 
 
56 
(2.7) 
 
 
679 
(33.3) 
 
1305              
(64) 
2040  
(100) 
p < 0.001 
 
2 years 
& more  
 
5 
(0.2) 
 
 
377 
(15.8) 
 
2002  
(84) 
2384 
(100) 
 
91 
(4.08) 
 
 
839 
(37.64) 
 
1299  
(58.28) 
2229 
(100) 
p value (Chi2 test) 
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Supplementary Table 10a. Living area of reported HFMD cases at place of admission in Hai Phong city 
 
 
Living 
area 
1
st
 Period of epidemic 2
nd
 Period of epidemic 
Commune  
health station &  
At home 
District 
hospital 
Hai Phong  
Pediatric hospital 
Sum p value 
Commune  
health station &  
At home 
District 
hospital 
Hai Phong  
Pediatric 
hospital 
Sum p value 
urban 
 
8 
(0.5) 
 
 
114 
(7.5) 
 
1427               
(92) 
1549  
(100) 
p* = 
0.261 
 
138 
(8) 
 
 
235 
(13.5) 
 
1358              
(78.5) 
1731  
(100) 
p < 0.001 
 
Not urban 
 
2 
(0.1) 
 
 
431 
(23.5) 
 
1397  
(76.4) 
1830 
(100) 
 
9 
(0.35) 
 
 
1283 
(50.55) 
 
1246 
(49.09) 
2538 
(100) 
p value (Chi2 test) 
p* value (Fisher exact test) 
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Supplementary Table 10b. Living area of reported HFMD cases at Hai Phong pediatric hospital 
 
Living area 
Hai Phong 
Pediatric hospital 
1
st
 period 2
nd
 period Sum p value 
urban 
 
1427 
(51.24) 
 
 
1358 
(48.76) 
 
2785 
(100) 
p = 0.233 
 
Not urban 
 
1397 
(52.86) 
 
 
1246 
(47.14) 
 
2643 
(100) 
p value (Chi2 test) 
 
Supplementary Table 10c. Living area and severity of reported HFMD cases in Hai Phong pediatric hospital city 
 
Living area 
Hai Phong pediatric hospital 
1st period 2nd period 
mild moderate severe sum p value mild moderate severe Sum p value 
Urban 
896 
(63.01) 
496 
(34.88) 
30 
(2.11) 
1422 
(100) 
p = 0.47 
47              
(3.46) 
1275 
(93.89) 
36 
(2.65) 
1358 
(100) 
p = 0.02 
Not urban 
846 
(60.82) 
526 
(37.10) 
29 
(2.08) 
1391 
(100) 
46 
(3.69) 
1143 
(91.73) 
57 
(4.57) 
1246 
(100) 
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Supplementary Table 11: Clusters (groups) of patients obtained by hierarchical classification  
 
Cluster HFMD cases Meanage 
Mean 
gender 
Mean 
delay 
Mean 
severity 
Urban living (%) Wave 1 Wave 2 Wave 3 Cluster description 
All 8824 2.02 0.58 2.10 1.61 
3745 
(42.44) 
3152 3932 1740 
 
cluster 1 1142 2.92 0.50 0.80 1.17 
415 
(36.33) 
455 556 121 mild cases before guidelines 
cluster 2 2087 2.65 0.56 2.35 1.57 
896 
(42.93) 
788 1061 238 homogeneous 
cluster 3 440 1.01 0.60 0.77 1.57 
166 
(37.72) 
227 117 96 young with short delay 
cluster 4 3373 1.29 0.60 2.16 1.84 
1447 
(42.89) 
652 1647 1074 after guidelines 
cluster 5 423 1.4 0.60 4.14 1.34 
222 
(52.48) 
339 40 14 W1, long delay 
cluster 6 119 1.88 0.59 5.65 1.11 
73 
(61.34) 
116 3 0 W1, long delay 
cluster 7 200 3.64 0.59 4.36 1.17 
123 
(61.50) 
180 20 0 W1, old children 
cluster 8 357 4.37 0.59 2.42 1.4 
173 
(48.45) 
166 161 30 Old children 
cluster 9 69 2.69 0.62 4.36 2.13 
43 
(62.31) 
50 15 4 sever cases W1 
cluster 10 614 1.46 0.61 0.99 2.21 
187 
(30.45) 
149 303 162 after guidelines, sever 
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Supplementary Table 12. Propagation of the HFMD epidemic among Hai Phong city districts according to median case. Rural and urban 
districts were differentiate (Type) and described according to major features (short + long description). Stratification (Group) was performed according 
to the relative order of median in the three waves (Suppl Fig 3). Date of the median case and relative order of the district was given for each waves. 
 
Name type Short long description Group Median W1 Wave1 Median W2 Wave2 Median W3 Wave3 
Ngô Quyền urban HPC Hai Phong city center G1 24/11/2011 1 21/04/2012 11 14/10/2012 12 
Hải An urban HPC area encompassing airport and harbor G1 25/11/2011 2 22/04/2012 13 14/10/2012 13 
Hồng Bàng urban HPC west suburb, industrial G1 27/11/2011 4 18/04/2012 10 10/10/2012 10 
Lê Chân urban HP close to Hai Phong city center G2 25/11/2011 3 16/04/2012 7 27/09/2012 5 
Kiến An urban HP new suburb, south G2 29/11/2011 5 16/04/2012 8 15/09/2012 2 
An Dương Rural W rural, west, along tracks + big crossroad G2 30/11/2011 6 21/04/2012 12 02/10/2012 7 
Dương Kinh urban HP new area close to highway G3 01/12/2011 7 10/03/2012 1 19/09/2012 4 
Đồ Sơn urban DS city in the south, harbor, industry G3 01/12/2011 8 14/04/2012 6 17/10/2012 14 
Thủy Nguyên Rural N rural, north G3 03/12/2011 9 31/03/2012 3 13/10/2012 11 
Kiến Thụy Rural E rural, south, between Hai Phong and Đồ Sơn G3 04/12/2011 10 23/03/2012 2 07/10/2012 8 
Tiên Lãng Rural S rural south G3 07/12/2011 11 04/04/2012 4 09/10/2012 9 
An Lão Rural W rural, west, motorway junction G4 09/12/2011 13 16/04/2012 9 02/10/2012 6 
Vĩnh Bảo Rural S rural, extrem south G4 16/12/2011 14 05/04/2012 5 17/09/2012 3 
Cát Hải Rural E island G5 07/12/2011 12 23/04/2012 14 29/08/2012 1 
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7. Figures legends 
 
Figure 1. Evolution of HFMD cases and clinical parameters (age, delay of admission 
and severity) over the epidemic period (2011-2012) 
 
a. Monthly HFMD cases in northern Vietnam (2011-2012) 
Number of HFMD cases reported to Vietnam Ministry of Health as routine surveillance in 
2011 and 2012. 
 
b. Weekly HFMD cases and severity distribution in Hai Phong city (2011-2012) 
Number of HFMD cases weekly reported to the National Institute of Hygiene and 
Epidemiology (NIHE), 2011-2012. Each epidemiologic week begins on Monday. 
Mandatory reporting of the disease began in 2011. Severity levels are based on guidelines 
from WHO for HFMD clinical assessment and cases management. Mild cases are cases 
free of complication (severity score = 1). Moderate cases are with severity score = 2a. 
Severe cases are characterized by febrile exanthematous symptoms affecting the central 
nervous system, frequently myoclonus and more severe neurological complications 
(severity score = 2b,3,4). 
 
c. Monthly distribution of age groups of HFMD patients in Hai Phong city (2011-2012) 
Age of the HFMD patient is divided in to 2 group; less than 2 year old and 2 year old and above. 
 
d. Monthly distribution of delay of admission of HFMD patients in Hai Phong city 
(2011-2012). 
The delay admission is the difference between the date of admission of the patient at the 
hospital and the date of onset. The distribution shows the proportion of delay of admission 
for the following classes: one day, two days, three days or four days and more. 
 
Figure 2. Spatio-temporal distribution of the PCR identifications in Hai Phong 
EVs represent all positive results with Enteroviruses using semi-nested PCR. 
EV-A71 represent all positive results with EV-A71 using semi-nested PCR.  
“Non-positive” represents all negative results with Enteroviruses using semi-nested PCR 
 
a. Time flow of the 257 PCR identification of HFMD epidemic in Hai Phong.  
b. Spatial distribution of the 257 PCR identifications in Hai Phong city.  
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Figure 3. Sites of emergence and expansion of the three waves of HFMD in Hai Phong 
city 
Shades of grey represent the five goups of districts. 
 
Supplementary Figure 1.  Hierarchical classification of HFMD cases 
A specific threshold (horizontal dashed line) was applied to defined ten clusters which are 
C1, C2, C3, C4, C5, C6, C7, C8, C9 and C10. The hierarchical classification was 
performed on type cases which represent all the patients displaying the same values for 
age, severity and time after onset to admission. 
 
Supplementary Figure 2. Spatio-temporal distribution of HFMD case in Hai Phong city 
 
a. Time and place of occurrence of HFMD case 
Colours represent interval of occurrence of the index case in each commune. Rivers 
are shown in blue and roads are shown in dark grey. Line width is proportional to 
the importance of the system. Numbers represent the referenced commune number. 
  
b. Land cover and human settlements 
The land cover map (GLC30, 2010) shows 6 main classes of objects detected on 
satellite images: cultivated land, artificial surface (settlements), forest, grassland, 
land water bodies and wetlands. Numbers represent the referenced communes. 
 
 
Supplementary Figure 3. Propagation of the HFMD epidemic among Hai Phong city 
districts according to median case. 
Rural and urban districts were differentiated (Type) and described according to major 
features (supplementary table 12). Stratification (Group) was performed according to the 
relative order of median in the three waves. Date of the median case and relative order of 
the district was given for each waves. 
!
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CHAPTER 2. EVOLUTION OF EV-A71 ENTEROVIRUSES IN VIETNAM 
 
2.1. Context of study 
 
Hand, foot and mouth disease (HFMD) is usually mild and self-limiting, in some 
cases HFMD can result in severe complications such as encephalitis, aseptic meningitis, 
pulmonary edema, myocarditis, and death (80). HFMD is caused by members of Human 
Enterovirus A, a family of picornavirus which includes Coxsackievirus A (CV-A) and 
Human Enterovirus 71 (EV-A71) (34). Both EV-A71 and CV-A infection has been 
associated with severe HFMD in young children, sometimes resulting in death (35), (36), 
(37). 
Enteroviruses are characterized by the presence of 4 structural proteins, VP4 being 
the internal capsid protein and VP1, VP2 and VP3 making the three external capsid 
proteins (30). VP1 is the most external and is the main component of the canyon on the 
surface of picornaviruses. VP1 is involved in viral pathogenicity, receptor binding and 
immune modulation of EV71 (73), (117). Differences in EV-A71 strains might contribute 
to the different severity of the disease (41), (44), and virulence determinants have been 
identified in the VP1 protein such as residues G/Q/R at position VP1-145, E at VP1-164 
(118), (119), (120). VP1 is used to classified enteroviruses. Based on the VP1 gene, EV-
A71 is classified into three independent genogroups: A, B, and C. The EV-A71 B and C 
genogroups are each further subdivided into five genotypes, B1 to B5 and C1 to C5 (39).  
Although EV-A71 was isolated for the first time in Vietnam in 2003, the first 
outbreak of HFMD was not reported in the southern provinces until 2005. The 2005 
outbreak was associated with EV-A71 C1, C4 and C5 genotypes and Coxsackievirus A16 
(22), (23). Since 2011, Vietnam have experienced continuosly large outbreaks of HFMD 
and the disease became a notifiable one in the national communicable disease surveillance 
system. Besides epidemiology features, etiological agents information of this disease in 
Viet Nam is mostly reported the distribution and some immunology aspects but mutation, 
pathogenicity, vilulent ananlysis of the pathogen still limited. The 2011 - 2012 HFMD 
outbreak was the first one to occur in North Vietnam providing thus a ground to study the 
etiology, origin and dynamic of the disease. We report here the analysis of the VP1 gene of 
strains isolated throughout North Vietnam during the 2011-2012 outbreak. 
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2.2. Objective 
To analyse pathogenicity-related mutations in the VP1 sequence of EV-A71 strains 
isolated throughout Northern Vietnam during the 2011-2012 outbreak. 
 
2.3. Discussion and conclusions 
This work provides an insight on the evolution and dynamic of the EV-A71 
enterovirus during the first outbreak recorded in North Vietnam in 2011-2012. The first 
conclusion is that the 2011-2012 outbreak in North Vietnam was not due a single 
exogenous strain imported from South Vietnam where HFMD outbreaks were present (24), 
or from another region. All variant populations observed during the 2011-2012 outbreak 
were already present in North Vietnam. The only exception is the VVV population which 
was found only in 2011 in three different provinces. However, the phylogenetic analysis 
indicated that this VVV variant was the closest to the root and therefore to the mother and 
oldest population. The reason for the lack of VVV variants in samples older than 2011 is 
most likely related to the low number of samples and to the low prevalence of this 
population. There is no clear explanation either for the surge of variants VII and IIV in the 
first part of the epidemic and altogether the question remains of what triggered the 
outbreak in 2011 although all virus populations were already present. All I/V populations 
present at the beginning of the outbreak were capable of triggering it as shown by the 
replacement in 2012. It is not related either to the subgenogroup since the populations 
which emerged in 2012 belonged to two different subgenogroups, the VIV variant 
belonging the subgenogroup C4 and the IVI variant being a member of subgenogroup C5. 
A partial explanation could be a differential susceptibility of the human population which 
could have been slightly more susceptible to the VII and IIV groups. Another explanation 
might be found in the spatial distribution of the various variant groups, the socio-economic 
pattern and the route of dissemination. This work was not structured to address this issue 
and specific sampling schemes as well as transversal analyses should thus be further 
undertaken.  
 
Another main outcome of this work is the observed correlation between the I/V 
variant groups and phylogeny, pathogenicity and ethnicity. The I/V groups, although based 
on the relative arrangement of only three amino-acids, overlap the different clusters 
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identified. These clusters correspond to genetically different populations characterized by 
specific polymorphism traits. This overlap between the specific combination of I/V 
residues at three positions and the phylogeny established over the whole sequence indicates 
the occurrence of a selective pressure on the I/V arrangement. The high conservation of the 
proteins, despite variability at the nucleotide level, indicative of a negative, or purifying, 
selection pressure, whereas the clustering at the protein level is driven by the I/V 
arrangement. The remaining question is what is the selective pressure acting on the I/V 
variants and what could be the role of these I/V mutations. The I/V mutations are located at 
positions 249, 262 and 284 of the Vp1 protein. The recurrent reports of the involvement of 
isoleucine and valine in the viral pathogenicity process in different viruses as well as their 
involvement in the selective pressure applied on the EV-A71 samples analyzed in this 
work suggest that the I/V pattern at positions 249, 262 and 284 on the VP1 protein might 
play a role in pathogenicity. The observed correlation of the I/V variant populations with 
severity and ethnicity strengthen this hypothesis. However, the ethnicity correlation could 
be a result of spatial structuration since ethnicity-2 is mostly present in the Hòa Bình 
province. This in turn would suggest that the various EV-A71 variants display a 
geographic specificity.  
 
Altogether, these data suggest that EV-A71 strains could remain in a low level, 
asymptomatic state, in genomic stasis and with a geographic structuration. The cause for 
outbreaks should thus be sought for in the socio-economic patterns rather than in 
exogenous emergence. Further investigations are needed to investigate this hypothesis and 
to bring valuable information for the management of this pediatric diseases. 
 
The results of this work are summarized in the article entitled “Valine/isoleucine 
variants drive selective pressure in the VP1 sequence of EV-A71 enteroviruses” is 
presented thereafter. 
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Abstract 
Background: In 2011-2012, Northern Vietnam experienced its first large scale hand 
foot and mouth disease (HFMD) epidemic. In 2011, a major HFMD epidemics was 
also reported in South Vietnam with fatal. This 2011-2012 outbreak was the first one 
to occur in North Vietnam providing thus a ground to study the etiology, origin and 
dynamic of the disease. We report here the analysis of the VP1 gene of strains 
isolated throughout North Vietnam during the 2011-2012 outbreak and before. 
 
Methods: The VP1 genes of 106 EV-A71 virus from North Vietnam and 2 from 
Central Vietnam were sequenced. Sequences alignments were analyzed at the nucleic 
acid and protein level. Gene polymorphism was also analyzed. A Factorial 
Correspondence Analysis was performed to correlate amino acid mutations with 
clinical parameters. 
 
Results: The sequences were distributed into four phylogenetic clusters. Three 
clusters corresponded to the subgenogroup C4 and the last one corresponded to the 
subgenogroup C5. Each cluster displayed different polymorphism characteristics. 
Proteins were highly conserved but three site bearing only Isoleucine (I) or Valine 
(V) were characterized. The isoleucine / valine variability matched the clusters. 
Spatiotemporal analysis of the I/V variants showed that all variants which emerged 
in 2011 and then in 2012 were not the same but were all present in the region prior to 
the 2011-2012 outbreak. Some correlation was found between certain I/V variants 
and ethnicity and severity. 
Conclusions: The 2011-2012 outbreak was not caused by an exogenous strain 
coming from South Vietnam or elsewhere but by strains already present and 
circulating at low level in North Vietnam. However, what triggered the outbreak 
remained unclear. A selective pressure is applied on I/V variants which matches the 
genetic clusters. I/V variants were shown on other viruses to correlate with 
pathogenicity. This should be investigated in EV-A71. I/V variants are an easy and 
efficient way to survey and identify circulating EV-A71 strains.  
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Background 
 
Hand, foot and mouth disease (HFMD) is an acute febrile illness in children with a 
papulovesicular skin rash at the palms or soles of the feet, or both. Presentation can 
be with or without inclusion of mouth ulcers. Although the disease is usually mild 
and self-limiting, in some cases HFMD can result in severe complications such as 
encephalitis, aseptic meningitis, pulmonary edema, myocarditis, and death (WHO, 
2011). HFMD is caused by members of Human Enterovirus A, a family of 
picornavirus which includes Coxsackievirus A (CV-A) and Human Enterovirus 71 
(EV-A71) (Ang et al., 2009; Chen et al., 2007). The EV-A71 viruses are genetically 
related to CV-A; indeed, it has been suggested that these viruses may have diverged 
as recently as the 1940s (Tee et al., 2010). Both EV-A71 and CV-A infection has 
been associated with severe HFMD in young children, sometimes resulting in death 
(Abu Bakar et al., 1999; Ooi et al., 2010; Zeng et al., 2010). 
 
Enteroviruses are characterized by the presence of 4 structural proteins, VP4 being 
the internal capsid protein and VP1, VP2 and VP3 making the three external capsid 
proteins (Carter and Saunders, 2007). VP1 is the most external and is the main 
component of the canyon on the surface of picornaviruses. VP1 is involved in viral 
pathogenicity, receptor binding and immune modulation of EV-A71 (Kataoka et al., 
2015; Yang et al., 2011). Differences in EV-A71 strains might contribute to the 
different severity of the disease (McMinn et al., 2001; Sanders et al., 2006) and 
virulence determinants have been identified in the VP1 protein such as residues 
G/Q/R at position VP1-145, E at VP1-164 (Li et al., 2011; Huang et al., 2015; Caine 
et al., 2016). VP1 is used to classified enteroviruses. Based on the VP1 gene, EV-
A71 is classified into three independent genogroups: A, B, and C. The EV-A71 B 
and C genogroups are each further subdivided into five subgenogoups, B1 to B5 and 
C1 to C5 (Brown et al., 1999).  
 
Although EV-A71 was isolated for the first time in Vietnam in 2003, the first 
outbreak of HFMD was not reported in the southern provinces until 2005. The 2005 
outbreak was associated with EV-A71 C1, C4 and C5 genotypes and Coxsackievirus 
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A16 (Tu et al., 2007; Khanh et al., 2012). In 2011, a major HFMD epidemics was 
reported in South Vietnam with fatal cases reported (Nguyen et al., 2014). This 
2011-2012 outbreak was the first one to occur in North Vietnam providing thus a 
ground to study the etiology, origin and dynamic of the disease. We report here the 
analysis of the VP1 gene of strains isolated throughout North Vietnam during the 
2011-2012 outbreak. 
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Methods 
Epidemiological information and source of specimens. All HFMD cases in Hai 
Phong city were reported to the National Institute of Hygiene and Epidemiology 
(NIHE) through the national communicable disease surveillance system since 2011. 
HFMD patients that were present to health centers or hospitals were diagnosed and 
classified in 4 severity levels. The evaluation of the disease was performed according 
to the guidelines specifically published by the Vietnamese Ministry of Health which 
are based on but slightly differ from WHO and Taiwanese guidelines (Huang et al., 
1999, WHO, 2011). 
 
Sampling and culture. Ninety four samples were obtained from hospitalized 
patients diagnosed with EV A71 HFMD in 19 out of 28 provinces in North Vietnam 
in 2011 and 2012 and stored at - 80°C. They were completed by fourteen reference 
samples obtained from previous cases of EV A71 HFMD between 2003 and 2010 in 
seven provinces in North Vietnam and two provinces in Central Vietnam (Table 1). 
All samples were sent to the Enterovirus Laboratory of NIHE for etiological assays. 
Enterovirus-positive and EV-A71-positive samples were identified according to Nix 
et al (2006) using SO (SO224/SO222), AN (AN88/AN89) and MAS 
(MAS01S/MAS02A) (Perera et al., 2004) primer sets. EV A71 viruses were 
cultivated on RD cell according to WHO procedure (WHO, 2011). Viral RNA was 
extracted from throat swab using QIAamp® Viral RNA Mini Kit (Qiagen, Valencia, 
USA). The cDNA was first synthesized from the RNA for 10 min at 25oC and 
followed by amplification at 42oC for 50 min, 72oC for 15 min using primers AN32, 
AN33, AN34 and AN35 (13). 
 
Sequence analyses. Sequences were deposited in GenBank and accession numbers 
are provided in Table 1. The VP1 genetic sequences were aligned in Seaview 4.6 
(Gouy et al., 2010) using Muscle algorithm (Edgar, 2004). Best-fitting evolutionary 
models were determined by JModelTest 2.1 (Darriba et al., 2012) or by ProtTest 2.4 
(Abascal et al., 2005) using the corrected version of the Akaike Information Criterion 
(AICc). The phylogeny of VP1 was performed by Maximum Likelihood (ML) 
inference using the model GTR+G+F with Seaview 4.6 (Gouy et al., 2010). The 
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robustness of nodes was assessed with 500 bootstrap replicates. ML analysis of the 
amino acid sequences was performed using the model JTT+I+G with Seaview 4.6 
(Gouy et al., 2010). The robustness of nodes was assessed with 500 bootstrap 
replicates. Sequence polymorphism was investigated using the DnaSP 5.10.01 
package (Librado and Rozas, 2009). 
 
Bias and Ethics. Training session HFMD cases definition and reporting were 
organized for the staff of the routine surveillance system to enhance quality and 
consistency of case report. This work was conducted following the requirements of 
the Vietnamese Ministry of Health and under the Law of Communicable Diseases 
Prevention and Control passed in 2007. 
 
Factorial correspondence analysis. A factorial correspondence analysis (FCA) was 
performed using XLSTAT software (Addinsoft®). Variables considered were: amino 
acid profiles on positions 151, 164 and 186 (V/I), respectively in this work (249, 262 
and 284 on the full length VP1 protein), severity level, ethnicity, age of patients, and 
patient location. The best descriptive axes were retained, explaining 34% of the data 
spread. 
 
Spatio-temporal analysis. Administration data were obtained from GADM database 
of Global Administrative Areas (version 2.8, November 2015). Spatial analyses were 
conducted with Quantum GIS, version 2.8.2. All spatial data are in the WGS 84 
coordinate system. 
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Results 
 
Clinical and epidemiological features. Data are shown in Table 1. Patients age 
ranged from 2 months to 12 years old (median at 1.8 years, IQR of 1.5 years). 
102/106 (96.23%) patients were under 5. The age-specific incidence highest in the 1-
2 years age group (44 cases, 41.51%) and remained very low for older children. The 
lowest incidence was observed in infants under 6 months (2.83%) and children above 
10 years old (0.94%). Patients came from all parts of the region including 
mountainous, rural and urban areas. Out of 83 cases, 59 (71.08 %) belonged to main 
Vietnamese ethnicity (Ethnicity 1) while the rest of patients belonged to the minority 
Hmong ethnicity (Ethnicity 2) (Table 1). All severity levels were reported for the 
patients. Mild forms (severity level 1) made the majority of cases (57 cases, 61.29%) 
while 15 patients displayed severe symptoms (16.13%). Among this group, 3 patients 
displayed a severity score of 3. No case with the highest level of 4 was recorded. 
Moderate forms of HFMD were found in 21 patients (22.58). (Table 1) 
 
VP1 phylogeny and population structure. Phylogenetic analysis of the VP1 gene 
sequences indicated the presence of four clusters (Figure 1a). Cluster 1, the closest to 
the root, was the main one, comprising 56 sequences and structured into several 
subclusters characterized by low bootstrap values. Cluster 2 and cluster 3 comprised 
respectively 23 and 12 sequences and segregated from cluster 1 to which they were 
separated with a low bootstrap of 30. The last cluster, cluster 4, comprising 17 
sequences was characterized by a high bootstrap value (100) and was a derivate from 
cluster 3. A similar tree topology was observed when using protein alignments 
(Figure 1b). With respect to the current genogroup classification, clusters 1, 2 and 3 
belonged to the subgenogroup C4 whereas cluster 4 belonged to the subgenogroup 
C5 (Table 1). The VP1 protein was characterized by a high rate of conservation. 
However, three sites displayed a consistent Valine (V) / Isoleucine (I) variation. 
These sites, sites A, B and C were at position 151, 164 and 186, respectively in this 
work and 249, 262 and 284 on the full length protein. Six types of I/V variants were 
observed when considering the amino acids at sites A, B and C: VVI (1 sequence), 
IVI (15 sequences), IIV (28 sequences), VII (38 sequences), VIV (23 sequences) and 
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VVV (3 sequences) (Table 1). When attributing a color code for each I/V variant 
population and applying it to the phylogenetic tree a clear overlap with the 
previously detected clusters was observed (Figure 1). Cluster 4 overlapped with the 
IVI population while clusters 2 and 3 comprised the VII variants. The VVV, IVV 
and VIV variants all corresponded to cluster 1. However they did not mix and each 
one corresponded to a specific subcluster. The VVI variant derived from the cluster 4 
/ IVI group. Three exceptions were found, with VII variants present in clusters 1 and 
4. With respect to phylogeny, the I/V variant closest to the root is VVV, the VIV 
population emerged from this group and gave rise in turn to the IIV group. The VII 
groups, derived from the VIV group with first cluster 2 from which cluster 3 
evolved. The well separated cluster 4 / IVI variants evolved from cluster 3. This 
overlap between clusters and I/V populations was even stronger at the protein level 
since almost all the variability was borne by the I/V mutations, the rest of the protein 
being highly conserved. Groups VII, IIV, VVV and VIV belonged to the 
subgenogroup C4 whereas groups IVI and VVI belonged to the subgenogroup C5. 
 
Nucleic acid polymorphism. When considering the polymorphism of the various 
clusters identified, very different traits were observed (Table 2). Cluster 1 was 
polymorphic (! = 14.58) but with a 2.5 times more parsimony informative sites than 
singletons and 10-times more synonymous mutations than non-synonymous ones, 
suggesting that it is not a recent polymorphism or expanding population. The Ka/Ks 
ratio was also characterized by a low value. Conversely, cluster 2 displayed a very 
low level of polymorphism with a q of 4.06 and a low number of mutations η (η = 
15). The Ka/Ks was slightly higher at 0.107. This is suggesting the existence of a 
bottleneck at the origin of cluster 2. Cluster 3 which originated from cluster 2 was 
more polymorphic with a slightly increasing ! (! = 6.92) and number of mutations 
η (η = 19). Only synonymous mutations were observed resulting in turn in a very 
low Ka/Ks ratio of 0.029. Cluster 4 was on the other hand displaying a very high 
polymorphism with a η of 113 for 109 and a very high level of synonymous 
mutations (105 out of 110) suggesting a strong negative selection acting on a 
mutating population. As a consequence, the Ka/Ks ratio was also very low at 0.011. 
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Distribution of mutations and correlation analysis. The correlation analysis 
indicated a partial structuration of cases (34% of dispersion explained) on different 
parameters (Figure 2). The VVI variant was not included in the analysis because all 
information was not available. The analysis was therefore conducted on only five 
variants, i.e. IIV, VII, IVI, VIV and VVV. Severity of HFMD seemed to correlate 
with the age of patient and the highest severity level was not observed above 11-
month old. The VII variant segregated from the other variants on the F1 axis and was 
associated with both low severity and with the ethnicity-2 group, 56,5% of patients 
from this ethnicity-2 group were infected by the VII variant, but this represented only 
46,4% of all samples harboring the VII protein. No variant was specifically 
associated with the highest severity whereas the IIV variant was correlated with mild 
severity. 
 
Spatiotemporal distribution of the virus populations. I/V variants present in the 
2011 outbreak belonged mostly the IIV and VII populations which were already 
present in Northern Vietnam (Figure 3a) The IIV population was previously detected 
in 2008 in the Ninh Binh province whereas VII variants were detected in Cao Bang 
and Hai Phong in 2007 and in Nam Dinh and Ninh Binh 2008. VII and IIV variants 
represented 46% and 33.3% of the samples collected in 2011, respectively (Figure 
3b, 3d). Other mutant populations detected in 2011 were: IVI (1.7%) already 
detected in 2007 in Yen Bai and Han Nam, in 2008 in Ninh Binh and in 2010 in Hai 
Phong and Bac Kan; VIV (14.3%) previously found in 2003 in Ha Noi and in 2006 
in Phu Yen; and VVV (4.8%) (Figure 3a). The VVV variants were not detected in 
samples collected prior to the 2011-212 outbreak. The mutant populations detected in 
2012 were IIV and VII which prevalence was reduced to 16.2% and 19.3% and VIV 
and IVI which prevalence rose to 38.7% and 25.8%, respectively (Figure 3c, 3d). 
The VVV mutant was found only in 2011 in Thanh Hoa, Nam Dinh and Ha Noi 
(Figure 3b, 3d). With respect to spatial distribution, the rise of variants VII and IIV 
observed in 2011 was not located in a specific area but covered most of the sampling 
sites (8 out of 11). The replacement of the IIV and VII variants by the IVI and VIV 
variants followed a similar pattern confirming the wide-spread diffusion of the 
outbreak. The number of sites with more than two variants was higher in 2011 than 
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in 2012. The IIV variant was the most widely spread in 2011 but became the least 
widely spread in 2012 (Figure 3b, 3c). Conversely, the IVI variant which was the 
least widely spread in 2011 and found in only one province, i.e. Hoa Binh, became 
the most widely spread in 2012. The VVV variant was found only in 2011 in three 
provinces, in the South Eastern part of North Vietnam each time in association with 
the IIV variant (Figure 3b, 3c). The VVI variant was detected only in Quang Nam, 
Central Vietnam and prior to 2011. 
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Discussion 
 
This work provides an insight on the evolution and dynamic of the EV-A71 
enterovirus during the first outbreak recorded in North Vietnam in 2011-2012. The 
first conclusion is that the 2011-2012 outbreak in North Vietnam was not due to a 
single exogenous strain imported from South Vietnam where HFMD outbreaks were 
present (Nguyen et al., 2014) or from another region. All variant populations 
observed during the 2011-2012 outbreak were already present in North Vietnam. The 
only exception is the VVV population which was found only in 2011 in three 
different provinces. However, the phylogenetic analysis indicated that this VVV 
variant was the closest to the root and therefore to the mother and oldest population. 
The reason for the lack of VVV variants in samples older than 2011 is most likely 
related to the low number of samples and to the low prevalence of this population. 
Furthermore, this 2011-2012 outbreak was also characterized by the cocirculation of 
the same four variant populations with a replacement between 2011 and 2012. The 
VII and IIV variants which were the most prevalent in 2011 were replaced by IVI 
and VIV populations in 2012. There is no clear explanation for the replacement of 
the main variant populations between 2011 and 2012 but it could be related to 
immunoresistance acquired during the first half of the outbreak in 2011 The surge of 
variants VII and IIV in the first part of the epidemic could not be related to any 
measured parameters and altogether the question remains of what triggered the 
outbreak in 2011 although all virus populations were already present. All I/V 
populations present at the beginning of the outbreak were capable of triggering it as 
shown by the replacement in 2012. It is not related either to the subgenogroup since 
the populations which emerged in 2012 belonged to two different subgenogroups, the 
VIV variant belonging the subgenogroup C4 and the IVI variant being a member of 
subgenogroup C5. A partial explanation could be a differential susceptibility of the 
human population which could have been slightly more susceptible to the VII and 
IIV groups. Another explanation might be found in the spatial distribution of the 
various variant groups, the socio-economic pattern and the route of dissemination. 
This work was not structured to address this issue and specific sampling schemes as 
well as transversal analyses should thus be further undertaken.  
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Another main outcome of this work is the observed correlation between the I/V 
variant groups and phylogeny, pathogenicity and ethnicity. One hypothesis is that 
fixation of mutations in VP1 could be related to the VP1 function itself. The I/V 
groups, although based on the relative arrangement of only three amino-acids, 
overlap the different clusters identified. These clusters correspond to genetically 
different populations characterized by specific polymorphism traits. This overlap 
between the specific combination of I/V residues at three positions and the 
phylogeny established on the nucleotide sequences suggests the occurrence of a 
selective pressure on the I/V arrangement. The high conservation of the proteins, 
despite variability at the nucleotide level, indicative of a negative, or purifying, 
selection pressure, indicates that the clustering at the protein level is driven by the 
I/V arrangement. The remaining question is what is the selective pressure acting on 
the I/V variants and what could be the role of these I/V mutations. The I/V mutations 
are located at positions 249, 262 and 284 of the VP1 protein. The region from amino 
acid 132 to 297 on the EV-A71 VP1 protein was shown to be crucial for increasing 
the strength of protein-protein interactions in the capsid and its stability. This 
increased stability strongly enhances the pathogenicity and survival of the virus in 
the gastrointestinal track (Lal et al., 2006). Isoleucine and valine are aliphatic 
hydrophobic amino acid mediating the core structure of the protein and have been 
reported to be involved in virulence and pathogenicity in several viruses. In the 
related cocksackievirus B3, a conformational change occurred when leucine at 
position 1092 was substituted for isoleucine or valine leading to susceptibility to 
pleconaril (Schmidtke et al., 2005). A valine to isoleucine substitution at position 25 
in gPr80env, the envelope precursor polyprotein of the Moloney murne Leukemia 
Virus, was shown to mediate temperature sensitivity, inefficient processing of the 
protein and neurovirulence (Szurek et al., 1989). A Valine to Isoleucine substitution 
at position 4 in the VP1 protein of the Infectious Bursal Disease virus (IBD), causing 
is a highly contagious disease in chickens known as Gumboro disease, was shown to 
be responsible for a decrease of pathogenicity and differential growth in cell culture 
(Yu et al., 2013). Similarly, a valine to isoleucine at positon 3 in the NS4A protein of 
the Japanese Encephalitis virus was shown to increase the virulence (Yamagushi et 
al, 2011). An I71V mutation in the capsid protein of the Simian-Human 
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Immunodeficiency Virus mediates the escape from cytotoxic T-lymphocyte (Peyerl 
et al., 2003). The recurrent reports of the involvement of isoleucine and valine in the 
viral pathogenicity process in different viruses as well as their involvement in the 
selective pressure applied on the EV-A71 samples analyzed in this work suggest that 
the I/V pattern at positions 249, 262 and 284 on the VP1 protein might play a role in 
pathogenicity. The observed correlation of the I/V variant populations with severity 
and ethnicity strengthen this hypothesis. However, the ethnicity correlation could be 
a result of spatial structuration since ethnicity-2 is mostly present in the Hòa Bình 
province. This in turn would suggest that the various EV-A71 variants display a 
geographic specificity.  
 
Conclusion 
Altogether, these data suggest that EV-A71 strains could remain in a low level, 
asymptomatic state, in genomic stasis and with a geographic structuration. The cause 
for outbreaks should thus be sought for in the socio-economic patterns rather than in 
exogenous emergence. Further investigations are needed to investigate this 
hypothesis and to bring valuable information for the management of this major 
pediatric disease. 
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Figures legends 
 
 
Figure 1. Phylogenetic analysis of partial VP1 sequences 
 a) Phylogenetic analysis of the nucleic acid sequences 
 b) Distribution of the protein sequences 
Trees were designed using Maximum Likelihood. 
Color code: Black: VVV; Light blue: VII; Yellow: IIV; Purple: VIV; Dark blue: VVI 
 
 
Figure 2. Factorial correspondence analysis. 
Variables analyzed were: amino acid profiles on positions 151, 164 and 186 (V/I), 
respectively in this work (249, 262 and 284 on the full length VP1 protein), severity level, 
ethnicity, age of patients, and patient location. 
 
 
Figure 3. Spatiotemporal distribution of I/V variants 
Color code: Black: VVV; Light blue: VII; Yellow: IIV; Purple: VIV; Dark blue: VVI 
 
 
  
 
134 
Table 1. Characteristics of the isolated EV-A71 strains 
Strain  Age (month) Gender Province Ethnicity Onset 
Date of 
collection 
Severity V/I Type Subgenogroup 
Accession 
number 
 
2003019 
  
12 
 
NAa 
 
Hà Nội 
 
NA 
 
13/05/2003 
 
17/03/2003 
 
NA 
 
VIV 
 
C4 
 
KX906272 
2005184  0 NA Quảng Nam NA 08/05/2005 10/05/2005 NA VVI C5 KX906332 
2006023  0 NA Phú Yên NA 07/04/2006 10/04/2006 NA VIV C4 KX906278 
2007015  24 NA Hà Nam NA 27/01/2007 30/01/2007 NA IVI C5 KX906365 
2007037  24 NA Yên Bái NA 23/03/2007 24/03/2007 NA IVI C5 KX906264 
2007041  144 NA Cao Bằng NA 28/03/2007 30/03/2007 NA VII C4 KX906262 
2007053  30 NA Hải Phòng NA 05/04/2007 08/04/2007 NA VII C4 KX906261 
2008014  24 1b Nam Định NA 12/05/2008 14/05/2008 NA VII C4 KX906263 
2008017  30 1 Ninh Bình NA 10/05/2008 13/05/2008 NA VII C4 KX906267 
2008021  30 2c Ninh Bình NA 14/05/2008 16/05/2008 NA IVI C5 KX906299 
2008022  24 2 Ninh Bình NA 14/05/2008 14/05/2008 NA IIV C4 KX906273 
2008044  30 1 Ninh Bình NA 15/06/2008 17/06/2008 NA IVI C5 KX906300 
2008065  30 1 Hải Phòng 1d 07/06/2008 10/06/2008 1 IVI C5 KX906345 
2010002  19 2 Bắc Kạn NA 30/04/2010 02/05/2010 NA IVI C5 KX906358 
2011011  20 2 Hòa Bình 2e 10/06/2011 11/06/2011 1 VII C4 KX906301 
2011020  24 2 Hòa Bình 2 15/06/2011 16/06/2011 1 VII C4 KX906289 
2011022  28 1 Hòa Bình 2 13/06/2011 14/06/2011 1 VII C4 KX906315 
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2011031  72 2 Hà Nội 1 19/06/2011 22/06/2011 2a VIV C4 KX906338 
2011033  26 1 Hòa Bình 2 31/07/2011 01/08/2011 1 VII C4 KX906274 
2011034  48 2 Hòa Bình 1 18/06/2011 19/06/2011 1 VIV C4 KX906292 
2011047  21 1 Sơn La NA 27/06/2011 01/07/2011 1 VII C4 KX906269 
2011048  22 1 Sơn La NA 27/06/2011 01/07/2011 2a VIV C4 KX906352 
2011060  21 2 Thanh Hóa 1 17/06/2011 20/06/2011 2a VVV C4 KX906265 
2011063  24 1 Hòa Bình 1 11/07/2011 13/07/2011 1 VII C4 KX906290 
2011095  19 1 Hòa Bình 2 20/07/2011 21/07/2011 1 VII C4 KX906337 
2011096  12 2 Hòa Bình NA 21/07/2011 24/07/2011 1 VII C4 KX906308 
2011097  7 1 Hòa Bình 1 22/07/2011 28/09/2011 1 VII C4 KX906335 
2011117  42 1 Thanh Hóa 1 22/07/2011 25/07/2011 2a IIV C4 KX906350 
2011123  12 2 Hòa Bình 2 27/07/2011 26/07/2011 1 VIV C4 KX906281 
2011124  9 1 Hòa Bình 2 25/07/2011 26/07/2011 1 VII C4 KX906329 
2011125  13 1 Hòa Bình NA 27/07/2011 28/07/2011 1 VII C4 KX906368 
2011158  11 2 Hòa Bình NA 30/07/2011 01/08/2011 1 IVI C5 KX906309 
2011161  21 1 Hòa Bình 2 31/07/2011 31/07/2011 1 VII C4 KX906296 
2011165  22 1 Hòa Bình 1 31/07/2011 01/08/2011 1 VII C4 KX906349 
2011278  21 1 Nam Định 1 16/08/2011 18/08/2011 1 VVV C4 KX906310 
2011282  23 1 Nam Định 1 24/08/2011 24/08/2011 1 IIV C4 KX906343 
2011340  2 1 Lào Cai 2 29/08/2011 30/08/2011 2a VII C4 KX906293 
2011488  60 2 Hòa Bình NA 12/09/2011 14/09/2011 1 VII C4 KX906319 
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2011490  38 1 Hòa Bình 2 12/09/2011 13/09/2011 1 VII C4 KX906276 
2011521  43 2 Hà Nội 1 18/09/2011 21/09/2011 1 VVV C4 KX906305 
2011571  32 1 Hòa Bình 2 27/09/2011 28/09/2011 1 VIV C4 KX906331 
2011573  12 1 Hòa Bình NA 26/09/2011 27/09/2011 1 VII C4 KX906307 
2011575  12 1 Hòa Bình 2 23/09/2011 27/09/2011 1 VIV C4 KX906341 
2011579  46 1 Hà Nội 1 28/09/2011 30/09/2011 1 IIV C4 KX906277 
2011586  20 2 Hà Nội 1 23/09/2011 26/09/2011 2a IIV C4 KX906366 
2011598  26 1 Thanh Hóa 2 27/09/2011 28/09/2011 1 VII C4 KX906339 
2011600  51 1 Bắc Kạn 1 03/10/2011 11/10/2011 2a VIV C4 KX906355 
2011647  22 2 Thanh Hóa 1 09/10/2011 17/10/2011 2a VII C4 KX906268 
2011662  11 1 Hà Nội 1 11/10/2011 13/10/2011 1 IIV C4 KX906297 
2011664  16 2 Hà Nội 1 17/10/2011 18/10/2011 2a IIV C4 KX906325 
2011665  11 2 Hà Nội 1 07/10/2011 10/10/2011 1 IIV C4 KX906266 
2011676  4 1 Điện Biên 2 19/10/2011 22/10/2011 1 IIV C4 KX906271 
2011677  13 1 Điện Biên 1 20/10/2011 23/10/2011 1 IIV C4 KX906322 
2011679  12 1 Thanh Hóa NA 17/10/2011 21/10/2011 1 IIV C4 KX906270 
2011754  8 1 Hòa Bình NA 04/10/2011 14/10/2011 1 IIV C4 KX906334 
2011799  12 1 Thanh Hóa 1 22/10/2011 24/10/2011 2b VII C4 KX906275 
2011805  9 2 Thanh Hóa 2 25/10/2011 28/10/2011 2a VII C4 KX906286 
2011816  22 1 Điện Biên 2 20/10/2011 28/10/2011 2a IIV C4 KX906357 
2011823  32 2 Tuyên Quang 1 01/11/2011 11/04/2011 1 IIV C4 KX906364 
  
 
137 
2011835  18 1 Hà Nội 1 31/10/2011 02/11/2011 1 VII C4 KX906313 
2011840  15 2 Hà Nội 1 30/10/2011 02/11/2011 2a VII C4 KX906340 
2011866  26 2 Bắc Ninh 1 06/11/2011 08/11/2011 1 IIV C4 KX906354 
2011868  52 2 Bắc Kạn 1 06/11/2011 15/11/2011 1 VIV C4 KX906330 
2011872  13 2 Điện Biên 1 02/11/2011 04/11/2011 2a IIV C4 KX906347 
2011881  26 2 Hải Phòng 1 18/11/2011 21/11/2011 2b VII C4 KX906360 
2011882  25 1 Hải Phòng 1 15/11/2011 21/11/2011 2b IIV C4 KX906287 
2011888  25 2 Hải Phòng 1 17/11/2011 21/11/2011 2b VII C4 KX906333 
2011891  26 1 Thanh Hóa 1 20/11/2012 23/11/2011 1 VII C4 KX906361 
2011894  20 1 Hải Phòng 1 19/11/2011 24/11/2011 2a IIV C4 KX906312 
2011896  17 2 Hải Phòng 1 19/11/2011 24/11/2011 2b IIV C4 KX906336 
2011897  11 1 Hải Phòng 1 18/11/2011 24/11/2011 2b VIV C4 KX906317 
2011925  13 2 Hải Phòng 1 24/11/2011 25/11/2011 2b IIV C4 KX906363 
2011927  41 2 Hòa Bình 1 06/11/2011 09/11/2011 1 VII C4 KX906283 
2011956  64 2 Tuyên Quang 2 15/11/2011 28/11/2011 3 VII C4 KX906304 
2011958  26 1 Tuyên Quang 2 21/11/2011 28/11/2011 3 VII C4 KX906323 
2011970  32 1 Hà Nội 1 13/11/2011 14/11/2011 2a IIV C4 KX906298 
2011984  13 1 Hải Phòng 1 30/11/2011 04/12/2011 2a IIV C4 KX906327 
2012018  18 2 Hải Dương 1 12/02/2012 15/02/2012 1 IVI C5 KX906295 
2012019  18 1 Hải Dương 1 13/02/2012 14/02/2012 1 VIV C4 KX906353 
2012053  12 1 Lào Cai 1 25/02/2012 28/02/2012 2a VIV C4 KX906359 
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2012095  20 1 Bắc Giang 1 28/02/2012 01/03/2012 2a IIV C4 KX906367 
2012114  20 1 Lào Cai 1 01/03/2012 02/03/2012 2a VII C4 KX906303 
2012117  20 1 Lào Cai 2 04/03/2012 06/03/2012 1 IVI C5 KX906280 
2012126  11 1 Hải Phòng 1 01/03/2012 06/03/2012 2b IIV C4 KX906346 
2012151  13 1 Hải Dương 1 11/03/2012 13/03/2012 1 VII C4 KX906320 
2012159  36 2 Phú Thọ 1 27/02/2012 02/03/2012 2a VIV C4 KX906314 
2012161  16 1 Phú Thọ 1 03/03/2012 07/03/2012 2a VIV C4 KX906302 
2012164  27 1 Phú Thọ 2 27/02/2012 29/02/2012 1 IIV C4 KX906306 
2012165  54 1 Phú Thọ 2 22/02/2012 22/02/2012 1 IIV C4 KX906362 
2012166  14 1 Phú Thọ 1 04/03/2012 09/03/2012 1 VIV C4 KX906356 
2012169  5 2 Phú Thọ 1 06/03/2012 09/03/2012 1 IVI C5 KX906294 
2012189  15 1 Hải Dương NA 10/03/2012 15/03/2012 1 VIV C4 KX906285 
2012225  7 1 Hà Nội 1 07/03/2012 12/03/2012 3 VIV C4 KX906348 
2012233  40 1 Bắc Kạn 2 01/03/2012 16/03/2012 1 IIV C4 KX906351 
2012237  84 2 Bắc Giang 1 13/03/2012 16/03/2012 2b IVI C5 KX906288 
2012260  25 1 Thanh Hóa 1 18/03/2012 20/03/2012 1 VIV C4 KX906311 
2012262  30 1 Thanh Hóa NA 12/03/2012 15/03/2012 NA VIV C4 KX906328 
2012264  9 1 Thanh Hóa 1 20/03/2012 23/03/2012 1 IVI C5 KX906284 
2012271  34 1 Ninh Bình 1 19/03/2012 20/03/2012 1 IVI C5 KX906279 
2012284  44 2 Hải Phòng 1 18/03/2012 20/03/2012 2b IVI C5 KX906282 
2012296  24 2 Sơn La NA 20/03/2012 22/03/2012 NA VII C4 KX906344 
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2012297  22 1 Tuyên Quang 1 14/03/2012 27/03/2012 1 VII C4 KX906342 
2012300  28 1 Tuyên Quang 1 18/03/2012 27/03/2012 1 VIV C4 KX906326 
2012319  57 2 Bắc Kạn 2 27/03/2012 27/03/2012 1 VIV C4 KX906318 
2012353  17 2 Hà Nội 1 31/03/2012 02/04/2012 1 VII C4 KX906316 
2012387  17 2 Lai Châu 1 06/04/2012 09/04/2012 2a IVI C5 KX906291 
20111000  14 2 Hải Phòng 1 05/12/2011 08/12/2011 2b IIV C4 KX906324 
20111003  19 1 Hải Phòng 1 04/12/2011 09/12/2011 2b VIV C4 KX906321 
 
 
a) NA: Not Available 
b) Gender 1 = Male 
c) Gender 2 = Female 
d) Ethnicity 1 = Main Vietnamese ethnic group 
e) Ethnicity 2 = Hmong ethnic minority 
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Table 2. Polymorphism and divergence data  
 N Hp Nt S η Pa Si θ MC Na Ns Ka/Ks  
Cluster  56 43 561   67   70   48 19 14.58   64 6   58 0.053  
Cluster  23 15 561   15   15     9   6   4.06   15 6     9 0.107  
Cluster  12 10 561   19   19   11   8   6.92   16 0   16 0.029  
Cluster  17 13 561 109 113   57 52 32.24 110 5 105 0.011  
Total  108 81 561 148 162 128 20 28.16 147 9 138 0.019 
 
N: Number of sequences 
Hp: Number of haplotypes 
Nt: Sequence size in nucleotides 
S: Number of mutated sites 
η: Number of mutations 
Pa: Number of parsimony informative sites 
Si: Number of singletons 
!: Number segregating sites (per sequence from S) 
MC: Number of mutated codons 
Na: Number of non-synonymous mutations 
Ns: Number of synonymous mutations 
Ka/Ks: Ka/Ks ratio  
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CHAPTER 3. MODEL OF A MULTIPHASE HFMD EPIDEMIC 
 
 
1.1. Context of study 
 
Hand, foot and mouth disease (HFMD) is usually a multiphase disease involving 
often a succession of different viruses. HFMD is not the only disease displaying this 
characteristic. A major problem in epidemiology is to distinguish the different phases and 
therefore to understand at what time a novel virus, with differing pathogenicity and 
virulence charcteristics, was involved in the ongoing epidemics and has replaced the 
previous causative agent. Although veru often mild, HFMD can result in severe 
complications such as encephalitis, aseptic meningitis, pulmonary edema, myocarditis, and 
death (WHO, 2011). This large panel of symptoms and variation over time depends for a 
good parts on the succession of viruses driving the epidemics. HFMD is caused by 
different viruses members of Human Enterovirus A, a family of picornavirus which 
includes Coxsackievirus A (CV-A) and Human Enterovirus 71 (EV-A71) (Ang et al., 
2009; Chen et al., 2007). This diversity of agents along with the aquired immunoresistance 
developed by patients generates a high dynamic of the disease which could become 
difficult to monitor and control in some cases. Such outbreaks occurred for instance in 
Cambodia in July 2012 causing the death of 52 young children out of 59 cases. 
 
However, if properly monitoring the disease is essential to detect the presence of a 
potential novel agent and adapt treatments and precautionary measures, it is not really 
possible to determine when a novel virus has replaced a previous one. For instance, during 
the 2011-2012 HFMD epidemics in Hai Phong, novel guidelines were edicted but in the 
middle of phase two and without any ink with the etiology. 
 
Current mathematical models are capable to represent a single phase and several 
phases in a separate, individual way, but not a series of several waves within a single 
outbreak as it is the case with the 2011-2012 HFMD outbreak in Hai Phong and more 
generally with many diseases. Such models cannot be developed owing the lack of 
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appropriate cohorts, large enough in size. In this study, we could have access to a large 
cohort allowing thus to develop a modelling approach. 
 
 
1.2. Objective 
 
The objective of this work was thus to take advantage of the very large number of 
cases collected (more than 9000) with a comprehensive and consistent clinical and 
epidemiological record, to develop a mathematical model capable of describing a 
multiphase epidemics. A second objective was to confront this model with actual data. 
 
1.3. Discussion and conclusion 
 
A model was developed based on Bernoulli differential equations to assess in a 
simple and accurate way the number of patients who present a community of symptoms as 
a function of time. The model is based on the following postulate: 1) If all along the 
epidemic the virulence is the same, then this epidemic is considered a single-wave 
epidemic. 2) If during the outbreak differential levels of virulence and/or pathogenicity are 
recorded, then this epidemic is considered a multi-wave epidemic. A single-wave outbreak 
can be considered as caused by a single pathogen or, but less likely, by different pathogens 
expressing the same phenotypic traits. A multi-wave epidemic is considered as caused by a 
series of successive causative agents diplaying different phenotypic traits. 
 
The model presented in this chapter allows to show that during the 2011-2012 Hai 
Phong epidemic: 
1) The waves were clearly present 
2) The level of interaction between the virus and the host, i.e. virulence and 
pathogenicity, was different for each wave 
3) Virulence was a discriminating factor, each wave displaying a different speed 
Wave 1 was characterized by the highest speed (highest virulence) 
Wave 2 was characterized by an intermediate speed (intermediate virulence). 
Wave 3 was characterized by the lowest speed (lowest virulence) 
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4) Starting from dates clinically assessed the model is capable to assign the 
beginning and end of each wave, with a highly significant fit, and to show that waves 
overlap in part, each wave starting before the end of the previous one. The model can thus 
well describe the replacement of virus along the epidemic. 
5) It is possible to calculate the probability for a patient to belong to a given wave 
and to classify the patients in specific clusters with a high level of confidence. 
6) The patient clusters can be associated with a specific typology of symptoms 
7) It is possible to estimate the end of an ongoing wave and to determine if a wave 
if starting, raising thus the possibility of a differing clinical context. 
  
Figure 1 
 
Figure 2 
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Figure 3 
 
 
The perspective with this part of the work is now to assess the predictive limit of 
the model and to determine the minimum number of patients required to identify a new 
wave. This would in turn permit the identification of the viral lineage involved and take 
necessary actions to adapt treatments and precautionary measures. 
The results of this work are summarized in the manuscript entitled article entitled 
“Modelling the dynamic of Hand Foot and Mouth Disease during the 2011-2012 Hai 
Phong outbreak”. This manuscript, currently under preparation, is presented thereafter. 
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Abstract 
The proposed approach is a general method to model over time a multi-wave epidemic. 
The originality of this model is to be based on the detection of differing 
virulence/pathogenicity. If the same rate of virulence/pathogenicity is observed over time it 
is a single, long wave epidemic which can analyzed with existing models. If difference of 
virulence/pathogenicity occurs it is a sign of a multi-wave epidemic which cannot be 
analyzed by currently available models ad for which the model described in this work was 
pecifically designed. This model was developed using the HFMD outbreak that spread 
over the city of Hai Phong from 08/2011 to 10/2012. This epidemic displayed 3 separate 
waves. A complete dataset was collected for more than 8000 patients during this period, 
allowing thus to develop the model with a good statistical confidence. The model showed a 
high accuracy at the adjustment of data for both the total number of cases and for the 
number of cases per week. As a consequence, the model was able to accurately determine 
the dates of beginning and end of each wave and to show that they overlapped. Using 
mathematical functions associated with this model, it was possible to calculate the 
probability for a patient to belong to a specific wave. This model is applicable to other 
diseases and can detect relatively early the occurrence of a differing wave and thus trigger 
appropriate clinical and preventive actions. 
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Introduction 
 
Hand, foot and mouth disease (HFMD) is often a multiphase disease involving a 
succession of different viruses and waves. The co-circulation of different serotypes and 
alternation between enterovirus A71(EV-A71) and coxackievirus A (CV-A ) were 
commonly observed during HFMD epidemics [1], [2], [3], [4]. However, co-infection is 
not a primary cause of severe forms [5], [6]. Epidemics could be due to both the 
accumulation of susceptible individuals in the community, patients are mostly young 
children under five and introduction of new genotypes or strains into the Asia-Paciﬁc 
region [30]7. Outbreaks in Taiwan in 1998 and 2000 were caused by EV-A71 C2 and B4 
strains, respectively [8]. Sentinel surveillance in Sarawak, Malaysia, demonstrated that the 
emergence of the novel subgenotype C1 of EV-A71 was the cause of the 2003 outbreak 
[9]. Although very often mild, HFMD can result in severe complications such as 
encephalitis, aseptic meningitis, pulmonary edema, myocarditis, and death [10] and can be 
devastating like in Cambodia in 2012 with a death rate of 88% ([11]. This large panel of 
symptoms and variation over time depends for a good parts on the succession of viruses 
driving the epidemics. 
 
A major problem in epidemiology is to distinguish the different phases and 
therefore to understand at what time a novel virus, with differing pathogenicity and 
virulence characteristics, has replaced the previous causative agent. Understanding the 
process of emergence of disease can be related to the ability to identify type samples from 
outliers. Dynamic models are therefore required for analyzing epidemics. However, if 
current models can analyze individual waves [12], there is still a need to model and 
compute a mutliwave epidemic. The 2011-2012 HFMD was the largest experienced in 
Vietnam and the first one to occur in North Vietnam. Hai Phong displayed the highest 
prevalence in North Vietnam providing thus a large cohort of ca. 9000 patients to analyze. 
This 2011-2012 outbreak in Hai Phong was also a three-wave epidemic involving EV-A71, 
CV-A6, CV-A16 and a still uncharacterized virus [13]. Based on this large cohort we 
report here a mathematical approach for discrimination of individuals within an outbreak 
time frame and a mathematical model for characterizing multi-wave outbreaks displaying 
differing wave-associated virulence or pathogenicity. 
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Results and discussion 
 
1. Model 
 
The number of cases over the one-year period of the study displayed three different waves, 
each separated by a minima, i.e. a drop in the number of cases followed by an increase. 
Each step was analyzed separately using the same Bernoulli model. 
 
In a first step, we assume that each wave is relatively well separated. It means when a 
wave is closing than the next wave is starting in a sense to be specified later. The function 
was therefore aiming at describing HFMD cases over time. The total number of HFMD 
cases for one wave is N. Over a defined period h, the number of new cases depends of the 
number of susceptible patients in the population Xs(t) and two parameters related to the 
epidemic: the probability K(t) to be exposed to the virus and K0 the probability to present 
clinical symptoms. These two probabilities reflect at epidemiological level two the virus 
associated parameters which are virulence and pathogenicity, respectively. 
 
The cumulative number Xm(t+h) of patients, is governed by the equation for one wave: 
 
( ) ( )0 0( ) ( ) * ,  (1)m m SX t h X t K K t X t h t t+ = + ≥  
 
with: 
 
( ) ( ) ( ) ( ) and ms m X tX t N X t K t
N
= − = , 
 
The dot K(t) Xs(t) is the expected number of exposed patients. The constant K0 is called 
interaction factor. This is the probability of an exposed patient to become sick. 
 
By passing to the limit as h tends to 0, we obtain a differential equation of Bernoulli (2) 
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with the two limits conditions: 
 
Indiquer le changement de variable pour resoudre l’équation 
 
The general solution of equation (2) is the well-known logistic function defined by 
three parameters (K0, K1, K2): 
 
 (3) 
 
With the help of the vector Y of observed values , the constant K0, K1, 
K2 are computed with a jacquard algorithm (ref) by minizing 
( ) ( ) ( )( )20 1 2
0
, , i m i
i
Ec K K K y t X t
τ
=
= −∑ (4).  
 
Note that τκ is the experimental end of the wave. This corresponds to the time of the 
last observed case of a given wave. The time t0 is the date of the first case observed for a 
given wave. Nevertheless, equation (3) can be interpreted with two limits conditions:  
 
   
 
N and N0 are theoretical values. They are respectively the total number of cases at 
the theoretical end of the waves   and the number of cases at the beginning of the 
wave. With equation (3), we have N=K2 and ).  
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Owing to the limits conditions and N>N0, it is possible to demonstrate that the
interaction factor K0 is positive and less than 1. Therefore, this factor can be seen as a 
probability.  
 
2. Wave specific model  
 
We assume that the time of the beginning of each wave (t0) is known. Therefore, 
the beginning of the wave 2:  occurred after the date of the last observed case of the 
wave 1 . The same condition is assumed for wave 2 and wave 3. This means that: 
. These dates are provided by physicians and clinical files. The 
theoretical time of the end of a wave is therefore t=+00. τ* is an under estimation of this 
date. It is defined as: , (Figure 1). 
 
To compute values (K0, K1, K2) of equation (3), we first began with wave 1 using 
the Jacquard algorithm, (Table 1 and Figure 2.a). The end of wave was estimated to 
occur at the 37th week. For wave 2, the observed frequencies were therefore corrected 
between the following date: beginning of the wave 2:  and  (numbers 
express weeks). The correction involved subtracting the frequencies of wave 1 to wave 2 
of those observed during the reporting period. The corrected frequencies allowed thus to 
take into account the overlapped of the two consecutive waves before applying the 
jacquard algorithm to wave 2, (Table 1). The end of wave 2 was estimated at week 62. As 
the observed frequencies were underestimated compared with the mathematical model 
(Figure 2.b), no correction was necessary for wave 3 (Figure 2.c). The computed 
parameters for wave 3 are given in Table 1. For all the waves, the quality of fit was high 
with a coefficient of determination R2 higher than 0.997, (Figure 2). The computation of 
the total number of cases: 
 
     (4), during the 
three waves is shown in Figure 3.  
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Parameters of interaction between disease and environment 
 
K0 parameter represents the observed speed of spread of the outbreak (Table 1). 
Wave 1 was significantly (p<0.05) the most virulent, followed by wave 3 and wave 2 in 
decreasing order. 
 
Patient classification 
 
With the help of the definition of XM(t) (3) applied to a wave W, it is possible to 
build the probability for an individual to belong to a specific wave. Indeed, with a specific 
constant A 
 
( ) ( ) ( )
0
0 0 0
1
,  with A=
w m m
t
f t X t t t t X t t dt
A
τ
= − ∀ ≥ −∫ (4),  
 
fw(t) is a density probability. So  
 
( )
0
0
0 ,
T
w
t
t u T
P f t t dt
W
≤ ≤ 
= −   ∫  
 
is the probability to have an inclusion time between [t0, T] when a patient belongs to a 
given wave W. It is therefore possible to extract patients belonging to a specific wave with 
a certain probability and then to express the probability for an individual to belong a 
specific wave.. 
 
Mapping the occurrence of cases for each wave 
HFMD cases were mapped for each wave for 14 days after the observed beginning of the 
wave (Figure 4). The observed beginning of the waves was selected as a starting point to 
avoid the overlap of waves. 
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Discussion 
This work was motivated by the need to develop a model capable of describing at once a 
multiwave epidemic and by the availability of a very large cohort making possible the 
computation and validation of the model. The model developed in this work is a simple 
model based on the virulence/pathogenicity constant, in other words, on the differing 
dynamic of host-virus interaction. The model is based on the principle that the key factor is 
not the overall number of patients but indeed the differing dynamic of host-virus 
interaction. Compiling the number of cases has for consequence to smooth all data and to 
show the epidemic as monomodal. Regardless of its true nature, the epidemic is considered 
associated with a single causative agent. The model developed in this work allows to 
breakdown the epidemic in its various components when they exist and display the 
epidemic as a multimodal curve. In this case each mode corresponds to a specific agent 
displaying a specific dynamic. 
 
The model demonstrates that three distinct waves occurred during the 2011-2012 Hai 
Phong HFMD epidemic, each one displaying a specific dynamic of expansion. The level of 
host-virus interaction, in particular the virulence, was different for each wave. Virulence 
was therefore a discriminating factor, each wave displaying a different speed, the highest 
virulence was associated to wave 1. Wave 2 displayed an intermediate speed whereas wave 
3 was characterized by the slowest speed of expansion. 
 
The model developed in this work also allowed to assign the beginning and end of each 
wave with a highly significant fit with observed data. It was thus possible to show that the 
three waves partly overlapped, each wave starting before the beginning of the previous 
one. This indicates that the replacement of causative agent occurs during the span a given 
wave and not after the wave. It is therefore difficult to only explain this phenomenon by an 
adaptation of the human population through immunoresistance. A hypothesis could be that 
each causative agent is capable of infecting only a specific, susceptible part of the human 
population and disappears when the available naive population falls below a given 
threshold. However, it is in this case difficult to explain why all viral strains do not expand 
at the same time providing they do not target the same populations and why there is a 
pattern of successive waves. The relative virulence of each viral strain might therefore play 
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a key role, in particular in asymptomatic patients where competition between strains might 
occur. Nevertheless, this also suggests that all strains circulate at the same time and that a 
given strain will predominate and expand depending on the ratio 
immunoresistance/virulence. Although we cannot clearly explain the phenomenon, the 
model developed in this work can thus well describe the replacement of virus along the 
epidemic and accurately determine the start and end of each individual component of the 
epidemic. 
 
Beyond that, the model is also capable of addressing the very important issue of 
calculating the probability of a patient to belong to a given wave and to classify the 
patients into specific clusters with a high level of confidence. These clusters can be 
associated with a specific typology of symptoms and dynamic traits. Doing so, the model 
allows to estimate during the span of the epidemic if a new wave occurred, before the peak 
of this new wave and to identify the patients affected by this new wave comparatively with 
patients affected by the previous wave. This in turn open ways for clinician to determine if 
a new treatment strategy or a new crisis management is needed and if so provides also the 
means of identifying the patients to be addressed. The most important aspect being that this 
can be done during the span of the epidemic. The model provides thus means to facilitate 
real time actions. 
 
Beyond the specific case of HFMD, the model described in this work can be applied to 
other diseases. If the disease considered is a single phase, monomodal disease caused by a 
single agent, the model will bring nothing more than existing single-wave models. 
Similarly, if the disease is a multiphase, multimodal, disease caused by different agents but 
displaying the same virulence/pathogenicity traits, it can thus be considered similar to a 
single wave disease and here also the model will bring nothing more than existing single-
wave models. However, if the disease is a multiwave disease involving causative agents 
characterized by differing virulence / pathogenicity traits, this model will bring very useful 
applications for managing this epidemic and for identifying an emerging wave associated 
to a potentially new strains. This work and the model presented can therefore bring very 
valuable support to public health in the management of multiwave infectious diseases. 
Indeed, it is to our knowledge the first time such a multiwave model with a very high fit 
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with observed data, capable of typing patients based on clinical description and 
determining the emergence of a new wave has been developed. Since it is not relaying on 
molecular or serological test, but only on clinical parameters, the model is fast and easy to 
implement with no delay in response. The implementation of such model on HFMD and 
other multiwave diseases will therefore bring valuable support in managing these 
important sanitary burdens. 
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Table 1.  
 
Wave  Parameter  Value   Standard error 
 
1  K1   -6.33   0.209 
  K0   0.368   0.014 
  K2   3673.906  67.640 
 
2  K1   -2.541   0.075 
  K0   0.259   0.009 
  K2   4104.45  44.29 
 
3  K1   -2.28   0.052 
  K0   0.275   0.008 
  K2   1746.58  21.290 
 
 
K0 is the interaction factor 
For wave 2, parameters displayed are the corrected parameters 
 
Figures legends 
 
Figure 1. Temporal characteristics of the 2011-2012 HFMD epidemic 
T0 is the beginning of a wave. 
The time  τ corresponds to the last known case for a given wave. 
The time τ* is an estimation of τ obtained by the model (equation 3). 
 
Figure 2. Representation of the dynamic of the outbreak for the three different waves 
2a. Representation of the dynamic for wave 1 
The observed t0 is 0 for wave 1 
2b. Representation of the dynamic for wave 2 
The observed t0 is 26 for wave 2 
2c. Representation of the dynamic for wave 3 
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The observed t0 is 53 for wave 3
Dots are associated to the observed values Y(t(i)). 
The solid curve is the theoretical number of case. 
 
 
Figure 3. Representation of the dynamic of the outbreak for the three waves together 
 Dots are associated to the observed values Y(t(i)). 
The solid curve is the theoretical number of case. 
 
Figure 4. Location of the initial foci of each of the three HFMD waves in Hai Phong
a) First wave 
b) Second wave 
c) Third wave 
Figure 1
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Figure 4 
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GENERAL CONCLUSION AND PERSPECTIVES 
 
This work analyzed all HFMD cases reported both in the community and hospitals in 
2011 and 2012 outbreak which was the largest to have ever occurred in Vietnam and the first 
recorded in the northern part of the country while Hai Phong city experienced the highest 
HFMD incidence in North Vietnam. It was a good model for investigating the dynamic of 
the disease without interference and potential remains from previous outbreaks or patient 
immunological adaptation and giving a broad view of the dynamic of the diseases. 
 
Beside the basic epidemiological features as 3 distinct epidemic waves; median age 
at 2, the most < 5 yrs (highest in 1-2 yrs group); boys is higher prevalence rate; severity: 
mild (42.80%); moderate (54.92%), severe (2.28%) and no fatal; both urban and rural areas 
were affected, the study provides also findings related to influence of HFMD guidelines 
during the outbreak period that never described before. The first effect of the guideline 
release was a significant increase of the severity score. Another positive effect was the 
reduced delay between onset and admission after guidelines publication. The most 
important feature of the second guideline was the decentralization and transfer of 
responsibility to health care facilities. This positive effect of guidelines is also of an 
increased awareness and precautious approach from parents and physicians leading to 
patients being majoritarily declared with severe symptoms in order to ensure a better 
treatment and surveillance. Awareness led to the modification of guidelines but changes 
occurred only after publication, suggesting that the legal framework created by the 
guidelines is needed for implementation even though awareness is present. Public and 
professional awareness are not sufficient for implementing changes. Evolution of clinical 
patterns should not be considered only in the light of the evolution or replacement of 
pathogens or host-pathogen interactions but also according to the evolution of behavior and 
social perception. 
 
This work is also an integrative analysis including genetic evolution and spatial analysis to 
describe the dynamic of HFMD in a well delimited area. Circulation of both EV-A71 and 
CV-A, alternatively replacement was recorded. EV-A71 detection with MAS primers 
should thus be systematically performed on SO primers products and SO222 primer should 
be redesigned to match with the 5’ part of the AN88 primer used for EVs detection. More 
attention should be therefore paid to the PCR negative patients. The observed correlation 
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between the I/V variant groups and phylogeny, pathogenicity and ethnicity. The EV-A71 
strains could remain in a low level, asymptomatic state and with a geographic 
structuration. The 2011-2012 outbreak in the North was not due to a single exogenous 
strain imported from outside. The cause for outbreaks should thus be sought for in the 
socio-economic patterns rather than in exogenous emergence. Further investigations are 
needed to investigate this hypothesis and to bring valuable information for the management 
of this pediatric diseases. 
Another main outcome of this work is the observed correlation between the I/V 
variant groups and phylogeny, pathogenicity and ethnicity. The recurrent reports of the 
involvement of isoleucine and valine in the viral pathogenicity process in different viruses 
as well as their involvement in the selective pressure applied on the EV-A71 samples 
analyzed in this work suggest that the I/V pattern at positions 249, 262 and 284 on the VP1 
protein might play a role in pathogenicity. The observed correlation of the I/V variant 
populations with severity and ethnicity strengthen this hypothesis. However, the ethnicity 
correlation could be a result of spatial structuration since ethnicity-2 is mostly present in 
the Hòa Bình province. This in turn would suggest that the various EV-A71 variants 
display a geographic specificity. 
 
This PhD work demonstrates the need of a comprehensive and coordinated approach 
when analyzing the dynamic of HFMD. Indeed, EV-A71 is first reported in Viet Nam in 
2003. There were then several small outbreaks occurring in the southern of the country. The 
cause of very large outbreak with exist pathogen since 2011 is still not explained clearly. The 
trigger for the outbreak need to be studied further especially in aspects of climate, immunity, 
the host factors and also for the molecular aspects. A first recommendation and perspective 
from this work would be therefore to analyze correlation of the variant with severity and 
ethnicity by deeply analysis on molecular from full gene of pathogen. 
The disease seems to have expanded following the eastbound river system to reach 
densely populated settlements from where it secondarily expanded through local roads. 
The average age of the patients, around 2, the source of contamination must be sought for 
within asymptomatic adults being contaminated during their occupational activities and in 
local and regional movements. 
The PhD work also addresses the mathematical modelling of a multiphase disease 
such as HFMD. It is essential to detect as soon as possible the emergence of new wave, 
associated to a novel agent. Owing to the large size of the cohort available for this work 
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(ca. 9000 patients), we have been able to develop a differential equation model providing a 
very high fit with the observed data. The model confirmed that three waves were present in 
2011-2012 with differing virulence. It also allows to characterize each wave, detect the 
start of a new one and associate groups of patients with specific patterns of symptoms. 
 
All together, there are some recommendations after this work. The first for 
surveillance: I/V variants are an easy and efficient way to survey and identify circulating 
EV-A71 strains. EV-A71 detection with MAS primers should be systematically performed 
on SO primers products. More attention should be paid to the PCR negative patients. AN89 
primer should be redesigned for better detection EVs. The seconde for disease control: 
Continue apply the guidelines for surveillance and disease control. Focus on high risk 
group (children < 5 yrs, and their carers, households members) at both urban and rural 
areas. Most important periods of time are in: Mar - May and Sep – Nov. Careful attention 
to patient age under 12 months because of severity risk regardless causative strains.  
Modeling should be applied for managing the epidemic of any multiwave infectious 
diseases in real time actions (new treatment strategy/ crisis management). The last for 
research: EV-A71 full gene should be investigated for correlation to the virulence/ 
pathogen and susceptible population. The cause for outbreaks should be sought for other 
aspects as socio-economic, climatology, environment  patterns rather than in etiological 
emergence. 
As a final word, this PhD work as underlined some key issues to be addressed in a 
coordinated way in order help developing an efficient surveillance and monitoring system 
for HFMD in Vietnam. Developing these systems and tools will thus be both a challenge 
and an exciting outcome of this work. 
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Résumé 
 
Ce travail a analysé tous les cas de HFMD déclarés à Hai Phong pendant 
l’épidémie de 2011 et 2012 qui a été la plus importante au Vietnam et la première 
enregistrée dans le nord du pays. Hai Phong a connu la plus forte incidence au Nord 
Vietnam. C’était donc un bon modèle pour étudier la dynamique de cette maladie sans 
interférence et reliquats de précédentes épidémies ou de patients immunoadaptés. 
La première section est consacrée à une revue de la littérature sur EV-A71 et les 
entérovirus. La seconde section est divisée en trois chapitres, chacun abordant un aspect 
spécifique du projet. 
Le premier chapitre aborde la dynamique de la maladie et le rôle des directives 
officielles pour la gestion de l’épidémie de 2011-2012. Outre les éléments de base, cette 
étude apporte des résultats sur l’influence des directives HFMD durant l’épidémie, ce qui 
n’avait pas encore été fait. La publication des directives a conduit à un accroissement du 
score de sévérité et d’une réduction du délai entre le premier pic de fièvre et l’admission. 
Cet effet est associé à un accroissement de la sensibilisation qui a conduit à déclarer la 
plupart des patients avec des symptômes sévères pour assurer de meilleurs traitements et 
suivis. The travail décrit dans ce chapitre a aussi démontré que trois vagues avec des 
caractéristiques différentes et causées par trois virus différents s’étaient succédées. La 
vague 1 et la vague 3 ont été causées respectivement par EV-A71 et par une combinaison 
de CV-A6 et CV-A16 alors que la vague 2 a été causée par un virus inconnu. Ce travail est 
aussi une analyse intégrative incluant une analyse spatiotemporelle. La maladie semble 
s’être étendue vers l’est en suivant les rivières pour atteindre les des zones plus peuplées à 
partir desquelles elle s’est répandue par les routes secondaires locales. Etant donné l’âge 
moyen des patients, environ 2 ans, la source de contamination doit être cherchée chez les 
adultes asymptomatiques contaminés lors de leurs activités professionnelles et des 
mobilités locales. 
Le deuxième chapitre aborde la phylogénie et la distribution spatiotemporelle de 
EV-A71 dans le nord du Vietnam et apporte un éclairage sur l’évolution et la dynamique 
de cet entérovirus. La protéine de capside VP1 a été ciblée. La première conclusion de ce 
chapitre est que l’épidémie de 2011 et 2012 n’a pas été causée par une souche exogène 
mais par des souches d’EV-A71 déjà présentes au Nord Vietnam. Ceci indique qu’elles 
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peuvent se maintenir à faible niveau, asymptomatique, en stase génomique et avec une 
structuration géographique. La cause de l’épidémie devrait donc être recherchée dans le 
tissu socio-économique plutôt que dans une émergence extérieure. Une autre conclusion de 
ce chapitre est la corrélation observée ente les groupes de variants I/V et phylogénie, 
pathogénicité et groupe ethnique. Les profils des mutations I/V aux positions 249, 262 et 
284 sur la protéine VP1 pourraient jouer un rôle dans la pathogénicité, ce qui est appuyé 
par la corrélation entre variants I/V et sévérité/ethnicité. 
Le dernier chapitre aborde la modélisation mathématique d’une maladie 
multiphases telle que HFMD. Il est essentiel de détecter aussi tôt que possible une nouvelle 
vague associée à un nouvel agent. Grace à la grande taille de la cohorte disponible pour ce 
travail (environ 9000 patients), nous avons pu développer un système d’équations 
différentielles apportant une forte correspondance avec les données observées. Le modèle a 
confirmé l’existence de trois vagues en 2011-2012, ayant des niveaux de virulence 
différents. Il permet aussi de caractériser chaque vague, de détecter l’apparition d’une 
nouvelle vague et d’associer des groupes patients à un tableau clinique.  
En conclusion, ce travail de thèse a permis de souligner plusieurs éléments clés à 
aborder de façon coordonnée afin de faciliter une surveillance efficace de l’HFMD au 
Vietnam. 
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Summary 
 
This work analyzed all HFMD cases reported in Hai Phong in 2011 and 2012 
outbreak which was the largest to have ever occurred in Vietnam and the first recorded in 
the northern part of the country. Hai Phong city experienced the highest HFMD incidence 
in North Vietnam. It was thus a good model for investigating the dynamic of the disease 
without interference and potential remains from previous outbreaks or patient 
immunological adaptation. 
The first section is dedicated to a review of the literature on EV-A71 and 
enteroviruses. The second section is divided in three chapters, each one addressing a 
specific issue of the project.  
The first chapter addresses the dynamic of the disease and the role of official 
guidelines in the handling of the 2011-2012 epidemic. Beside basic epidemiological 
features, the study also provides findings relating to the influence of HFMD guidelines 
during the outbreak period that has never been described before. The guideline release led 
to a significant increase of the severity score and reduced delay between onset and 
admission. This effect is linked to an increased awareness leading to patients being mostly 
declared with severe symptoms in order to ensure a better treatment and surveillance. The 
work presented in this chapter also demonstrated that three waves occurred with different 
characteristics and caused by three different viruses. Wave 1 and wave 3 were caused by 
EV-A71 and a combination of CV-A6 and CV-A16, respectively while Wave 2 was caused 
by an unknown virus. This work is also an integrative analysis including a spatiotemporal 
analysis. The disease seems to have expanded following the eastbound river system to 
reach densely populated settlements from where it secondarily expanded through local 
roads. Owing to the average age of the patients, around 2, the source of contamination 
must be sought for within asymptomatic adults being contaminated during their 
occupational activities and in local movements. 
The second chapter addresses the phylogeny and spatiotemporal distribution of EV-
A71 in North Vietnam and provides an insight on the evolution and dynamic of the EV-
A71 enterovirus. The VP1 capsid protein was used as target. The first conclusion of this 
chapter is that the 2011-2012 outbreak was not caused by an incoming strain but by EV-
A71 strains which were already present in North Vietnam. This indicates that they can 
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remain in a low level, asymptomatic state, in genomic stasis and with a geographic 
structuration. The cause for outbreaks should thus be sought for in the socio-economic 
patterns rather than in exogenous emergence. Another outcome of this chapter is the 
observed correlation between I/V variant groups and phylogeny, pathogenicity and 
ethnicity. The I/V pattern at positions 249, 262 and 284 on the VP1 protein might play a 
role in pathogenicity. The observed correlation of the I/V variant populations with severity 
and ethnicity strengthen this hypothesis. 
The last chapter addresses the mathematical modelling of a multiphase disease such 
as HFMD. It is essential to detect as soon as possible the emergence of new wave, 
associated to a novel agent. Owing to the large size of the cohort available for this work 
(ca. 9000 patients), we have been able to develop a differential equation model providing a 
very high fit with the observed data. The model confirmed that three waves were present in 
2011-2012 with differing virulence. It also allows to characterize each wave, detect the 
start of a new one and associate groups of patients with specific patterns of symptoms. 
As a conclusion, this PhD work as underlined some key issues to be addressed in a 
coordinated way in order help developing an efficient surveillance and monitoring system 
for HFMD in Vietnam. 
'
 
